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ABSTRACT
OXYBENZONE AND THE MAMMARY GLAND:
IMPACT OF AN ENVIRONMENTAL POLLUTANT ON
HEALTH, DISEASE & ETHICAL DECISION-MAKING

FEBRUARY 2022
KLARA MATOUSKOVA, M.D. CHARLES UNIVERSITY
M.P.H. UNIVERSITY OF WOLVERHAMPTON
Ph.D. UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Laura N. Vandenberg

The environmental pollutant and common sunscreen compound oxybenzone is a
benzophenone type UV light chemical filter used in industrial and consumer goods.
This chemical widely contaminates human tissues, non-human species, and
environmental matrices. In this dissertation, oxybenzone is investigated for its effects
on the mouse mammary gland in the offspring following perinatal exposure; after
perinatal and prepubertal exposures as a dual environmental insult during two
sensitive times of development; and in adults after exposure during pregnancy &
lactation as an environmental factor potentially increasing the tissue susceptibility to
mammary tumors. Chapter 1 introduces the mammary gland. Chapter 2 reviews UV
screening chemicals with a focus on oxybenzone. Chapter 3 summarizes methods
used in this dissertation. Chapters 4 and 5 present two aspects of our studies
quantifying the impact of perinatal exposure to oxybenzone on the epithelial and
stromal compartments of the mammary gland. Chapter 6 evaluates the effects of
exposures during two sensitive periods of development: the perinatal and
prepubertal periods. Chapters 7 and 8 present a concise summary of breast cancer,
vi

its trends, its genetic and environmental causes, and findings on tumors acquired in
BALB/c mice transplanted with p53-/- epithelium and exposed to oxybenzone during
pregnancy and lactation. Chapter 9 takes an ethics-based approach to modern-day
pollutants, including endocrine disrupting chemicals, in the process of decisionmaking towards sustainable environmental and human health. Finally, chapter 10
summarizes and hints on future directions for oxybenzone research. The results of
this work make a case for oxybenzone’s disruption of the mammary gland’s epithelial
and stromal compartments during several vulnerable periods of development. Our
data also support an argument that animals genetically susceptible to breast cancer
may have heightened sensitivity to environmental chemicals. Lastly, we propose six
principles of environmental health that are imperative in decision-making on
synthetic compounds. The data presented herein contribute to the body of evidence
postulating that oxybenzone is an endocrine disruptor, and that developmental
exposures to everyday synthetic chemicals used for human safety and/or
convenience elicit later-in-life effects on susceptibility to chemical environmental
exposures, on health and disease.
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CHAPTER 1
INTRODUCTION

Human ontogenesis, i.e. the process of individual development by which all of
the organs and tissues are formed from conception through adulthood, is a complex
series of actions with several discrete programming windows that are ultimately
responsible for dictating the individual’s biological destiny. To become a fertile male
and to feel like one, three times – early in gestation, shortly after birth and at puberty
- testosterone levels must be high and shift the developmental fates of cells, tissues,
and organs. The female phenotype, on the other hand, is widely considered the
“default” developmental pathway in mammals; and however oversimplified this view,
in the reproductive system a person acquires a female-like phenotype in the
absence of testosterone signaling, with specific features responsive to estrogens at
specific stages of the developmental clock.
Endocrine organs in both males and females (e.g., the ovaries and testes),
and sexually dimorphic structures (e.g., the penis and clitoris, and the mammary
gland) are indistinguishable between the sexes early in organogenesis. At 6 weeks
in utero however, XY human individuals activate the sex-determining region on the Y
chromosome (SRY), leading to the production of the testes-determining transcription
factor (TDF). TDF is first expressed in the somatic cells that will later develop into
Sertoli cells in the testis. These supportive cells prove indispensable for the male
reproductive tract as they: 1. Establish the development of the germ cells (that have
just moved into the primordial gonads from the mesenchyme of umbilical cord), and
2. produce anti-Műllerian hormone that will cause the paramesonephric ducts - that
would otherwise turn into female genital ducts including the uterus - to dissipate. By
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gestational week 8 in humans, the Leydig cells have inundated the male embryosoon-to-become-a-fetus with the first surge of testosterone. Since female is the
default phenotype in mammals, during embryonic and fetal life, XX individuals do not
require signaling beyond the instructions provided by the genotype to establish the
elementary structure and functional features of the reproductive organs.
The mammary gland, too, represents a sexually dimorphic organ that
undertakes most of its development during the postnatal period. Mammary gland
development in utero begins in both sexes with a mesenchymal-epithelial induction
event: along the mammary ridges [i.e., the two epidermal lines reaching from the
armpits to the inguinal area, dependent on Wnt and FGF signaling (Chu et al., 2004)
(Hens & Wysolmerski, 2005)], the underlying
mesenchyme induces thickenings of the
overlying skin epithelium, creating epithelial
placodes that will eventually form into the
nipples (FIGURE 1.1).

1.1

The male mammary gland:
development & hormonal regulation
In male mice, the first surge of

testosterone occurs around embryonic day
(ED)13. This is the first point where the male
and female mammary gland begins to
develop into dissimilar phenotypes; by ED14
the mammary bud manifests clear dimorphic

Figure 1.1: Milk lines. A) Human
mammary ridge/crest forming
seven possible locations of
placodes & mammary glands,
during 5th and 4th week of prenatal
development. B) Mouse mammary
ridge: the five pairs of mammary
glands; embryonic day 11.5. C)
Epithelial placode as a thickening
of skin ectoderm.

structures (Hogg, Harrison, & Tickle, 1983). In the window of ED13 and ED16, the
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mesenchyme surrounding the invaginated epithelium becomes responsive to
testosterone via the temporary expression of the androgen receptor (Kratochwil &
Schwartz, 1976). Thus, the binding of testosterone to the androgen receptors
expressed in the mammary mesenchyme activates the fibroblasts to condense
around the stemming mammary bud and gradually detach the stem of epithelial cells
from its ectodermal placode. This causes both the stem and the placode to regress.
Of note, a series of experiments in genetically androgen-insensitive mice in
the 1970s showed that the epithelial regression observed in a typical XY male
mouse is achieved due to AR-sensitive mesenchyme cells (Kratochwil, 1971;
Kratochwil & Schwartz, 1976). Later, seminal experiments showed that the
epithelium induces the receptors in the underlying mesenchyme in a process
dependent on parathyroid hormone-related protein (Dunbar & Wysolmerski, 1999;
Durnberger & Kratochwil, 1980). Activated parathormone-related protein receptor
(PTHrP) in the mesenchyme then activates outgrowth of the epithelium (Hens et
Wysolmerski, 2005)
The second testosterone peak, sometimes referred to as minipuberty, takes
place in human males between two and four months after birth. Thereafter,
concentrations of the hormone decrease to a minimal level until the real puberty
around the age of 12 for boys and weeks 3.5-5 in mice (Brix et al., 2019; Falconer,
1984; T. Ma et al., 2021). Even after this second testosterone surge, a male
mammary gland below an absentee – in mice, or present – in humans, nipple form
rudimentary mammary ducts surrounded by stromal connective tissue, all residing in
the mammary fat pad (FIGURE 1.2A). Of course, these epithelial structures are
much smaller and less elaborated compared to females, and the absence of a nipple
in mice makes them non-functional.
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The perinatal male mammary gland does not grow beyond two or three
primary and a few secondary branches; in CD1 mice, the area comprised of
mammary ducts reaches 0.19 mm2 at ED18 and 0.5mm2 at PND5 (Vandenberg,
Schaeberle, Rubin, Sonnenschein, & Soto, 2013). Around puberty, the size of the
mammary epithelium increases about ten times, but in CD-1 males it regresses to
about a half of its pubertal area at 7 to 9 months of age (Pokharel, Kolla,
Matouskova, & Vandenberg, 2018). BALB/c males will increase the ductal area from
about 0.2-0.25 mm2 at PND21 (the right mammary gland being consistently larger) to
0.35 mm2 at puberty, and 0.5mm2 at 9-11 weeks postnatally (K. Matouskova, Jerry,
& Vandenberg, 2019). In terms of complexity, prepubertal male CD1 mammary
glands display about ten branches, and BALB/c males typically have about seven.
As discussed more in Section 1.2, mice lacking one or more hormone
receptor have been instrumental in determining the role of endocrine signaling in the
development, growth, and function of the mammary gland and other organs. For
example, in males lacking estrogen receptor α (the ERαKO mice), reproductive
fitness is poor due to suppressed mating behavior and reduced sperm count, and
later in adulthood the weight of the testis decreases (Couse & Korach, 1999).
However, the consequences of the absence of ER on the male mammary gland
have not been examined. On the other hand, exposure to ER agonists such as
bisphenol A and S, and ethinyl estradiol (S. Kolla, M. Morcos, B. Martin, & L. N.
Vandenberg, 2018; Vandenberg et al., 2013), along with oxybenzone (K.
Matouskova et al., 2019), and agricultural chemicals (Altamirano et al., 2015) alter
the structure and other endocrine-sensitive parameters of the male mammary gland.
While rare compared to other diseases in male populations such as prostate and
testicular cancers, both gynecomastia and breast cancer affect male populations
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with increasing prevalence (Koch, Brauner, Busch, Hickey, & Juul, 2020). An
aggravating widespread pollution with endocrine disrupting chemicals and sensitivity
of the mammary gland to those compounds makes research into the male mammary
gland and regulatory consideration for the organ a pressing matter (Szabo &
Vandenberg, 2021).

1.2

The female mammary gland: development & regulatory signaling
In contrast to the male, the female mouse mammary gland sustains profound

re-organizational changes during several periods through the life course. The
earliest hint of the mammary gland amounts to no more than a thickening of the
epidermis: the placode, which arises at ED11-E12. At ED12.5, a more pronounced
structure, the mammary bud, is formed by the mammary epithelium arising from
basal keratinocytes which overexpress PTHrP, and the underlying epitheliuminduced mesenchyme (Foley et al., 2001). At ED13.5, the surface epidermis shows a
slight invagination of the mammary epithelial anlage into the underlying ventral
mesenchyme, and at ED15.5, the developing mammary gland is marked by a
distinct invagination on the surface and a cleft on the bottom of the mammary
epithelial sprout indicative of branching (Hogg et al., 1983; Robinson, 2007). By
ED18, the surface epidermis is fully modified into the skin of the nipple and by ED19,
10-15 branches of the ductal tree now advance through a fat pad.
The epithelial cells of the placode and the early mammary bud arise from
migrating keratinocytes and indeed, the average mitotic index each day before ED14
is only 0.218% suggesting that proliferation of these cells is rare; yet from ED16
through the end of gestation it increases to over 1% (Balinsky, 1950). Morphogenetic
processes of epithelial proliferation and differentiation, tissue elongation and
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branching generate a ductal tree of the size of 0.18-0.2 mm2 at ED18 with 2-4
branch points, and a considerably larger gland (2.5-4 mm2 and 15-20 secondary
branches present at birth (Hens & Wysolmerski, 2005). After birth, a typical female
mouse mammary gland grows isometrically to the size of the body until just before
puberty. Because the female phenotype is considered the default in mammals, and
early developmental acquisition of female characteristics are not dependent on the
production of ovarian hormones (e.g., estrogens or progesterone) the pre-pubertal
mammary gland will have a normal appearance even in females where the
fundamental hormonal influence, the ER, is knocked out (Bocchinfuso & Korach,
1997). Embryonic mammary glands devoid of receptors for growth hormone or
prolactin – such as IGF-1R and EGFR or PrlR – do not have a distinct phenotype
either, a circumstance that further stresses the hormone-independence of embryonic
development of the organ (Hovey, Trott, & Vonderhaar, 2002).
Female puberty marks the beginning of extensive changes in the mammary
gland, and it is characterized by formation of terminal end buds (TEBs).
Microscopically, TEBs consist of a mass of loosely connected, E-cadherin
expressing body cells and an exterior line of highly regenerative, P-cadherin-positive
cap cells covered with a permeated basal lamina (Paine & Lewis, 2017). Contrary to
their name, terminal end buds open the tips of the ducts to an active growth; behind
the TEBs, the mammary epithelial network elongates and branches into a complex,
fractal geometry (FIGURE 1.2A).
Tissue changes at puberty arise from gonadotropin releasing hormone (GnRH)
released by the hypothalamus, further inducing the release of follicle stimulating
hormone (FSH) and luteinizing hormone (LH) from the hypophysis. FSH stimulates
granulosa cells of the primary (and advanced/older) ovarian follicle to convert
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androgens (from the cells of theca externa et interna) to estrogens; LH supports the
theca cell and triggers ovulation – i.e., releasing the egg and forming the
progesterone-producing structure, the corpus luteum. In the mammary gland,
estrogens bind their respective receptors (see further discussion below) and elicit
ductal growth. During puberty, ERα expressed in the mammary epithelium is the
primary and essential target of estrogens, whereas the stromal ERα (Mallepell,
Krust, Chambon, & Brisken, 2006a) acts in a paracrine manner impacting the
neighboring cells (J. Russo, Ao, Grill, & Russo, 1999). Progesterone signaling at
puberty supports side-branching of the mammary epithelium by working synergically
with IGF-1 whose transcription is activated via growth hormone; IGF-1 activates IGF1R in epithelial cells (W. Ruan & Kleinberg, 1999).
By the end of puberty (approximately 6 weeks in mice), the TEBs have
regressed, and the mammary ductal epithelium spans nearly the entire fat pad.
Estrous cycles (in mice) or menstrual cycles (in women) bring about only minor
adjustments in the epithelial network: with each cycle there is modest epithelial cell
proliferation and occasional tertiary branching, as well as incomplete differentiation
of alveolar buds. Each cycle is followed by macrophage influx to remove the
cyclically regressed alveolar cells (Richert, Schwertfeger, Ryder, & Anderson, 2000).
Over adulthood and especially during pregnancy and lactation, progesterone
along with prolactin plays a lead role in outfitting the ducts with alveolar buds (in
mice) or tubulo-alveolar units (in women) namely via paracrine signaling (Slepicka,
Somasundara, & Dos Santos, 2021). When oxytocin launches the processes of
parturition though uterine contractions, the same pituitary hormone also induces
contractibility in mammary myoepithelial cells. Interestingly, dams with mutated
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oxytocin were able to deliver normally but could not commence nursing (Young et
al., 1996).

Figure 1.2: Mammary Gland Development. A) epithelial ductal mammary tree during
lifetime in the female and male. Embryonic stage reproduced from (Hens &
Wysolmerski, 2005). B) Pregnancy – Lactation – Involution cycle in the mammary
epithelium
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At the end of the lactational period, upon weaning, the mammary gland enters
two phases of involution: 1) A reversible, 1 to 2-day phase in mice, that reduces milk
production. In this phase, epithelial cells in alveolar structures begin to undergo
apoptosis coinciding with infiltration of lymphocytes and macrophages. 2) An
irreversible phase that protects the ducts from milk accumulation with massive
elimination of epithelial cells and remodeling of the mammary gland that includes
repopulation with adipocytes (O'Brien, Martinson, Durand-Rougely, & Schedin,
2012). Signaling pathways during the irreversible stage of involution resemble those
guiding wound healing processes, namely signals inducing the activation of matrix
metalloproteases tasked with degradation of extracellular components and
cyclooxygenases activating immune responses in the remodeling period (Slepicka et
al., 2021). Interestingly, many of the pathways and genes expressed during
involution also contribute to breast cancer development and metastatic processes
(Jena, Jaswal, Kumar, & Mohanty, 2019; O'Brien et al., 2012; Wallace, Tarullo,
Crump, & Lyons, 2019).

1.3

Hormonal Signaling in the Mammary Gland and beyond
The hypothalamic- pituitary–gonadal axis reaches maturity at puberty and

around PND31, the height of puberty in mice, an allometric growth of the mammary
epithelial network begins simultaneous with increasing circulations of gonadotropins.
Yet proliferation of epithelial cells in the mammary gland requires multiple hormones,
growth factors, and their receptors.
Estrogens are ancient hormones that bind evolutionarily highly conserved
estrogen receptors; estrogens are required for ductal outgrowth (Korach et al., 1996;
Thornton, Need, & Crews, 2003). FSH released from the hypophysis activates
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production of estrogens in the ovarian granulosa cells of forming follicles. Other sites
of estrogen synthesis include post-ovulation corpora luthea and adipose tissue
where estrogens can be synthesized using aromatase, namely in postmenopausal
women (Simpson, Ackerman, Smith, & Mendelson, 1981). In estrogen-responsive
organs, two classes of nuclear estrogen receptor (ER) are now recognized: ERα and
ERβ, and remarkably, the two were discovered more than thirty years apart (Jensen,
1962; Kuiper, Enmark, Pelto-Huikko, Nilsson, & Gustafsson, 1996) although their
roles are quite contrasting – and possibly also complementary. During active
development of the mammary ductal tree, expression of ERα is high, consistent with
the temporal epithelial cell proliferation. while ER β low; on the other hand, the
reverse is observed in periods of organ “maintenance” – ERα expression wanes
while ERβ increases (Dall et al., 2018). ER β is expressed in adult tissues including
the ovaries, vagina, and uterine endometrium, testes and prostate (Taylor & AlAzzawi, 2000). In the mammary gland ER β has been detected in animals older
than 6 weeks in rats and FVB mice (Dall et al., 2018; Saji et al., 2000), and in both
active and resting human breast (Taylor & Al-Azzawi, 2000). Despite challenges in
producing the ERβ KO mouse model (Warner et al., 2020) and most studies relying
on cell cultures, the evidence up to date is leaning towards ER β downstream
pathways inhibiting cell proliferation and promoting cell differentiation (or apoptosis)
in breast cancer tissues (Leygue & Murphy, 2013), and even in genetically
disadvantaged p53 null cells (Thomas, Strom, Lindberg, & Gustafsson, 2011). ERβ
KO mice develop a normal mammary gland and can lactate normally (Brown,
Manzolillo, Zhang, Wang, & Lamartiniere, 1998). The presence of ERβ might be one
of the answers to the long-term protective effect of parity as the ratio of ERα and
ERβ cells shifts toward the latter in older parous dams (Dall et al., 2018).
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ERα is encoded in the mouse by the gene Esr1 and is well-appreciated for its
indispensable, estrogen-driven mediation of proliferation during both normal and
pathological conditions in the mammary gland (Couse & Korach, 1999; Hall &
Korach, 2002). In their seminal paper, Mallepell and colleagues investigated ductal
morphogenesis in ERα-/- mice, specifically the role of epithelial vs stroma ERα. They
concluded that mammary epithelium is “the prime compartment of ERα signaling
both before and during pregnancy” while stromal ERα plays a supportive role
(Mallepell et al., 2006a; Mueller, Clark, Myers, & Korach, 2002).

Figure 1.3 : Endocrine Components of Reproductive Organs & Tissues

Classic nuclear ERs regulate expression of target genes via binding the
estrogen response element (ERE) on the DNA. Yet, two other ER pathways with
different mechanisms of action have been discovered. G protein-coupled estrogen
receptors 1 (GPER1), which are structurally unrelated to the nuclear receptors, are
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located on the cell membrane. GPER1 is responsible for rapid non-genomic effects
of estrogen via a host of second messengers and kinases regulating gene
expression through phosphorylated transcription factors (Madak-Erdogan et al.,
2008). Signaling via GPER1 is responsible for phenotypic effects including sexually
dimorphic differences in a variety of organs including those of the cardiovascular
system and gastro-intestinal tract (Doolan & Harvey, 2003; Puglisi et al., 2019). In
addition, ER may bind DNA indirectly through various co-factors involving genomic
but “non-classical” signaling (Safe & Kim, 2008). Collectively, estrogen actions are
no longer seen as simplified measures, equal to uterotrophic ERα-induced
responses; rather, estrogens elicit variable effects via actions through more than one
estrogen receptor. This is not only true for endogenous estrogens like estradiol:
recent research points to xenoestrogens acting via non-genomic receptors often with
remarkable intensity. For example, bisphenol A is considered a weak ER agonist
judging by its action on nuclear ERs, yet nanomolar concentrations of BPA are
capable of increasing calcium oscillation in the pancreas to levels comparable to
estradiol (Hall & Korach, 2002; Nadal et al., 2000).
Downstream of estrogen signaling in the mammary gland, amphiregulin binds
epidermal growth factor receptor (EGFR) and in a paracrine manner triggers several
other local growth factors (Ciarloni, Mallepell, & Brisken, 2007). In both health and
disease, amphiregulin is a key transcriptional target of ERα (McBryan, Howlin,
Kenny, Shioda, & Martin, 2007) and in initiated ERα-sensitive breast tumors, the
absence of amphiregulin significantly extends time-to-tumor in Tp53-/- mice (Meier,
Girtman, Lofgren, & Kenny, 2020).
In the mammary gland, estrogens act in concert with progesterone, another
potent gonadotropin that often stays in the shadow of estrogens in the clinical
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setting. Yet it is the synchronous action of the two hormones that supports good
health of the female reproductive system, as well as the cardiovascular system,
brain, and bones throughout the reproductive years (Prior, 2020). Two main
progesterone receptor (PR) isoforms were identified: PR isoform A and isoform B,
both encoded on a single gene in both humans and rodents (Kariagina, Aupperlee, &
Haslam, 2008). A third isoform has also been recognized, PRC, yet not extensively
studied – research from different cell-culture and tissue models provide hints of
contradictory effects it may have both inhibiting activation effects on PRA and PRB
(Condon, Hardy, Kovaric, & Mendelson, 2006; Wei et al., 1996). Research on the
two main isoforms also suggests different distribution and regulation in different
organs and tissue cultures (Vienonen, Syvala, Miettinen, Tuohimaa, & Ylikomi,
2002). For example, in MCF-7 cells, 17β estradiol preferentially upregulates PRA
while in ZR751 breast cancer cells PRB is preferred.
In the mammary gland, PR is present in both mammary compartments; in the
stroma where progesterone signaling promotes ductal outgrowth and in the
epithelium in which PRs are required for formation of alveolar buds during pregnancy
(Humphreys, Lydon, O'Malley, & Rosen, 1997). Although progesterone plays a mere
supporting role during puberty, it gets promoted to a co-lead over adulthood (with a
role in the regulation of the estrous cycle) and during pregnancy. Its absence at
puberty delays mammary ductal outgrowth, and both side branching and formation
of alveolar buds are absent in PR-/- female mice (Brisken & Ataca, 2015).
Ovariectomized adult mice administered progesterone alone increased proliferation
in luminal and myoepithelial cells although not as significantly as estradiol-treated
alone, while in a combined treatment, progesterone enhanced the mitogenic effect of
estrogens (Aupperlee & Haslam, 2007). A combined estrogen+progesterone
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treatment enhanced also side branching via PRA in adult females and
alveologenesis via PRB over pregnancy.
Downstream PR signaling induces a release of Elf5, the “master regulator of
alveologenesis” and signature transcription factor in luminal cells (Oakes et al.,
2008), as well as RANKL and Wnt4. All three are common targets between
progesterone and prolactin (see below). Overlapping with estrogen signaling
pathways is amphiregulin. This transmembrane glycoprotein has been found to be
critical for mammary ductal development via autocrine and paracrine manner in both
normal growth at puberty and disorderly outgrowth in breast cancer (Aupperlee,
Leipprandt, Bennett, Schwartz, & Haslam, 2013; McBryan, Howlin, Napoletano, &
Martin, 2008).
Prolactin is another mammary mitogen required for alveologenesis and milk
secretion (Das & Vonderhaar, 1997) (Brisken et al., 1999). However, in females in
adulthood, prolactin is also indispensable for nearly every aspect of reproduction
including mating and maternal behavior, ovulation, fertilization, and uterine
receptivity (Kelly et al., 2002). In males, prolactin is partially replaceable in
reproduction; only half of the homozygous Prl-/- males were completely or nearly
infertile, leaving half with functional reproduction (Ormandy et al., 1997). The
expression of PrlR in macrophages and lymphocytes in human peripheral blood
samples, as well as secretion of several cytokines that can be blocked by anti-PRL
antibodies, suggest it has an immunomodulating role (Chavez-Rueda et al., 2005)
Prolactin is a peptide hormone synthesized and secreted from the anterior
hypophysis and its regulation is predominantly inhibitory – dopamine released by the
hypothalamus is its key inhibitor. On the other hand, a number of physiological and
pathological factors increase circulating prolactin levels including pregnancy and
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nursing, exercise and stress, estrogens and licorice, pituitary tumors and severe
renal and liver diseases (Javorsky, 2018). Thyroid hormones, too, exert positive
control over prolactin; T3 and T4 regulate binding of prolactin in the mammary gland,
and hypothyroidism induces repairable stunted growth of the gland (Vonderhaar &
Greco, 1979).
Molecular pathways specific for prolactin signaling include phosphorylation of
the prolactin receptor that induces the JAK2 – STAT5 signalizing pathway; dimerized
and phosphorylated Stat5 translocates to the nucleus and consequently induces
expression of milk proteins (Brisken & Ataca, 2015; Hennighausen, Robinson,
Wagner, & Liu, 1997)
The anabolic growth hormone (GH) induces expansion of the mammary
ductal tree as well. GH expression is high during puberty and its inhibition stunts
growth of the mammary gland, particularly side branching and lobuloalveolar
development (Sejrsen, Purup, Vestergaard, Weber, & Knight, 1999). Although their
receptors are located in different tissues, GH, prolactin and epidermal growth factor,
activate the STAT5 pathway in the mammary gland; prolactin activates the pathway
in epithelial cells while GH appears to induce growth via its stromal-bound receptors
(Gallego et al., 2001). GH action is mediated directly via the GH receptor and
indirectly via insulin like growth factor 1 (IGF-1) (Hu, Li, & Zhang, 2021). IGF-1 is
most likely responsible for the interplay between GH and estrogens both in normal
development (where estrogens enhance the GH-IGF-1 axis) and in breast cancer
(where IGF-1 may serve as prognostic or diagnostic tool and/or possible treatment).
Based on their effects on MCF7 cells, a breast cancer cell line, antibodies against
IGF-1 receptor may reduce tumor cell proliferation (Laban, Bustin, & Jenkins, 2003).
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Figure 1.4: Components of Endocrine, Paracrine, and Autocrine Signaling
in the Mammary Gland

Lastly, apart from endocrine signaling, paracrine and autocrine signaling
growth factors and receptors are involved in the regulation of mammary gland
morphogenesis. A clear understanding for the role of paracrine signaling came with
the discovery of ER- and PR-positive epithelial cells that were distinct in location
from proliferating cells in the mammary ducts (Clarke, Howell, Potten, & Anderson,
1997). Soon after this discovery, the Brisken lab uncovered that both PR (Brisken et
al., 1998) and ERα (Mallepell et al., 2006a) act in a paracrine manner. Along with
amphiregulin, a molecule regulated via ER, EGF and PR (discussed above), the
most common mediators of paracrine communications in the mammary gland
include Wnt4, and Elf5 – RANKL; these pathways are associated with PR signaling
(Beleut et al., 2010; Brisken et al., 2000) and prolactin-regulated IGF-2 signaling
during lactation (Brisken et al., 2002).
Paracrine signaling may take place either within a tissue compartment, i.e.
among epithelial cells, or between tissue compartments. In the mammary gland, this
would be between the epithelial and stromal compartments. From the earliest stage
of placode formation, the mammary tissue compartments induce each other via a
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host of local molecules. For example “inhibins and activins” of the transforming
growth factor β (TGF β) are required for effective differentiation of epithelial cells,
particularly the inhibin βB subunit is involved in stromal induction of epithelium
(Robinson & Hennighausen, 1997). Bone morphogenetic proteins (BMPs) are also
members of the TGFβ family of signaling complexes and in the mammary gland, the
PTHrP – which sensitizes BMP4 in the embryonic mesenchyme - stimulates fetal
outgrowth of the epithelial ducts (and inhibits hair follicles in the surrounding
epidermis) (Hens et al., 2007). In a recent study, BMP1 was demonstrated to
facilitate communication between myoepithelial and luminal cells, and regulating
timely formation of alveolar buds during late pregnancy (Shao et al., 2021). In early
development, PTHrP induces androgen-responsive peri-epithelial mesenchyme in
the male embryonic mammary bud (Hens & Wysolmerski, 2005) however it seems
dispensable during puberty and even lactation – contrary to previous hypotheses
(Boras-Granic, VanHouten, Hiremath, & Wysolmerski, 2011). Also critical is the role
of matrix metalloproteinases in remodeling both the normal and diseased mammary
gland (Benaud, Dickson, & Thompson, 1998). Finally, Wnt pathways are perhaps the
most challenging and the most complex set of signaling molecules that play a role in
practically every stage of pre- and postnatal mammary gland development (Q. C. Yu,
Verheyen, & Zeng, 2016). Both canonical and non-canonical Wnt pathway are
triggered in formation of the milk ridge, mammary bud, and ductal lumen of TEBs
(Paine & Lewis, 2017), and in the stromal and luminal cells in adulthood and
throughout pregnancy (Q. C. Yu et al., 2016).
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1.4 Disruption to the Mammary Gland Signaling
As depicted in the sections above, mammary morphogenesis and functioning
involves a spatially- and temporally-sensitive set of events and interactions.
Disruption to either endocrine or paracrine signaling have been investigated in all
stages of mammary gland development. While prepubertal development of the
mammary gland is not dependent on estrogen signaling, it is indeed sensitive to
xenoestrogens.
Evidence from both human and animal studies demonstrates that early
exposures to pharmaceuticals and environmental estrogens are associated with
increased breast cancer risk later in life. Iatrogenic exposures of human embryos
and fetuses to diethylstilbestrol (DES), a pharmaceutical estrogen, exacted an
enormous physical and emotional toll on millions of women and men worldwide
(Reed & Fenton, 2013). DES is a potent ER agonist that activates both nuclear and
G protein-coupled ERs, but its estrogenic disruptions go beyond binding ERs. Like
bisphenol A (BPA) - a synthetic estrogen related to DES in structure but not in
application (e.g., BPA is used predominately in plastics and related materials
requiring durability) – DES is considered an endocrine disruptor, meeting nine out of
ten key characteristics as suggested in a recent consensus statement (La Merrill et
al., 2020). Endocrine disruptors – including DES, BPA, as well as the pesticide DDT
and its metabolite DDE, and industrial chemicals such as polychlorinated biphenyls
(PCBs) - are defined as chemicals that act as agonists or antagonists of hormone
receptors, as well as compounds that alter secretion, synthesis, or transport of
hormones, or alter cell behaviors (e.g., proliferation, apoptosis) in hormone sensitivecells, as well as compounds that induce epigenetic alterations in endocrine organs
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(Calaf, Ponce-Cusi, Aguayo, Munoz, & Bleak, 2020). Alterations in paracrine
signaling has also been suggested as a mechanism of endocrine disruption
(Ustundag & Emekli-Alturfan, 2020).
Normal development of the breast is key to mammalian reproduction because
this organ is responsible for nursing and nourishing of the young. Beyond
breastfeeding, women carry this hormone sensitive tissue around for many years
before and many years after pregnancy. Breast cancer incidence has been
increasing in human populations both before and long after pregnancy (DeSantis et
al., 2019; Lima, Kehm, Swett, Gonsalves, & Terry, 2020). Perturbations to the
mammary gland induced by environmental chemicals during sensitive periods of
breast development – during gestation, perinatal and pubertal development,
pregnancy and lactation – have been associated with permanent adverse alterations
to the mammary gland (Macon & Fenton, 2013; Schwarzman et al., 2015; Soto,
Brisken, Schaeberle, & Sonnenschein, 2013). In this dissertation, I have evaluated
the effects of oxybenzone, an environmental benzophenone-type chemical
sunscreen with endocrine disrupting properties, on the mammary gland.
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CHAPTER 2

UV SCREENING CHEMICALS

Large portions of this chapter are published as:
Matouskova, K. and Vandenberg, L.N. (2021). Chapter 48: UV screening chemicals.
In: Gupta, R. (Ed.) Reproductive and Developmental Toxicology, Third Edition.
Elsevier Academic Press.

2.1 Abstract
UV absorbing chemicals are used in numerous consumer products including overthe-counter sunscreens and other personal care products. Furthermore, UV
stabilizing chemicals are now widely used in consumer goods including plastics,
fabrics, paints, and building materials to protect the products from UV damage. The
widespread use of UV absorbing and UV stabilizing chemicals in consumer goods
has led to contamination of environmental matrices (including water, sewage,
sediment, and dust), wildlife populations, and human bodies. In this chapter, we
review the evidence for this widespread contamination, as well as what is known
about the effects of some of these chemicals including the UV absorbing chemical
oxybenzone (and its metabolites), and benzotriazole derivatives, a class of UV
stabilizing chemicals.
KEYWORDS

benzophenone, skin cancer, endocrine disruptor, liver toxicity, ecosystem,
carcinogenesis, coral, pollution
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2.2 Introduction
Humans have long protected their skin from prolonged sun-exposure as we
understand from ancient Egyptian texts instructing the application of rice bran to
absorb the sunlight, and the Native American
custom of shielding the skin with powder from
aspen trunks (Aldahan, Shah, Mlacker, &
Nouri, 2015; Rabinowitz & Tripp, 2015). Still,
traditional robes worn by members of desert
tribes like the Bedouins and Tuareg Berbers

“Under the name “sailor’s skin,” I have
described an affection of those parts of
the skin exposed to the weather, which
I have chiefly observed in those
spending their lives at sea. [….] To this
first stage of erythema, pigmentation
and hyperkeratosis, which may last for
years, there succeeds a further one, in
which large, warty-like growths,
hypertrophies of the sebaceous glands,
and papillary and ulcerating
carcinomata appear.”
Unna, 1896 p.719

are suggestive of the ancient and judicious
use of fabrics to protect human hairless skin (Urbach, 2001). Our ancestors
apparently recognized that their skin could become painfully burned when exposed
to uncontrolled sunlight. Yet, modern medical science first described the phenomena
of the skin deteriorating due to continued exposure “to the weather” at the end of 19 th
century with the term “sailor’s skin” (Unna, 1896). Within a few years of this
description, a number of experimental studies described the first health effects
caused by ultraviolet (UV) light (Widmark, 1889). Elegant experiments demonstrated
that the burns induced by UV rays, were distinct from burns induced by exposure to
“heat”, e.g., infrared spectrum irradiation (Hammer, 1892; Hockberger, 2002).
Experimental discoveries from rodent models soon indicated that extended exposure
to UV rays produced both benign and malignant skin lesions. In addition, it was
shown that applying a carcinogen – in the early days, tar - directly to the skin caused
effects beyond those observed in animals exposed solely to UV irradiation (Findlay,
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1928). In the clinical field, cancerous diseases of the human skin, too, began to be
described as UV-induced skin conditions (Paul, 1918).
In modern times, sun protection emerged as a cultural phenomenon; a pale
complexion has been long valued as a societal symbol in the phenotypically fair-skin
nations in the Euro-Atlantic region (Etcoff, 2000). Historically, members of nonworking classes could seek shade, stay indoors, and protect their skin with clothing
and accessories when engaged in outdoor activities. This trend was reversed in the
1930s when pop-culture icons like Coco Chanel and skilled marketers like Eugene
Schueller, the founder of L’Oréal, promoted a tanned skin as fashionable and a sign
of good health (Cole, 2018). In the US, the eventual establishment of the 40-hour
workweek and 2-day weekend boosted popularity of beach-time in the summer and
skiing in the winter. Vacationing in those destinations built a niche for convenient and
esthetically pleasing skin protection against ad hoc excessive sunlight exposure.
The first formulated chemical sunscreens were based on natural extracts
such as quinine, aesculin, and salicin; these were first sold in Europe around 1911
and in the US starting in 1928 (Lowe, 2006; Urbach, 2001). Early sunscreen
products blocked or absorbed primarily the UVB light spectrum (wavelength of 280315 nm) that is known to cause skin burning. Although, UVB constitutes only 5% of
the sunlight that reaches the Earth’s surface – 90 % of UVB is absorbed by the
ozone layer – the UVB-spectrum waves penetrate into the epidermis, reaching both
epidermal cells and melanocytes in the basal layer, straining the epidermal tissue
with erythema, e.g., reddened patches, comprised of cells containing DNA mutations
(Ikehata et al., 2013). UVA on the other hand, penetrates deeper than UVB, reaching
beyond epidermal keratinocytes to dermal fibroblasts and Langerhans cells, and
further into the dermal matrix of collagen and elastin fibers. Well-established effects
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of UVA rays include suntan due to activation of melatonin – once a desired effect
reflected in the trend of indoor tanning facilities consisting mainly of high levels of
UVA light. But later evidence has built a case for enhanced photoaging and
mutagenicity of UVA light (Marrot, Belaidi, & Meunier, 2005). These findings lead to
the classification of indoor tanning radiation as carcinogenic to humans (El Ghissassi
et al., 2009) – and a sharp decline in indoor tanning worldwide (Rodriguez-Acevedo,
Green, Sinclair, van Deventer, & Gordon, 2020).
The era of synthetized and patented sunscreens began in 1943 with paraaminobenzoic acid (PABA), a UVB absorber whose derivatives have been embodied
in a wide range of products while its use as a sunscreen is less common at present
(Kluczyk et al., 2002). The first over-the-counter sunscreens targeting UVA rays
were approved by the U.S. FDA in the 1970s and with effects primarily advertised as
anti-photoaging, UVA filters too have made for an attractive consumer product. As of
2020, FDA approves sixteen over-the-counter sun screening compounds used
individually or in a mixture of chemical screens (FDA, 2021). Combining chemicals
that individually absorb UVA and UVB rays is common in “broad spectrum”
sunscreens, while only a few individual chemicals can screen against both UVA and
UVB (Moyal & Fourtanier, 2008; Wahie, Lloyd, & Farr, 2007).
Sun screening chemicals in general have been profitable products and
industry data suggest that the outlook remains positive from a market profit
perspective (Osterwalder, Sohn, & Herzog, 2014). The use of UV absorbing
chemicals [TABLE 2.1] has expanded beyond sunscreens to include other personal
care products. Now, UV absorbing and UV stabilizing chemicals are being added to
other consumer products including food contact materials, toys, building materials,
plastic storage containers, paints, and fabrics. The use of these chemicals is
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intended to extend the shelf-life of a material, or to protect the products stored within
these materials. With the current global problem of plastic pollution, it is also clear
that these chemicals are contaminating many environmental matrices as UV
protecting chemicals are released from these products. In this chapter, we focus on
two examples of prototypical sunscreens: oxybenzone, a compound commonly used
in personal care products including dermal sunscreens and in other consumer goods
such as fabrics and inks used in food contact materials, and benzotriazole
derivatives, a class of chemicals added to plastics, paints, building products, and
other consumer goods to protect against product fading and damage from UV rays.

Table 2.1: UV absorbing chemicals commonly used in sunscreens
Substance

CAS
number
131-577

Synonyms

Octinoxate

546677-3

Eusolex
2292
Uvinul
MC80

Enzacamene

3686147-9

EHMC
ethylhexyl
methoxycinnamate
octyl
methoxycinnamate
4-MBC
4-methylbenzylidene
camphor

PBSA

2750381-7

2-phenylbenzimidazole5-sulfonic acid

Ensulizole
Eusolex
232
Neo
Heliopan

Octisalate

118-605

EHS
Ethylhexylsalicylate
Octyl salicylate

Oxybenzone

Trade
Names

benzophenone 3
2-hydroxy-4methoxybenzone

Eusolex
6300
Parsol
5000
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Structure

2.3 Oxybenzone
2.3.1

Sources of exposure to oxybenzone and other chemical sunscreens

Oxybenzone was invented in 1962 and intended as a product that protects
human skin on the occasions of excessive sunlight exposure. Among the 16 UV
sunscreens approved for use on the U.S. market since the FDA’s Monograph on the
subject published in 1999 (FDA, 1999), oxybenzone is in demand for assorted
sunscreen formulations. Yet, its producers have conceived many more applications
and within a short period of several decades oxybenzone has found its way to
countless other personal care products, as well as industrial materials and products
such as coatings, ink wetting agents, paints, as well as paint removers (T. D. EPA,
2015). The uses of oxybenzone in this wide range of consumer products means that
there are two major routes of exposure to humans: dermal and oral. Dermal
exposure to those chemical compounds comes naturally as a consequence of
applying sunscreens directly on the skin (Han, Lim, & Hong, 2016) but a number of
personal care products including hair sprays, shampoos, lotions, lipsticks, and
fragrances represent important and continuous sources of exposure. Oral exposure
to oxybenzone occurs due to unintentional consumption of oxybenzone from drinking
water, and foods and drinks encased in oxybenzone-treated packaging. Perishable
drinks such as fermented liquids or beer must be kept in either dark or UV-protective
containers and UV absorbing chemicals can leach into the contents (Markarian,
2004). The industrial inks used on cardboard food packaging are often enhanced
with oxybenzone to serve as a photo-initiator and wetting agent (T. D. EPA, 2015).
Curiously enough, oxybenzone may be also added to candy as a stabilizing and
flavoring agent (T. D. EPA, 2015).
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All the above exposures also contribute to high volumes of oxybenzone that
are released into the environment. On occasion, additional dermal exposures occur
from swimming in surface waters polluted with sunscreens. Several analytical
studies indicate that both outdoor and indoor swimming pools and spas contain ngmg/L concentrations of various sunscreens (Ekowati et al., 2016; Poiger, Buser,
Balmer, Bergqvist, & Muller, 2004). Of note, interaction of oxybenzone with chlorine
used to disinfect water for recreational activities as well as drinking water may result
in the formation of haloacetic acids, with enhanced toxicity and increased
mutagenicity compared to the parent compound (Liu, Chen, Wei, & Du, 2014;
Manasfi et al., 2019; Teo, Coleman, & Khan, 2015; J. Wang, Gong, & Xian, 2020).
These results are not specific to oxybenzone; high concentrations of
phenylbenzimidazole sulfonic acid (PBSA), a UVB absorber, were documented in
outdoor pools and recreational lakes in South Bohemia – with concentrations as high
as 13 μg/L. The documented concentrations of PBSA were considerably higher than
those of oxybenzone (620 ng/L) (Grabicova et al., 2013). Despite the ability of some
plants – like the umbrella plant, Cyperus alternifolius – to remediate oxybenzone
contamination in water (F. Chen, Schnick, & Schroder, 2018), it pollutes drinking
water because common water treatment facilities are not designed to completely
remove chemicals from personal care products and other consumer goods (C. P. da
Silva, Emidio, & de Marchi, 2015; Stackelberg et al., 2004) (Rodil et al., 2012; Wu et
al., 2018). Even if the water treatment processes were fully successful and all
oxybenzone was relegated to sewage sludge, this and similar chemicals would likely
find their way back to the food chain. As discussed in later sections of this chapter,
organisms in the environment as distant as even earthworms experience negative
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impacts of UV screening chemicals on their reproduction and with increased
mortality (Casquero, Trigo, Guitarte, & Novo, 2020).
Inhalation is a minor yet not insignificant route of human exposure because
oxybenzone and other UV absorbing chemicals have been detected in indoor air and
dust. Although this may seem surprising, house dust components commonly include
environmental chemicals such as UV filters due to the shedding of keratinocytes
treated with personal care products, as well as shedding of fibers from UV-proof
clothing, carpeting, and furniture (Mitro et al., 2016). A study from the US
demonstrated that homes are not the highest source of indoor air exposures to
oxybenzone. Rather, concentrations twice as high as home concentrations were
reported in public places such as coffeeshops and libraries, and more than three
times higher concentrations of oxybenzone (up to 72 ng/m3) were measured in air
collected from the interior cabin of automobiles (Wan, Xue, & Kannan, 2015).

2.3.2

Human exposure levels

Nearly every person in the general population (98.9%) in the US has
detectable urinary concentrations of oxybenzone at any point in time. The mean
concentration in ppb (μg/L) may not seem like a meaningful amount, yet there are
several reasons for concern. First, the population urinary concentration has not
remained constant over the last decade or more. Rather, the last documented mean
concentration from a large biomonitoring study of the US population was 36.3 μg/L –
a 58.6% increase compared to the 22.9μg/L mean concentration reported only six
years prior (Calafat, Wong, Ye, Reidy, & Needham, 2008; Meeker et al., 2013).
Second, exposures during the critical windows of gestation and the perinatal
period have been documented. A biomonitoring study of the US public revealed that
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all tested pregnant women (and 98% of non-pregnant women) have detectable
urinary concentrations of oxybenzone (Woodruff, Zota, & Schwartz, 2011). In a
smaller cohort of postpartum women from North Carolina in the US, 56% of the
participants had levels higher than 0.51 μg/L of oxybenzone in breast milk (Hines et
al., 2015). Further, 80% of breastfeeding participants had detectable levels of the
compound in their urine, and the milk:urine ratio was as high as 1:738. Out of eight
UV filters analyzed (including oxybenzone) in a Swiss cohort, 85% of milk samples
had detectable concentrations of UV filters (Schlumpf et al., 2010). Although some of
the quantitative differences in measured concentrations of oxybenzone in human
milk are due to differences in the precision and accuracy of the methods used
(Molins-Delgado et al., 2018), detection and concentrations of the parental
compound prevail over detection of its main metabolites (Rodriguez-Gomez, ZafraGomez, Dorival-Garcia, Ballesteros, & Navalon, 2015).
In addition to the excretion of chemicals in human breast milk, plastic
containers used to contain this milk also commonly include various UV filters –
namely oxybenzone, 4,4-dihydroxybenzophenone and benzotriazole UV320 – that
leach into the contents (Molins-Delgado et al., 2018). Along with data documenting
oxybenzone in amniotic fluid and cord blood (Krause, Frederiksen, Sundberg,
Jorgensen, Jensen, Norgaard, Jorgensen, Ertberg, Juul, et al., 2018), these data
suggest that human neonates - who have arguably never used sunscreens - are
exposed to an estimated 69.1 μg/ kg body weight of chemical UV filters daily
(Molins-Delgado et al., 2018).
As discussed later in this chapter, a number of chemical sunscreens act as
endocrine disruptors. Based on the principles of endocrinology that are also relevant
to endocrine disrupting chemicals (Vandenberg et al., 2012; R. T. Zoeller et al.,
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2012), low doses of chemicals like oxybenzone may induce significant effects during
critical windows of development. In men, UV filters have been detected in semen,
suggesting the potential for preconception exposures as well (Leon, Chisvert,
Tarazona, & Salvador, 2010).
A third reason that even low levels of human exposure may be concerning is
that oxybenzone exposures are difficult to avoid. On the one hand, urinary
concentrations of oxybenzone correlate to self-reported frequency of using
sunscreens - from an average of 9.3 μg/g creatinine in participants “never” using
sunscreen to an average of 116.8 μg/g in individuals reporting “always” using
sunscreen (Zamoiski, Cahoon, Freedman, & Linet, 2015). Another study
documented the change in urinary concentrations between “never” and “always”
groups as 509.8 percent (Ferguson, Colacino, Lewis, & Meeker, 2017).
Furthermore, oxybenzone is present in human urine samples year-round, even
during wintertime when sunscreen use is generally infrequent (Krause et al., 2012)
although exposures to UV filters vary also seasonally within-individuals (Kunisue et
al., 2012) and also in environmental matrices (C. P. da Silva et al., 2015; Loraine &
Pettigrove, 2006a), with higher exposures measured in the summer months. For this
reason, a spot measurement may not correctly represent individual exposures over
longer periods (Dewalque, Pirard, Vandepaer, & Charlier, 2015).

2.3.3

Measurements in the environment

Occurrence of sunscreen chemicals in the environment have been highest in
recreational waters and untreated wastewater. Approximately 25% of applied
sunscreen is washed off the skin (Danovaro et al., 2008), therefore popular beach
areas are especially prone to high concentrations of sunscreen chemicals both in
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water and sediments. Coastal waters of Greece (Giokas, Sakkas, & Albanis, 2004),
the Canary Islands (Rodriguez, Sanz, & Rodriguez, 2015), the Hawaiian archipelago
(Mitchelmore et al., 2019), and the Virgin Islands (Bargar, Alvarez, & Garrison, 2015)
have measured exponentially increasing concentrations of sunscreen chemicals with
decreasing distance from the coastal line, consistent with a human source.
Fresh surface waters including lakes, lagoons, and rivers typically have a
higher presence of oxybenzone metabolites (namely benzophenone 4 and
benzophenone 1) than oxybenzone itself (Careghini, Mastorgio, Saponaro, &
Sezenna, 2015). Rivers and lakes in Switzerland (Balmer, Buser, Muller, & Poiger,
2005; Fent, Zenker, & Rapp, 2010) contain oxybenzone at concentrations ranging
between the detection limit of 2 μg/L to 652 μg/L; rivers in England, Spain, and South
Korea also have comparable levels (Kasprzyk-Hordern, Dinsdale, & Guwy, 2008;
Rodil et al., 2012; Yoon, Ryu, Oh, Choi, & Snyder, 2010). Overall, it has been
estimated that freshwaters worldwide contain anywhere up to 125 μg/L of
oxybenzone (S. Kim & Choi, 2014).
Wastewater is a substantial source of oxybenzone and its metabolites for
pollution of fresh water. Treated wastewater can account for up to 20% of the water
in rivers near urban areas (Rodil et al., 2012), and removal of oxybenzone and other
similar contaminants via water treatment technology is not absolute. For example,
wastewater treatment plant effluents in Shanghai document divergent removal of
different benzophenone sunscreens: 100% of benzophenone 2 was removed versus
only 24% of benzophenone 4 (and 82% of oxybenzone) (Wu et al., 2018).
Furthermore, sewage sludge and environmental releases from urban industrial
coatings (Plagellat et al., 2006; Z. Zhang et al., 2011), sediments, and landfill
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leachates (Cuderman & Heath, 2007; Giokas et al., 2004) commonly have
detectable concentrations of chemical sunscreens including oxybenzone.
Groundwaters replenish slowly from surface water, and because of natural
filtration processes their levels of pollution are typically lower compared to surface
waters. For this reason, groundwater is often used as drinking water making their
pollution with synthetic chemicals especially alarming (Jurado et al., 2014; Stuart,
Lapworth, Crane, & Hart, 2012). Drinking water, too, is often contaminated with
residues of UV filters: in southern California, octinoxate and benzophenone have
been measured at 260 and 280 ng/L, respectively (Loraine & Pettigrove, 2006a).
Saõ Paulo residents drink water with octinoxate and oxybenzone at concentrations
up to 101 and 115ng/L, respectively (C. P. da Silva et al., 2015). Further, in Spain,
oxybenzone was measured in local tap water at similar concentrations (295 ng/ L)
along with four other common UV filters (with concentrations ranging from 35 - 260
ng/L) (Diaz-Cruz, Gago-Ferrero, Llorca, & Barcelo, 2012).

2.3.4 ADME

Adsorption
Chemical sunscreens applied to the skin do not stay on the surface of the
skin and instead are transferred into the epidermal and dermal layers and ultimately
the underlying blood supply. This movement across the skin barrier has been
demonstrated in in vitro studies (Treffel & Gabard, 1996), experimental rodent
models (Okereke, Abdelrhaman, & Friedman, 1994) and epidemiological
investigations (Janjua et al., 2004; R. Jiang, Roberts, Collins, & Benson, 1999). The
rate of a chemical sunscreen’s penetration into the stratum corneum depends on the
lipophilicity of the vehicle, the study conditions, and the sunscreen formulation – but
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has been estimated at 1-2% (Hayden, Roberts, & Benson, 1997) to 4%(C.
Fernandez, Nielloud, Fortune, Vian, & Marti-Mestres, 2002); for formulations
containing oxybenzone, dermal absorption of 8% has been calculated for products
comprised of 2% oxybenzone and absorption of 9.9% has been observed for
products containing 6% oxybenzone (the maximum concentration approved by the
U.S. FDA) (T. D. EPA, 2015). Interestingly, both hydro- and lipophilic vehicles
promote high penetration of oxybenzone or metoxycinnamate (Gupta, Zatz, & Rerek,
1999). Mixtures of these two UV screening agents resulted in higher
retention/penetration rates throughout the basal membrane into the layer of dermis,
e.g. the connective tissue containing not only collagen and elastic fibres but also
blood vessels – arterioles, venulles, and capillaries.
Distribution
Because these chemicals are drawn into the blood stream, sunscreen plasma
concentrations can be measured effectively and evaluated over time. A safe
threshold of exposure set by the US FDA is 0.5 ng/mL in circulation for all over-thecounter sunscreens approved for the US market: the US FDA “expects that a
systemic carcinogenicity study would not be needed to support a [determination of
generally recognized as safe and effective] for a sunscreen active ingredient if an
adequately conducted human pharmacokinetic [maximal usage trial] resulted in a
steady state blood level less than 0.5 ng/mL” (FDA, 2019b). However, a recent FDA
study examining six sunscreen ingredients revealed that this threshold level was
reached and exceeded 2 hours after application of sunscreen products containing
oxybenzone, and between 3-21 hours for the remaining five tested sunscreen
chemicals. Blood concentrations were maintained above this threshold for 23 hours
in all participants following application of sunscreens containing oxybenzone and
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homosalate; more than 75% of participants had these high blood concentrations
after using products containing avobenzone, octinoxate, octocrylene, and octisalate.
The maximum plasma concentrations exceeded the threshold limit by at least 6
times (3.3 ng/mL for avobenzone in a pump spray) and as much as 500 times (258.1
ng/mL for oxybenzone in a lotion). Moreover, three of the tested sunscreens
remained above the threshold for seven days following the last application in the
majority of the tested individuals (95% for avobenzone, 75% for octisalate, and 90%
for octinoxate), for 10 days in 67% of participants treated with products containing
octocrylene, and a full three weeks for 55% of participants treated with homosalate
and 96% of participants treated with products containing oxybenzone (Matta et al.,
2020). Collectively, these results indicate that sunscreens are easily absorbed
across the skin barrier, and remain in circulation for days, or weeks, after application.
Metabolism
Transformation of oxybenzone via two main metabolic pathways,
demethylation and hydroxylation, produces several metabolites [Figure 1]. By giving
up its methyl group and accepting a hydrogen, oxybenzone (benzophenone 3) is
transformed into benzophenone 1 (2,4, dihydroxybenzophenone) (Vione, Caringella,
De Laurentiis, Pazzi, & Minero, 2013). The main product of hydroxylation is
benzophenone 8 (2,2’ dihydroxy-4-methoxybenzophenone); however, hydroxylation
on either of the rings also yields 3-hydroxy-benzophenone-3 or 5-hydroxybenzophenone-3 (Cheng, 2014; Kamikyouden et al., 2013). Activation of the
hydroxylation pathway further produces two oxybenzone metabolites that have been
documented in breast cancer cells and isolated rat hepatocytes: 2,3,4trihydroxybenzophenone (2,3,4 THB) and 2,4,5 -trihydroxybenzophenone (2,4,5
THB) (Kerdivel et al., 2013; Nakagawa & Suzuki, 2002).
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Figure 2.1: Metabolism of oxybenzone. Oxybenzone is metabolized through the
demethylation (dotted lines) and hydroxylation (solid lines) pathways. After initial
transformation, metabolites can be further transformed using both pathways.

The above transformations rely on the family of cytochrome P450 (CYP)
enzymes, specifically CYP1A and CYP2D6 (Watanabe et al., 2015). These enzymes
are localized in the rough endoplasmic reticulum and mitochondria, primarily in adult
hepatocytes, but their expression and activity are protean which proves to be
important on two grounds. First, the perinatal period is a particularly vulnerable time
of exposure to exogenous substances, including chemical sunscreens, due to
underdeveloped detoxication mechanisms involved in phase I of xenobiotic
metabolism (de Wildt, Kearns, Leeder, & van den Anker, 1999; Sadler et al., 2016).
For that reason – as well as the immaturity of the skin barrier until at least 2 years of
age – limited use of products with oxybenzone are recommended for infants.
Specific sun protection guidelines have been created for neonates and toddlers by
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regulatory agencies that oversee the regulation of personal care products (R. Jiang
et al., 1999; Paller et al., 2011). Second, due to circulation of the parental
compounds including detection in the uterine environment, and primarily maternal
metabolism of chemicals in utero, fetal exposure is likely to be qualitatively as well
as quantitatively different from maternal exposure.
Oxybenzone readily metabolizes into products with dissimilar activities and
abilities to dissolve in polar vs non-polar solvents. For example, benzophenone 1 is
more hydrophilic than oxybenzone owing to the loss of a methyl group (S. Kim &
Choi, 2014), and can be detected in surface waters more frequently and in higher
concentrations than oxybenzone (Jeon, Chung, & Ryu, 2006). On the other hand,
neighboring hydroxyl groups or a 5-hydroxyl group on the A-phenyl ring of
oxybenzone seems to decrease some biological activities – e.g., the estrogenic
behaviors of oxybenzone metabolites (Watanabe et al., 2015).
Excretion
In mice, the free and conjugated forms of oxybenzone are excreted
comparably by both the urinary and fecal routes (EC, 2006). In rats, however, the
kidneys exclusively excrete the compound (Kadry, Okereke, Abdel-Rahman,
Friedman, & Davis, 1995).
In humans, sunscreens chemicals and their metabolites are commonly
detected in urine, suggesting a role for the kidneys in excretion. In a study designed
to evaluate uptake and excretion of oxybenzone after dermal exposure, participants
self-applied 40 g of sunscreen containing 4% oxybenzone (approximately 1.6 g of
the active compound) (Gustavsson Gonzalez, Farbrot, & Larko, 2002). At the end of
the study (48 hours later), the participants had excreted approximately 11 mg of
oxybenzone, less than 1% of the oxybenzone that had been applied to the skin. This
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does not mean that the remainder of the oxybenzone bioaccumulated, because this
study design could not determine how much of the applied oxybenzone crossed the
dermal barrier. Importantly, the researchers concluded that there was large
variability in the excretion patterns between human volunteers, although urinary
concentrations of oxybenzone were typically highest in the first 24 hours after
application. In a second study, lotions containing oxybenzone, octylmethoxycinnamate (OMC), or 3-(4-methylbenzylidene) camphor (4-MBC) were
provided to male and female participants; total lotion was 2 mg/cm 2 and the
concentrations of each sunscreen ingredient were 10% (w/w) (Janjua et al., 2004).
Urinary concentrations of oxybenzone were high in women 24-96 hours after
application (60 ng/ml) and even higher in men (140 ng/ml). Urinary concentrations of
OMC and 4-MBC were much lower (5-8 ng/ml for each compound). At this time,
much more work needs to be done to evaluate urinary excretion of oxybenzone and
its metabolites after single and repeated applications of products to the dermal
surface, as well as controlled oral dosing, using human volunteers.

2.3.5

Aquatic toxicity and effects on wildlife

Chemical UV filters added to personal care products and UV protecting
coatings inevitably enter the water systems – rivers, lakes, coastal areas – and the
aquatic biota as well as the tissues of aquatic organisms (Balmer et al., 2005;
Sanchez-Quiles & Tovar-Sanchez, 2015). From the very bottom of the aquatic food
chain to large marine animals, virtually all seafaring species are exposed to humanmade and human convenience-driven chemical UV filters [Figure 2.2].
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Figure 2.2: Oxybenzone in the aquatic environment. Oxybenzone and its
metabolites have been studied in aquatic – and related – species. From the
lower trophic levels up to the higher species, aquatic organisms carry a
double burden: they accumulate the compounds in their tissues and are
affected by the exposures.
Corals are a remarkable species whose multiple stages of development
depend on synchrony - and that synchrony relies on environmental clues including
lunar cycles, sunlight, temperature and wind (Shlesinger & Loya, 2019). Thus, from
the carefully timed event of coral spawning, through the drifting of sperm and eggs
with the ocean’s currents, to coral planulae searching for suitable substrates to settle
on and polyps beginning to develop their exoskeleton, corals are susceptible to
environmental insults (Gleason & Hofmann, 2011; He et al., 2019). Oxybenzone
induces premature formation of coral skeletons, increases stress in mature corals
that are symbiotic with marine zooxanthellae. Oxybenzone causes the coral to expel
their symbionts, which may represent a short-term adaptation yet with long-term
consequences for the health of the coral and its’ survival (Downs et al., 2016). The
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first evidence on the effects of sunscreens on corals and their symbiont was brought
by Danovaro et al (2008). In their earlier discovery the team demonstrated high longterm lytic bacterial activity and oscillating viral abundance in marine bacterioplankton
immersed in 500 μL/L of sunscreen (Danovaro & Corinaldesi, 2003). A similar
mechanism has been shown between coral and their symbiotic zooxanthellae. The
light-sensitive coral was bleached due to a loss of photosynthetic pigment and
membrane integrity when ambient seawater was treated with sunscreen; the coral
released its zooxanthella rapidly following treatment with oxybenzone, enzacamene,
octinoxate and octisalate (Danovaro et al., 2008).
Chemical sunscreens are also detected in other lower aqueous species.
Green algae and cyanobacteria take up oxybenzone – in a paradoxical pattern of
“the lower the concentration the higher the uptake” (Mao, He, Kushmaro, & Gin,
2017). Following exposures, both species suffer restricted growth rates and reduced
production of vital chlorophylls and carotenoids. The effects of four common
sunscreen chemicals were tested on plants: all four compounds were absorbed
through the roots, inhibited photosynthesis, and decreased the plant’s respiration –
effects that increase oxidative stress (Zhong et al., 2020).
Fish tissues tend to concentrate lipophilic environmental contaminants. The
bioaccumulation factor in fish depends on the lipophilicity of a specific chemical and
can lead to internal concentrations that are hundreds to thousands of times higher
than the surrounding environment (Brausch & Rand, 2011). As an example, 3benzylidene camphor concentrations are 313 times higher in fathead minnow tissues
compared to the environment (Kunz, Gries, & Fent, 2006). Oxybenzone is a
moderately hydrophobic compound with a partitioning coefficient, logP ow, of 3.64,
and it accumulates in fish tissues in their natural environment (Gago-Ferrero, Diaz39

Cruz, & Barcelo, 2013) as well as under experimental conditions (Schlumpf et al.,
2001). Octocrylene concentrates up to 2.4 μg/g in estuarial fish (Buser, Balmer,
Schmid, & Kohler, 2006), while exposures of experimental fish to concentrations of
octocrylene that are described as “practically non-toxic” still accumulate in Danio
rerio at concentrations up to 17 μg/g wet body weight (Bluthgen, Meili, Chew,
Odermatt, & Fent, 2014). Further, 4-methylbenzylidene camphor, oxybenzone, and
octyl methoxy cinnamate were demonstrated to bioconcentrate in lake fish (with
concentrations of 166, 123, and 64 ng/g lipids, respectively) (Balmer et al., 2005;
Buser et al., 2006). Mollusks, unlike fish, are sessile organisms filtering bottom water
and surface sediments, and so are known for their ability to accumulated
contaminants, including UV filters (Sang & Leung, 2016). Although typically tolerant
to stresses, clams, too, responded to 1 mg/L of oxybenzone in microplastics with
increased oxidative stress and genotoxicity (O'Donovan et al., 2020).
Of note, both chemical UV filters and UV stabilizers with a substantive
bioaccumulation potential also indirectly affect organisms in the upper ranks of the
food chain (Langford, Reid, Fjeld, Oxnevad, & Thomas, 2015). Molluscivorous and
piscivorous birds – e.g., oystercatchers and cormorants - are particularly susceptible
to lipophilic pollutants due to their consumption of a diet consisting of contaminated
muscles and fish. Moreover, throughout their life course, birds accumulate large
concentrations of pollutants and may dispose the chemicals in their eggs. A study
sampled several UV filters in Swiss aquatic ecosystems and measured the lipophilic
sunscreen, ethyl-hexyl-methoxy cinnamate, in cormorants at concentrations as high
as 701 ng/g lipids compared to concentrations of dozens ng/g lipids in small fish and
lake muscles (Fent et al., 2010). Consistently measured concentrations of
benzophenone sunscreens and even higher concentration of their metabolites in
40

unhatched eggs of birds in a natural reservation in Spain suggest bioaccumulation of
sunscreen in higher species (Molins-Delgado et al., 2017).
Importantly, aquatic species are affected by multiple stressors, and this may
exacerbate the toxic effects of sunscreen chemicals on wildlife. For example,
increasing temperatures in the oceans combined with UV filters enhance the
expression of stress-induced genes and decrease larvae survival of riparian insects
(Muniz-Gonzalez & Martinez-Guitarte, 2020). Also, the increasing acidification of the
ocean seems to potentiate new targets of environmental pollutants: oxybenzone per
se does not affect carbon anhydrase in the digestive tract of a mollusk
Amarilladesma mactroides after exposures to concentrations of 1 μg/L when the pH
was maintained at 8.1, but the chemical increased the enzyme’s activity at lower pH;
in fact, a decrease of only 0.5 pH units affected the carbon anhydrase with effects on
shell formation (Lopes, de Castro, Barbosa, Primel, & Martins, 2020).
In summary, chemical UV filters are continuously supplied to blue water, fresh
and sea waters alike. Compounds of ranging hydro- and lipophilic potentials
accumulate in sediments and aquatic biota across the food chain. Importantly, these
effects are not only seen in fish; effects have been documented on marine birds and
species at the top of the food chain. Yet, equally relevant is that riparian life –
namely plants and insects – are affected by these chemicals as well [Figure 2].

2.3.6

Acute and subchronic toxicity

Toxicity Testing in Rats
The National Toxicology Program (NTP) conducted a series of toxicity tests
on oxybenzone using F344/N rats (French, 1992). First, a relatively small study (5
males and 5 females) examined the effects of oxybenzone after 2 weeks of
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exposure. The animals were provided chow containing 0, 3125, 6250, 12500, 25000
or 50000 parts per million (ppm) oxybenzone (equivalent to intake of approximately
300, 600, 1200, 2400, and 4500 mg/kg/day). In males, all five doses of oxybenzone
increased the weight of the liver and increased liver weight was also seen in females
exposed to the four highest doses. Increased relative weight of the kidney was also
increased in males exposed to the four highest doses. When evaluated
histologically, 4 of 5 males fed chow with 50000 ppm oxybenzone had focal dilation
of the renal tubules.
A second two-week toxicity study examined the effects of oxybenzone in
male and female rats administered oxybenzone dermally, either in acetone or in a
lotion. The applied formulations contained 0, 5, 10, 20, 40 or 80 mg/ml; a total of
0.25 ml was applied to the skin of rats per day, with applied doses of 1.25, 2.5, 5, 10
or 20 mg/animal. Females, but not males, administered the three highest doses in
acetone had significantly heavier livers at the end of the administration period. In
males dermally administered oxybenzone in lotion, increased liver weights were
observed across the treatment groups. No histopathological changes were observed
in the livers of rats from either sex.
A thirteen-week toxicity study examined the effects of dietary oxybenzone
exposure on rats (n=10 per sex), again with diets containing 0, 3125, 6250, 12500,
25000 or 50000 parts per million oxybenzone. During the conduct of the study, both
male and female rats developed discolored urine and stains in the perineal fur,
consistent with effects on the kidney. Relative kidney weight was significantly
increased only in the highest dose groups, but again, increased liver weight was
observed at all five doses in both males and females. There were also effects
observed on hematologic evaluations; different doses increased platelet counts,
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segmented neutrophils, and reticulocytes at different points in the exposure period.
In male rats, the highest dose of oxybenzone decreased the weight of the epididymis
and decreased sperm concentrations; in female rats, the highest dose increased the
length of the estrous cycle.
Finally, a thirteen-week dermal toxicity study evaluated rats exposed to doses
of 0, 12.5, 25, 50, 100 or 200 mg/kg with the oxybenzone applied to the skin in
acetone. Females from the four highest dose groups had heavier kidney weights at
necropsy; effects on male relative kidney weight were also observed in the 25 and
100 mg/kg groups. Yet, there were no effects on the male or female reproductive
organs or on most of the hematologic or clinical chemistry parameters.

Toxicity Testing in Mice
The National Toxicology Program (NTP) also conducted a series of toxicity
tests on oxybenzone with B6CF1 mice (French, 1992). Again, the first study was
relatively small (5 males and 5 females) and examined the effects of oxybenzone
after 2 weeks of dietary exposure. The animals were provided chow containing 0,
3125, 6250, 12500, 25000 or 50000 parts per million (ppm) oxybenzone (equivalent
to intake of approximately 1000, 2000, 4000, 8000 or 20000 mg/kg/day). Again, an
increase in liver weight was observed in the oxybenzone-treated animals, in all five
dose groups for females and in the four highest dose groups for males. There were
histopathological changes (e.g., cytoplasmic vacuolarization in the hepatocytes) also
observed in these liver samples after exposures to 2000 mg/kg/day or higher doses.
A second two-week toxicity study examined the effects of oxybenzone in
male and female mice administered oxybenzone dermally, either in acetone or in a
lotion. The applied formulations contained 0, 5, 10, 20, 40 or 80 mg/ml; mice were
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administered 0.1 ml per day producing applied doses of 0.5, 1, 2, 4 or 8 mg/mouse.
Interestingly, body weight was increased in both males (8 mg) and females (1 and 4
mg) dermally administered oxybenzone. Increased liver weights were observed in
males from the two highest dose groups, and in females from all oxybenzone groups
(significant in the 1, 4 and 8 mg groups). Increased kidney weight was also observed
in males from the two highest dose groups.
A thirteen-week toxicity study examined the effects of dietary oxybenzone
exposure on mice (n=10 per sex), again with diets containing 0, 3125, 6250, 12500,
25000 or 50000 parts per million oxybenzone. These diets altered body weight,
which was decreased by as much as 16% in males administered the highest dose,
and as much as 13% in females administered the highest dose. Increased liver
weight was again observed in both males and female mice administered the four
highest doses, and microscopic changes in liver histology were observed in the two
highest dose groups. Altered kidney weights were also recorded for males in the
highest dose group (significantly decreased compared to controls) and in females
from the four highest doses (significantly increased compared to controls).
Histopathologic lesions of the kidney were observed in numerous oxybenzonetreated animals including several homogeneous eosinophilic casts in renal tubules,
dilated renal tubules, and inflammatory cell infiltrates in the renal interstitium. There
were also effects of oxybenzone on sperm concentration (decreased after exposures
to the highest dose) and the percentage of sperm with cellular abnormalities
(increased after administration of feed with 3125, 12500 or 50000 ppm oxybenzone,
the only three dose groups evaluated). Length of the estrous cycle was also
increased in mice exposed to the highest dose.
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Finally, a thirteen-week dermal toxicity study evaluated mice dermally
administered 0, 22.75, 45.5, 91, 182, or 364 mg/kg in acetone. In this study, no
significant changes were observed in the weight of the kidney or liver in either male
or female mice; there were also no abnormal histopathological findings of these
organs or skin samples collected from the site where the oxybenzone and acetone
were applied. Sperm concentration and was also significantly decreased in all three
treatment groups evaluated for this outcome (22.75, 91, and 356 mg/kg) but there
were no significant effects on estrous cycle length in oxybenzone-treated females.

Figure 2.3: Toxicity of oxybenzone from acute and subchronic toxicity
evaluations. A) Effect of oxybenzone administered in feed on relative liver weight in
rats. B) Effect of oxybenzone administered in feed on relative liver weight in mouse. C)
Effect of oxybenzone on relative kidney weight after 13-weeks of administration in
rats. D) Effect of oxybenzone on relative kidney weight after 13-weeks of
administration in mouse. E) Effect of 13-weeks of oxybenzone exposure on epididymal
sperm count. M = males, F = females. * p<0.05 compared to untreated controls, as
determined by the original study authors. All data from (French, 1992).
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NTP’s Toxicity Summary of 2- and 13-week oral and dermal exposures
After this series of 2-week and 13-week studies in mice and rats, evaluating
the effects of oxybenzone administered either orally or dermally, the NTP panel
came to a number of conclusions (French, 1992). First, there were similar effects
across the two species, and similar effects observed in rodents that were
administered oxybenzone either orally or dermally. The most common changes were
increased weight of the liver (FIGURES 2.3A,B) and kidney (FIGURES 2.3C,D), and
in the 13-week studies there were consistent effects on epididymal sperm density
(decreased, see FIGURE 2.3E) and estrous cycle length (increased), providing a
hint of reproductive toxicity or endocrine disruption.
Based on the 2-week and 13-week studies, the NTP concluded that the noobserved adverse effect level (NOAEL) for microscopic lesions was the 6250 ppm
dietary administration for both mice and rats. The NTP panel concluded that it was
not possible to identify a NOAEL dose for effects on sperm, because all of the doses
tested altered sperm counts. The NTP panel also concluded that oxybenzone is a
renal toxicant, with more severe toxicity observed after oral exposures compared to
dermal exposures. This provides evidence that the dermal exposures produce lower
systemic exposure concentrations. Renal effects were also more severe in rats than
in mice and histopathological abnormalities included tubule dilatation with
regeneration of tubular epithelial cells, interstitial inflammation, and papillary
necrosis.

Skin sensitization
Animal testing to evaluate allergic reactions to dermally applied oxybenzone
did not revealed any dermal sensitization in guinea pigs. However, human trials have
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given a contrasting picture (EC, 2006). The most recent European photopatch
testing ranked chemical UV absorbers, including oxybenzone and octocrylene, as
the “second most frequent cause of positive photopatch test reaction” (SubiabreFerrer et al., 2019). The common chemical structure of benzophenone-based UV
filters suggests the potential for cross-sensitivity and individual clinical cases
document indiscriminate allergic reactions across ages and body parts for some
individuals, and even an anaphylactoid reaction in a 49-old healthy woman following
a sunscreen application (Hanson & Warshaw, 2015; Schram, Glesne, & Warshaw,
2007; Tawfik & Atwater, 2019). Similarly, although earlier animal and human testing
made no case for phototoxic or photosensitizing reactions to oxybenzone, individual
cases illustrate the potential of oxybenzone to cause allergic reactions, especially in
combination with radiant energy (Kiec-Swierczynska, Krecisz, & SwierczynskaMachura, 2005; Knobler et al., 1989; J. P. Russo et al., 2018). Collectively, the
evidence to date indicates that oxybenzone can cause both contact allergy and
photoallergic reactions in humans.

Reproductive toxicity testing in mice
To evaluate whether oxybenzone is a reproductive or developmental toxicant,
pregnant Harlan Sprague-Dawley rats were administered oxybenzone in their chow
from pregnancy day 6 through the entire lactational period (Nakamura et al., 2015).
The concentrations in feed were 0, 1000, 3000, 10000, 25000 or 50000 ppm,
equivalent to intake of approximately 0, 65, 220, 700, 2500 and 4500 mg/kg/day (but
with somewhat different daily doses based on physiological stage, changes in food
intake, and changes in body weight throughout pregnancy and lactation).
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In the dams, there were no effects observed on reproductive outcomes
including number of pups born, birth weight of pups, number of implantation sites,
number of resorptions, or sex ratios in the oxybenzone-treated litters compared to
the controls. The mothers did display signs of overt toxicity, with a significant
decrease in body weight observed in the highest dose group apparent as early as
gestational day 10 and maintained throughout the pregnancy period. Increased liver
weight and kidney weight were observed in oxybenzone-treated dams at the end of
the lactational period. Interestingly, there were non-monotonic dose responses
observed for weight of the ovaries and uterus at lactational day 23, with a significant
increase in the weight of both organs in the lowest dose group.
In the clinical chemistry analysis, serum was collected from pregnant mice at
gestational days 10, 15 and 20, and from lactating mice prior to weaning (lactational
day 23). Although effects were observed across many measures of clinical
chemistry, the most consistent effects observed across these four time points were
for alanine aminotransferase (ALT), and total bile acids (TBA), which were
significantly increased in the two highest doses at all four timepoints. Alkaline
phosphatase (ALP) was also significantly elevated at all four timepoints in dams from
the three highest dose groups.
Both male and female pups were evaluated throughout the postnatal period
as well (Nakamura et al., 2015). Pups from litters exposed to the two highest doses
were lighter than controls. Clinical chemistry evaluations also suggested changes in
both male and female offspring, with decreases in serum ALT and increases in
serum cholesterol levels in the two highest dose groups. At postnatal day (PND) 23,
relative liver weights were significantly increased in females from the three highest
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dose groups; kidney weights were also lighter in both males and females from the
highest dose group.
Measures relevant to reproductive development were also disrupted in mice
following perinatal exposures to oxybenzone. First, a decline in male anogenital
distance (AGD) was observed at PND 23, even after accounting for differences in
body size (statistically significant only at the highest dose). Males from the highest
dose group also had lighter testes weights, and remarkably, number of
spermatocytes was significantly decreased in males from the four highest dose
groups. Serum testosterone levels were decreased by approximately 25-40% in all
oxybenzone-exposed males (but these differences were only statistically significant
in males from litters from the 3000 and 25000 ppm groups). In female offspring,
ovarian weights were significantly decreased at PND 23 in the two highest dose
groups, and the number of ovarian antral follicles was also decreased in females
from these groups. Uterine weight was also significantly lighter in pups from the
highest dose group.
A follow-up reproductive toxicity study (Nakamura et al., 2018) examined
additional endpoints in males collected from the developmental and reproductive
toxicity study described above. After weaning on PND 28, males from litters exposed
to two doses (3000 and 30000 ppm) were evaluated on PND 30. There were some
signs of toxicity including decreased body weight, decreased liver weight, and
decreased kidney weight, all observed in the higher dose group. Reproductive
toxicity was observed with decreased weight of the epididymis, decreased weight of
the testis, and decreased weight of the prostate. Gene expression profiles revealed
effects of both doses on cell cycle and cancer-related gene expression in the
prostate.
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2.3.7

Endocrine Disruption

In 2020, the European Union’s Scientific Committee on Consumer Safety
released a draft report on benzophenones including oxybenzone. One portion of this
report was dedicated to the question of whether oxybenzone is an endocrine
disrupting chemical as defined by the World Health Organization and United Nations
Environment Programme, i.e. “an exogenous substance or mixture that alters
function(s) of the endocrine system and consequently causes adverse health effects
in an intact organism, or its progeny, or (sub) populations” (Damstra, Barlow,
Bergman, Kavlock, & van der Kraak, 2002). This definition of an endocrine disruptor
presumes that a chemical has an endocrine mode of action, that it induces adverse
effects, and that there is a plausible link between the endocrine mode of action and
the adverse effects. This definition is widely used by regulatory agencies, but it relies
on problematic definitions of what constitutes an adverse effect, and the use of
expert judgement to evaluate biological plausibility (Zoeller et al., 2014). Considering
this regulatory definition, and the more simplified definition proposed by experts with
the Endocrine Society (an endocrine disruptor is “an exogenous chemical, or mixture
of chemicals, that interferes with any aspect of hormone action” (R. T. Zoeller et al.,
2012), there is evidence that oxybenzone should be characterized as an endocrine
disruptor.
As described in more detail below, UV filters have been commonly studied for
their estrogenicity, yet they are arguably even more relevant as estrogen receptor
(ER) and androgen receptor (AR) antagonists: out of nineteen sunscreens studied
with human ERα and AR assays, only five chemicals exhibited full estrogenic activity
while thirteen possessed full anti-estrogenic; and nineteen full anti-androgenic
activity (Kunz & Fent, 2006b). Also relevant to its classification as an endocrine
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disruptor, oxybenzone and its metabolites affect hormone signaling in vivo animals,
including humans (Ghazipura, McGowan, Arslan, & Hossain, 2017; Maipas &
Nicolopoulou-Stamati, 2015) and demonstrate endocrine activity in vitro, as well.

ER agonist activities
In competitive binding assays, yeast recombinant or two-hybrid assays
(Kawamura et al., 2003; Morohoshi et al., 2005; Schreurs, Lanser, Seinen, & van der
Burg, 2002), and reporter cell lines (Molina-Molina et al., 2008), oxybenzone has a
weak binding affinity to ER, with a higher affinity for ERα than ERβ (R. H. M. M.
Schreurs, E. Sonneveld, J. H. J. Jansen, W. Seinen, & B. van der Burg, 2005).
Some other studies have failed to report ERβ agonist activity at all (Schlumpf et al.,
2004; Suzuki et al., 2005). In the MCF7 human breast cancer cell assay,
oxybenzone induces proliferation up to 95 % of the total induced by ethinyl estradiol,
a positive control for ER agonist activity (Schlumpf et al., 2001). The EC50 for cell
proliferation in the MCF7 cell assay is 3.73 μM, similar to other estrogenic endocrine
disruptors, but much lower than the EC50 for 17β estradiol (1.22 pM).
Thus, in vitro, oxybenzone itself is often characterized as a weak ER agonist,
but some of its metabolites show very strong estrogenic activity. For example, all of
the benzophenones tested in yeast hERα assays were estrogenic – although full
estrogenic activity was only exhibited when the hydroxyl-group was situated in the
para- or, ortho- and para-positions, i.e. benzophenone 1, benzophenone 2, and
2,4,4, trihydroxybenzophenone (Kunz & Fent, 2006b; Suzuki et al., 2005; Watanabe
et al., 2015). The main oxybenzone metabolites were further found to exhibit
stronger ER agonist behaviors than the parent compound – and when combined with
the parent compound, an additive estrogenic effect was observed in the yeast hERα
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assays (Heneweer, Muusse, van den Berg, & Sanderson, 2005; L. Wang & Kannan,
2013). In other yeast assays, oxybenzone produced both cytotoxicity and ER
agonistic effects (Balazs et al., 2016; Kunz, Galicia, & Fent, 2006). Lastly,
transcriptional activity of both ERα and ERβ was increased by 10-5 and 10-4 M
concentrations of oxybenzone (Schreurs et al., 2002).
Importantly, in vivo effects cannot be always assumed from in vitro data
(Schreurs et al., 2002). Exposure to 3 mg oxybenzone/kg/day throughout pregnancy
and lactation increased expression of Esr1 in the uterus of ovariectomized Balb/C
mice, without increasing uterine weight (LaPlante, Bansal, Dunphy, Jerry, &
Vandenberg, 2018) and an acute, 4-day, orally administered exposure to 1525
mg/kg/day oxybenzone in prepubertal rats elicited a significant increase in uterine
weight (Schlumpf et al., 2001); both doses and effects are consistent with the
characterization of oxybenzone as a relatively “weak” ER agonist. In a rat
uterotrophic assay, a 3-day, intraperitoneal exposure to 20, 100 or 500mg/kg doses
of oxybenzone did not change the weight of the uteri in ovariectomized females
(although increased uterine weight was observed in females administered 50 μg/kg
of ethinyl estradiol, a high dose of a positive control for estrogenicity) (Suzuki et al.,
2005). A significant increase in uterine weight was, however, observed in rats
exposed to 500 mg/kg of benzophenone 1 or 300 mg/kg of 2,4,4’
hydroxybenzophenone - both oxybenzone metabolites that are demethylated and
hydroxylated with three hydroxyl groups, respectively. Uterotrophic assays have
evaluated other oxybenzone metabolites including 2,4,4’ trihydroxybenzophenone
and 4 hydroxy-, 2,4 hydroxy- and 2, 2’,4,4’ hydroxybenzophenones administered to
immature Crj:CD (SD) rats. Doses ranging from 40 to 200 mg/kg increased the
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blotted uterine weight following three days of subcutaneous injections with the tested
compounds (Yamasaki et al., 2003).
Other effects consistent with ER agonist behavior have been documented in
mice exposed during early development. For example, the mammary gland exhibits
stimulated growth parameters, including increased numbers of differentiated
epithelial structures, following perinatal exposure to 3 mg oxybenzone/kg weight/day
(administered to the mother during pregnancy and lactation) (K. Matouskova et al.,
2019). These effects on the mammary gland are somewhat similar to the effects that
have been observed in female mice administered other ER agonists such as ethinyl
estradiol and bisphenol S (S. Kolla et al., 2018), i.e. an increased number of alveolar
ducts and decreased number of epithelial mitotic events while oxybenzone at
3mg/kg/day but not BPS increases ductal area and number of TEBs.
Estrogenic effects have also been observed in fish. Vitellogenin is the yolk
protein that serves as a marker of ER agonist disruption in several fish species.
Oxybenzone in wastewater and sediment induces vitellogenin in male medaka,
California halibut (Sapozhnikova et al., 2005; Schlenk et al., 2005) and juvenile trout
(Coronado et al., 2008). These effects may be due to oxybenzone itself, or the
actions of more potent estrogenic metabolites, e.g., benzophenone 1 and 2,4,4,
trihydroxybenzophenone.

ER antagonist activity
Fewer studies have evaluated ER antagonistic activity of oxybenzone. In one
study, yeast reporter assays were used to evaluate anti-estrogenic properties of
oxybenzone, other benzophenones, and metabolites (Kunz & Fent, 2006b). To
identify ER antagonists, the yeasts were treated with 17β-estradiol at concentrations
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that induce 65% of the maximal response, and then co-treated with increasing
concentrations of the test compounds. Oxybenzone was the most potent ER
antagonist evaluated, showing an antiestrogenic potency only “45 times less potent
than the known antiestrogen 4-hydroxytamoxifen” and an IC50 of 1.8 x 10-5 M. Other
UV filters had ER antagonist properties in yeast reporter assays, including 4-MBC,
but only at higher concentrations.

AR agonist and antagonist properties
AR agonist and antagonist activities of benzophenone-type UV filters have
been evaluated both in in vitro assays and in vivo assays. Using yeast expressing
human AR, benzophenone 2 exhibited “submaximal to full androgenic activity [..] and
full antiandrogenic activity” (Kunz & Fent, 2006b). Furthermore, in the yeast assay,
oxybenzone, benzophenone 1 benzophenone 4, and 4 hydroxy- and 4,4’
dihydroxybenzophenone were pure anti-androgens without any AR agonist activity.
The IC50 value for oxybenzone was 3.7 x 10-6 M, similar to the positive control for
AR antagonist activity, flutamide (IC50 = 4.3 x 10-6 M) (Balazs et al., 2016; Kunz &
Fent, 2006b).
Evaluations of AR agonist and antagonist behavior in MDA-kb2 cells similarly
concluded that neither oxybenzone or benzophenone 4 displayed any AR agonist
action but oxybenzone significantly reduced dihydrotestosterone-induced AR
activation, consistent with an AR antagonist (R. Ma, Cotton, Lichtensteiger, &
Schlumpf, 2003). Furthermore, in a HELN cell luciferase assay, all tested
oxybenzone metabolites as well as the parental compound showed anti-androgenic
properties (Molina-Molina et al., 2008).
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In vivo, the homology between the rat and human AR ligand binding domain
has led to the presumption that analogous effects would be observed between the
species (Kelce, Gray, & Wilson, 1998). The Hershberger assay is used to test
androgenic and anti-androgenic effects of chemicals. In 8-week old Brl Han: Wistar
Jcl(Galas) rats administered 4 hydroxybenzophenone and 4,4,
dihydroxybenzophenone via gavage for 10 days had only minor effects on prostate
and bulbocavernosus levator ani muscle weight (Yamasaki et al., 2003). On the
other hand, 300mg/kg/day 2,4,4’ trihydroxybenzophenone significantly suppressed
the effects of testosterone on the prostate and seminal vesicles and so
demonstrated its anti-androgenic potential (Suzuki et al., 2005).
Further in vivo, AGD is considered an important indicator of endocrine
disruption. The distance between the anus and perineum measures typically about
twice as long in males than in females. In both animal and human studies (Bornehag
et al., 2015), AGD shortens as a result of disruption of testosterone activity during
prenatal development (Salazar-Martinez, Romano-Riquer, Yanez-Marquez,
Longnecker, & Hernandez-Avila, 2004). Perinatal exposure to 212 μg/kg
oxybenzone induced a lower AGD (adjusted for body weight) in both male and
female mice offspring (K. Matouskova et al., 2019). While in males those reductions
suggest an anti-androgenic effect of oxybenzone (Fisher et al., 2016; Swan et al.,
2005; C. J. Wolf, LeBlanc, Ostby, & Gray, 2000), in females a shorter anogenital
distance cannot be quite easily explained. As noted in the sections above, shortened
AGD was also reported in male mice in a standardized developmental and
reproductive toxicology study, but only after much higher doses (Nakamura et al.,
2015).
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Finally, the effects of oxybenzone on androgen-sensitive gene expression
was examined in adult male zebrafish (Bluthgen, Zucchi, & Fent, 2012). Exposures
to 84 μg/L – an environmentally relevant concentration – led to downregulated
expression of ar and cyp19b in the brain; interestingly, statistically significant
negative fold change in the expression of these genes was not observed after
exposure to higher or lower concentrations - 2.4 and 312 μg/L. Effects were also
observed for gene expression in the testes, consistent with AR antagonism.
(Bluthgen et al., 2012).

Summary of endocrine disrupting properties
When considering the potential for chemical sunscreens to have endocrine
disrupting properties, there are two important aspects to consider. First, there can be
multiple, and even opposite, endocrine activities of individual compounds. The fact
that personal care products, including UV filters, have more than one endocrine
mode of action does not appear to be rare. For example, homosalate, oxybenzone,
and 4-methylbenzylidene camphor each exhibited both ER agonistic as well as ER
antagonistic actions (Mueller et al., 2003; Schreurs et al., 2002), and alkylphenols
elicited both ER agonist and AR antagonist activities in vitro (Sohoni & Sumpter,
1998). Although it may appear counter-intuitive, compounds possessing both agonist
and antagonist activity towards a single receptor (so called selective ER modulators
– SERMs) are relatively common and have been effective pharmaceutical therapies
used for endocrine mediated diseases, e.g., osteoporosis and breast cancer (Jensen
& Khan, 2004; Lindsay, Gallagher, Kagan, Pickar, & Constantine, 2009).
Second, there are possible synergistic effects when multiple compounds are
applied in conjunction. Traditional approaches to evaluate chemical mixtures,
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including UV filters, assume the resulting endocrine effect can be calculated as a
sum of the individual endocrine effects measured for individual chemicals in the
mixture. Contrarily, synergistic effects of endocrine disrupting compounds are no
longer considered rare, particularly in real-life mixtures of chemicals (Kunz & Fent,
2006a; Martin et al., 2021). For example, a mixture of eight compounds, individually
considered weak ER agonists (including one of oxybenzone’s metabolites, 2,4,
dihydroxybenzophenone) significantly exceeded the estimation of estrogenic effects
based on effect summation (Silva, Rajapakse, & Kortenkamp, 2002).
Both of the issues described above (the multiple endocrine modes of action
and the additive or synergistic effects of chemical mixtures), have implications on
human health and wildlife species. These issues also have potential implications for
how endocrine disruptors are addressed in risk assessments and policy.

2.3.8

Genotoxicity & Carcinogenesis

A number of approaches have been used to evaluate oxybenzone’s potential
for genotoxicity (National Toxicology Program, 2006). The NTP used E. coli
mutagenesis assays with multiple bacterial strains and found no evidence for
mutagenesis, either with or without liver extract (to evaluate metabolites as well).
Others that have evaluated oxybenzone for mutagenicity reported conflicting results
based on the bacterial strain used with either no or weak mutagenic properties of
oxybenzone observed in a Salmonella assay (Zeiger et al., 1987).
Genotoxicity tests using other approaches have examined the frequency of
micronucleated erythrocytes in the blood of mice from subchronic toxicity studies. In
males, there was a modest decrease in the number of micronuclei that were
observed, but this trend was not statistically significant. In females, there were no
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significant differences between oxybenzone and control groups, but there was a
statistically significant dose-response trend for increased number of micronuclei (Witt
et al., 2000).
The NTP conducted a two year carcinogenesis study evaluating the
carcinogenic potential of oxybenzone in male and female Harlan Sprague-Dawley
rats exposed in utero starting on gestational day 6 through feed administered to the
mother (National Toxicology Program, 2006); post-weaning, the male and female
offspring continued to be administered oxybenzone in the feed for 105 weeks. The
diets contained 0, 1000, 3000 and 10000 ppm oxybenzone. In the males, an
increase in testicular interstitial cell hyperplasia, a non-neoplastic effect, was
observed at the highest dose. Malignant meningioma (a brain malignancy) was
observed in males from the two lowest dose groups, but this effect was considered
equivocal because it was not also observed in the highest treatment group. In female
rats, an increase in atypical hyperplasia of the uterine endometrium was observed in
all three oxybenzone-treated groups, and an increase in hypertrophy in the adrenal
cortex was reported for animals administered 1000 and 3000 ppm. More females
from the two mid-dose groups had uterine stromal polyps and females from all three
oxybenzone groups were more likely to have thyroid C-cell adenomas, but again,
these findings were considered “equivocal”.
The NTP conducted a similar study in B6C3F1/N mice, exposed for 2 years
(but without the prenatal exposure that was administered to the rats) via diets
containing 0, 1000, 3000 or 10000 ppm oxybenzone. Although there were signs of
general toxicity (e.g., a loss of 10% or more body weight) in both male and female
mice, there were no neoplastic effects observed. Non-neoplastic changes that were
observed included a striking increase in the number of animals with pigmented bone
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marrow (an effect observed in every single male and female from the highest dose
group), an increase in the number of males and females with altered spleen
pigmentation, and kidney metaplasias in 10% of females from the highest dose
group. The vast majority of males from the highest dose group also had syncytial
alterations in liver hepatocytes and cytoplasmic alterations of the renal tubules.
Based on the outcome of the NTP’s rat and mouse carcinogenesis studies,
the NTP expert panel concluded that there was equivocal evidence of carcinogenic
activity in male and female rats. There was no evidence of carcinogenic activity
observed in mice.

2.3.9

Epidemiology

To date, a few dozen epidemiology studies have examined oxybenzone
(and/or its metabolites) and associations between exposures and human diseases.
These studies have varying strengths based on their study designs (cross-sectional
versus case-control versus cohort), the size of the populations evaluated, the quality
of the methods used to quantify exposures, and other considerations (e.g.,
confounding, latency between exposure and effect, etc.) Considering these
limitations, we summarize the results of epidemiology studies evaluating endpoints
affecting reproduction and endocrine functions.
Endometriosis is an intricate disease characterized by the presence of
misplaced functional endometrium-like tissue outside the uterus. The diverse
symptoms associated with this disease include chronic pelvic pain, infertility and
higher risk of gynecological cancer and cardiovascular disease. Endometriosis
affects an estimated 10-15% of women of childbearing age (Eisenberg, Weil,
Chodick, & Shalev, 2018). The causal factors are yet to be elucidated but the known
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sensitivity of the endometrial tissue to estrogens hints at a potential role for
endocrine disrupting chemicals as important factors in the onset or promotion of
endometriosis. A case-control study evaluating women undergoing abdominal
surgery found an increased risk of endometriosis associated with urine oxybenzone
and benzophenone 1 (OR = 4.98 and 5.1, p = 0.011 and p = 0.008 respectively)
(Peinado et al., 2020). Interestingly, the associations were only observed for women
in the second tercile of urine concentrations (e.g., the mid-range of exposures), and
the risk was increased when measures of oxidative stress were included in the
statistical models. In another study examining a large US cohort, the presence of
benzophenone 1, and to some extent also oxybenzone in urine samples correlated
with risk of endometriosis (Kunisue et al., 2012). This in vivo outcome is supported
by the potent ER agonist features of benzophenone 1 observed in in vitro
experiments.
Successful conception may not occur if environmental signaling interferes
with the events that coordinate male and female fertility and the health of the
gametes. Oxybenzone (along with bisphenol A and triclosan, two common endocrine
disrupting chemicals) was measured in the large biomonitoring study, the U.S.
National Health and Nutrition Examination Survey (NHANES). In a cross-sectional
study utilizing NHANES data, the urinary levels of oxybenzone, bisphenol A and
triclosan were clustered together and the triad was positively associated with selfreported female infertility (prevalence ratio = 1.13, 95%CI 1.04-1.24, p = 0.007)
(Arya, Dwivedi, Alvarado, & Kupesic-Plavsic, 2020). On the other hand, in a
prospective cohort study, oxybenzone concentrations were measured in urine
samples from women undergoing infertility treatment (Minguez-Alarcon et al., 2019).
All three fertility endpoints in the study – probability of implantation, clinical
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pregnancy, and live birth – were positively associated with the urinary oxybenzone
levels, suggesting that oxybenzone promotes fertility in women experiencing
infertility. However, these associations were only observed in the cohort of women
who also reported the most time spent outdoors doing “moderate/heavy work”. Sun
exposure and physical activity outdoors are frequent confounders in studies
evaluating multi-causal conditions. As the authors suggest, their results may suggest
that the link between successful conception and pregnancy outcomes may rather
point to lifestyle and environmental factors than the sunscreen ingredient. Although
the link between excessive UV exposure and skin cancer is well established,
moderate sunlight exposure in two Swedish cohorts was negatively correlated with
all-cause mortality (Lindqvist et al., 2014a; Yang et al., 2011); and so, the above
results point beyond the risks and benefits of sunscreen chemicals only.
In other epidemiology studies, birth outcomes, too, were correlated with urine
concentrations of oxybenzone. With higher levels of serum oxybenzone in the
mothers, there was a decrease in birth size in female newborns; gestational
measures of oxybenzone were positively associated with offspring weight and head
circumference in male infants (Philippat et al., 2012; Wolff et al., 2008). In both
sexes, maternal urinary oxybenzone measures were also associated with shorter
gestation (Tang et al., 2013).
Children’s behavior outcomes were evaluated in a prospective, longitudinal
cohort study. Researchers reported inverse associations between maternal urinary
concentrations (median 0.37 ug/L, min. 0.08 and max 485 ug/L) and scores on prosocial behavior (Guo et al., 2020). No associations were observed between
childhood urinary oxybenzone concentrations (median 1.76 ug/L, min. 0.98 and max
783 ug/L) and pro-social behaviors. An earlier study failed to see differences in
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prosocial behaviors associated with oxybenzone in a cohort of 5-year-old boys
(Philippat et al., 2017), but important confounders, such as breastfeeding,
socioeconomics, and postnatal levels of other chemicals that are closely associated
with neurobehavioral adverse
effects in humans were not
accounted for in this study.
Thyroid hormone
balance plays an essential
role in neurodevelopment as
well as metabolic and energy
homeostasis throughout the
lifetime. Using NHANES data,
a cross-sectional evaluation
suggested that oxybenzone
had significantly inverse
associations with the levels of
serum thyroid hormones – both
free and total T4 and total T3

Figure 2.4: Summary of epidemiology
studies of oxybenzone. To date, most of
the epidemiology studies examining
associations between oxybenzone and
health effects have focused on outcomes
relevant to fertility, birth outcomes, and
other endocrine effects.

(S. Kim, Kim, Won, & Choi, 2017). Oxybenzone exposure levels are also modestly
associated with increases in the pituitary hormone thyroid stimulating hormone.
These results are consistent with results from in vitro studies, which reveal potent
inhibiting activity of benzophenone 2 towards thyroid peroxidase; benzophenone 2
also decreased total T4 concentrations in vivo, but oxybenzone failed to show an
effect on these outcomes (Schmutzler et al., 2007).
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In other human organs, oxybenzone has been detected in the adipose tissue
of female breasts and its concentration positively correlates with the incidence of
tumors in the lateral region of the breast (Barr, Alamer, & Darbre, 2018). In human
placenta, oxybenzone concentrations were associated with lower placental weight and
placenta-to-fetal weight (Philippat et al., 2019). Further, correlations between
oxybenzone exposures have been suggested in the incidence of a rare birth defect
associated with failure of neural crest cells to migrate to the intestine (Huo et al., 2016).
Although the number of epidemiology studies evaluating oxybenzone remain
limited, these studies suggest that exposures – especially during vulnerable windows
of development – may contribute to diseases. To date, the current available evidence
for effects on human populations is relatively weak, but the possibility that oxybenzone
might cause harm to human populations is particularly concerning because of the
ubiquitous exposures that have been documented. These widespread exposures will
also contribute to challenges in future epidemiology evaluations, similar to those that
have been documented for other non-persistent chemicals.

2.4 Benzotriazole UV Stabilizers
UV stabilizers are chemicals added to products to prevent degradation of the
product [TABLE 2.2]. These are added to plastics, paints, building products, and
other consumer goods to protect against damage from harmful UV radiation; they
also can prevent product fading, inhibit corrosion, and minimize fog.
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One of the most common classes of chemicals used as a UV stabilizer is
benzotriazole and its derivatives. These chemicals are currently produced in
volumes that exceed 8000 metric tons per year. Compared to oxybenzone, there are
fewer studies that have evaluated the health hazards or environmental impact of
benzotriazole-based UV stabilizers. However, because of evidence that one
benzotriazole derivative, UV-328, is environmentally persistent, the Swiss
Table 2.2: UV stabilizing chemicals commonly used in plastics and other
consumer goods
Substance

CAS
Synonyms
number
95-14-7 BTA, BtaH
1HBenzotriazole
1,2,3, Benzotriazole
7032186-7

Trade Names

2-(2H-benzotriazol2-yl)-4,6-di-tertbutyl-phenol

384671-7

UV-320

Tinuvin 320

2-(5-chloro-2Hbenzotriazol-2-yl)-6(1,1-dimethylethyl)4-methyl

389611-5

UV-326

Tinuvin 326

2-(2′-Hyroxy-3′,5′-di- 3864tert-butylphenyl)-5- 99-1
chlorobenzotriazole

UV-327

Tinuvin 327

2-(2H-benzotriazol2-yl)-4,6-di-tertpentylphenol

UV-328

Tinuvin-328

Benzotriazole

2-(2H-benzotriazol2-yl)-4,6-bis(1methyl-1phenylethyl)

2597355-1

Tinuvin 234 FF
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Structure

Government has proposed that its use should be limited and eventually eliminated.
Switzerland proposed that this UV stabilizer should be added to the Stockholm
Convention, a list of the most hazardous chemical substances that
governments agree to restrict to protect human health and the environment.
There are a large number of individual UV stabilizers that are benzotriazole
derivatives. In this portion of the chapter, we will review these chemicals as a class
and will indicate when the results are specific to a single compound.

2.4.1

Uses in Products / Sources of Exposure

UV stabilizers are added to plastic packaging used to contain food, drugs,
and cosmetics. They are also added to plastic products such as toys and sports
equipment, to fabrics used in clothing, upholstery and other furnishings, and to
building materials including paints. A study that examined new products found
detectable levels of UV stabilizers in plastics used in food packaging including
plastics made from polypropylene, polyethylene terephthalate, and polyethylene
(Rani et al., 2017). UV stabilizers were also measured in plastics used in the
fisheries industry including fish traps, ropes, and floats.
Plastics made from polyethylene terephthalate with the UV stabilizer UV-234
are commonly used as food containers for products ranging from beer bottles to food
jars to condiment containers (Begley, Biles, Cunningham, & Piringer, 2004). A
migration study using food simulants found temperature- and time-dependent
migration characteristics; after 10 days at 40°C, the amount of UV-234 that migrated
to an ethanol-based simulant was 2 μg per 100 cm2.
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2.4.2

Measurements in the Environment

Plastic pollution is a serious global environmental challenge. Because UV
stabilizers are widely used in different plastic products, one way that their
environmental impact has been evaluated is to measure their concentrations in
plastics collected from the environment [Figure 2.6]. Marine plastic debris collected
from the coast of Korea had measurable concentrations of UV stabilizers including
UV-320, UV-326, UV-327, and UV-328 (Rani et al., 2017). When the concentrations
measured in the debris were compared with new products, the concentrations
differed. UV-320 concentrations were lower in marine debris compared to new
products, consistent with release to the environment. In contrast, UV-326
concentrations were typically higher in plastics recovered from the marine
environment compared to new plastics, consistent with adsorption of this UV
stabilizer from sources in the environment. Another study of plastic fragments
collected from beaches in Hawaii measured detectable levels of UV-326, UV-327
and UV-328 in both small (4-7 mm) and large (15-80 mm) fragments (Tanaka,
Takada, Ikenaka, Nakayama, & Ishizuka, 2020). One or more of these chemicals
were detected in 6 of the 9 small fragments, and in 18 of the 23 large fragments, at
concentrations as high as 813 μg/g plastic for UV-326 and 763 μg/g plastic for UV327. UV-328 was only detected in a single plastic fragment at a concentration of 0.2
μg/g plastic. The authors concluded that fragmentation of plastics does not induce
“exhaustive leaching” of UV stabilizers from plastics.
In addition to the measurement of plastics in the environment, UV stabilizers
that have leached from consumer products have been measured in environmental
matrices including wastewater, sludge, and sediment [Figure 6]. In a study from the
Spanish Canary Islands, six benzotriazole derivatives were evaluated in
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environmental samples (Montesdeoca-Esponda, Torres-Padrón, Sosa-Ferrera, &
Santana-Rodríguez, 2021); more than 60% of all sludge samples contained
detectable levels of UV-328 and UV-360. Although detection rates were lower for
UV-329, the maximum measurable concentrations of this UV stabilizer in
environmental matrices were very high (1933 ng/L in wastewater influent, 57 ng/L in
wastewater effluent and 859 ng/L in seawater). Another study from the Canary
Islands reported high concentrations of UV-328, UV-329 and UV-360 in sewage
samples collected between 2016 and 2017 (Montesdeoca-Esponda, Álvarez-Raya,
Torres-Padrón, Sosa-Ferrera, & Santana-Rodríguez, 2019). Results reported from
other studies of wastewater treatment plants in Canada (Lu, Smyth, Peart, & De
Silva, 2017), China (R. Liu et al., 2014; Song, Ruan, Wang, Liu, & Jiang, 2014),
Spain and Portugal (Carpinteiro, Ramil, Rodríguez, & Nogueira, 2012), and sewage
sludge from China (T. Ruan et al., 2012) indicate that benzotriazole derivatives are
routinely detected in both liquid and solid samples, with differences in the detection
rates, concentrations, and identities of specific monomers based on location. These
findings indicate that there are geographic differences in the use of benzotriazoles,
likely due to their use in different products and the handling of products during
disposal. In Norway, four benzotriazoles were detected in wastewater treatment
plant effluents and landfill leachates in concentrations that suggest the possible
bioaccumulation potential of all compounds (Langford et al., 2015).
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UV stabilizers have also been documented in seawater including coastal
waters from China, Japan, Korea, Hong Kong, India, Indonesia, the Philippines, and
the United States between 2003 and 2007 (Nakata et al., 2012). Although there were
differences between geographic locations, UV-328 was measured in seawater
samples from both Asian
nations and the United
States. Other
evaluations of the both
seawater and sediment
from other locations,
including the North and
Baltic Sea, revealed that
these waters are
routinely contaminated
with benzotriazole
derivatives, with UV-360

Figure 2.0.5: Benzotriazole derivatives are measured in
environmental matrices. UV stabilizing chemicals are
released into the environment during production, and also
from the breakdown of products. The widespread reach of
plastic pollution, and degradation of consumer goods, has
led to the detection of benzotriazole derivatives in coastal
waters, wastewater, sewage sludge, freshwater, and
house dust.

accounting for the
majority of the UV stabilizers measured in northern European waterways (Apel,
Joerss, & Ebinghaus, 2018). Further, in the Chinese Bohai and Yellow seas, UV-329
was the most predominant benzotriazole compound, especially around the
Shandong Peninsula (Apel, Tang, & Ebinghaus, 2018). River inputs to the Bohai and
Yellow seas were determined to be the major source of the UV stabilizers measured
in seawater. Importantly, a study evaluating the concentrations of benzotriazoles in
coastal areas around a production site on the Northeast coast of the United States
found that concentrations remained largely unchanged even after production of the
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monomers ceased (Cantwell et al., 2015). The authors concluded from this study
that these chemicals persist in the environment and resist degradation in
environmental matrices.
Benzotriazole-based UV stabilizers are routinely detected in freshwater
including rivers in China (Peng et al., 2017; Z. Zhang et al., 2011) and India
(Vimalkumar et al., 2018), and in urban creek waters and sediments collected in
Canada (Lu, De Silva, et al., 2016). These chemicals were also detected in dust
samples collected from homes in either an urban area or homes located in an area
near a municipal dump in the Philippines (J. W. Kim et al., 2012); detection
frequencies for five benzotriazoles ranged from 82-94% in urban residences and 6595% in residences near the municipal dumpsite. Concentrations of UV-234, UV-326,
and UV-328 were the highest in the dust samples. The presence of these chemicals
in house dust suggest that they are shed from products routinely used in the home.

2.4.3

Measurements in Wildlife and Humans

With benzotriazole derivatives measured in water and sediment samples
around the world, it is perhaps no surprise that these chemicals have also been
widely measured in fish and other aquatic biota. Fish collected from three rivers in
India had detectable levels of six UV stabilizers including UV-9, UV-P, UV-326, UV327, UV-328, and UV-329 (Vimalkumar et al., 2018). There were differences in the
concentrations of each monomer between the three rivers, with an influence of the
season (dry versus wet) as well. Benzotriazoles were also measured in fish collected
in the Philippines (J. W. Kim, Ramaswamy, Chang, Isobe, & Tanabe, 2011), Canada
(Lu, Peart, Cook, & De Silva, 2016), the Canary Islands (Montesdeoca-Esponda et
al., 2020), and China (Peng, Jin, Wang, Ou, & Tang, 2015).
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Numerous studies have evaluated animals across the kingdom including
shellfish (clams and oysters), crustaceans, aquatic predators including marine
mammals and sharks, and coastal birds. These studies document benzotriazole
exposures in animals collected from Japan (Nakata, Murata, & Filatreau, 2009;
Nakata, Shinohara, Murata, & Watanabe, 2010), the North American Great Lakes
(Lu et al., 2018) and other locations in Canada (Lu, De Silva, Zhou, et al., 2019)
including Arctic sites (Lu, De Silva, Provencher, et al., 2019).
Although exposures have been well documented in animals, human
exposures are less-well studied. Two studies have evaluated human breast milk
samples collected from four Asian countries (Japan, the Philippines, Vietnam, and
Korea. Multiple benzotriazole UV stabilizers were measured in milk samples,
typically in the range of 1-75 ng/g lipid when examined individually. In Korea, the
sum of eight benzotriazole derivatives measured in human milk was 181 ± 317 ng/g
lipid (S. Lee et al., 2015). In Vietnam, the Philippines, and Japan, the sum of eight
UV stabilizers was 300 ± 240 ng/g, 100 ± 130 ng/g, and 28 ± 34 ng/g lipid,
respectively (J. W. Kim et al., 2019).

2.4.4

ADME

A rodent study of 2-(2’-hydroxy-3’,5’-di-tert-butylphenyl)benzotriazole (HDBB),
a UV stabilizer and absorber used in plastics, documented several metabolic
outcomes in rats administered 0.5, 2.5 or 12.5 mg/kg/day for 28 days (HirataKoizumi et al., 2009). Following intragastric administration, HDBB was rapidly
absorbed into the bloodstream, with concentrations that peaked 5-8 hours after daily
intake. In animals administered the highest dose, maximal plasma concentrations of
HDBB were in the range of 3-5 μg/L with no clear sex-specific effects. Furthermore,
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the toxicokinetic parameters were similar after the first administered dose and the
28th administered dose, and no HDBB metabolites were ever measured in plasma
samples.
In a human study, a single volunteer was administered a single dose of UV328 (0.3 mg/kg) and blood samples were collected 2, 4, 6, 8, 10, 24, 34 and 48
hours after exposure. The maximum blood concentration was measured at 8 hours
(1.31 mg/L) post-exposure, and five metabolites were measured at this time point
(Denghel & Göen, 2021). Analyses of urine samples collected from this individual
revealed that urinary concentrations of the parent compound had no detectable
levels of UV-328 in samples collected at 24 hours post-exposure, but four
metabolites were measured at concentrations ranging from 1.4 – 9.2 μg/L (Denghel
& Göen, 2020). A more complete human metabolism study is promised for the
future.

2.4.5

Toxicity

The hazards of specific benzotriazole UV stabilizers have been evaluated in
invertebrates, fish, and rodents in controlled laboratory studies. Although many of
the benzotriazoles have not been studied, and there is a need for studies to evaluate
environmentally relevant mixtures, the few studies that are available suggest
potential adverse effects across the animal kingdom.
In studies evaluating the freshwater crustacean Daphnia magna, neither UV234 or UV-328 altered neonate number, size, or number of molts (Giraudo et al.,
2017). There were also no effects of either benzotriazole on oxidative stress gene
expression in this species. Yet, both benzotriazoles altered expression of oxidative
stress genes in C. reinhardtii, a species of freshwater green algae; production of
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reactive oxygen species was also increased after exposure to UV-328 in this
species.
Other studies have examined the effects of benzotriazole UV stabilizers on
measures of toxicity in zebrafish (Liang, Adamovsky, Souders, & Martyniuk, 2019).
Effects of UV-234 were observed on embryo hatching time, measures of
mitochondrial and non-mitochondrial respiration, expression of genes involved in
oxidative stress, and responses in a photokinesis behavioral experiment. Different
effects were observed in zebrafish exposed to UV-320, which did not affect hatching
time but altered measures of basal and non-mitochondrial respiration, expression of
genes involved in oxidative stress, and genes associate with innate immunity.
In rats, administration of HDBB for 28 days induced numerous changes
associated with toxicity (Hirata-Koizumi et al., 2007). Doses at or above 2.5
mg/kg/day altered red blood cell counts, hematocrit and hemoglobin levels, and
blood glucose levels. HDBB exposures altered other clinical chemistry measures
including blood cholesterol and triglyceride levels, and increased liver and kidney
weights at necropsy. Histopathological evaluation revealed degeneration of the
cardiac myocardium, cell infiltration in the heart, follicular cell hyperplasia in the
thyroid, and hypertrophy of liver hepatocytes in exposed males. A follow-up 28-day
study examined the effects of HDBB in castrated male and female rats (HirataKoizumi, Matsuyama, et al., 2008). Again, exposures to HDBB increased the weight
of the liver at necropsy with effects that were more extreme, and observed at lower
doses, in males compared to females. However, the sex-specific effects that were
observed in liver histopathology were absent in castrated males, suggesting a role
for hormones in the etiology of these effects.
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A chronic toxicity study evaluated rats exposed to HDBB daily over a period
of either 13 or 52 weeks (Hirata-Koizumi, Ogata, et al., 2008). Significant effects of
HDBB (usually observed in animals exposed to 0.5-2.5 mg/kg/day) were observed
on red blood cell count, hematocrit measures, and platelet counts in males. Effects
were also observed on blood biochemistry, with greater effects on males than on
females. In males, long-term effects were observed on organ weights (lungs, testes,
kidneys, liver, and heart, which were all heavier than controls) and body weights
(which were lighter than controls). In females, effects were only observed on liver
weight.
Collectively, these results suggest that the benzotriazole UV stabilizer HDBB
is toxic, with effects that are more severe in males than in females. This outcome
provides an indication that the actions of HCBB may be mediated by hormone
receptors, or there could be sex-specific effects on HCBB metabolism and excretion.

2.5 Risk / Benefit Analysis of Chemical Sunscreens
Chemical sunscreens were designed to be an effective tool to improve public
health so that “in the foreseeable future most skin cancer can be prevented”
(Urbach, Forbes, Davies, & Berger, 1976). That assurance has not been realized.
Quite the contrary, skin cancer both originating in keratinocytes (squamous and
basal cell carcinomas) and melanocytes (melanomas) are on a gradual but steady
rise (NIH, 2020; Rogers, Weinstock, Feldman, & Coldiron, 2015b).
While the use of chemical sunscreens has increased, especially as these
chemicals are added to more and more personal care products, evidence continues
to mount that chemical sunscreens are a detriment to the health of humans, wildlife,
and whole ecosystems. Popular use of oxybenzone has polluted organisms on
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virtually all the branches of the phylogenetic tree. This circumstance with
oxybenzone creates two reactions: astonishment & hope. Astonishing is the rate in
which oxybenzone has spread everywhere on the planet and the volume in use that
allows it to keep polluting. Hope is that the damage can be undone. Because
oxybenzone can be metabolized, its more judicious use in the future could mean that
pollution of environmental matrices can be mitigated.

2.6 Alternatives to Chemical Sunscreens
Inorganic sunscreens based on metals were once frowned upon due to their
unattractive formulation. Yet, mineral sunblockers today are largely designed as
nanostructures, most commonly of zinc oxide and titanium dioxide. As pollution with
chemical sunscreen has become a concern, nano-sunblockers have been reexamined for their possible market potential and hope as safer sun protection. But
nanoparticles are not without risks. When applied to the skin, zinc nanoparticles
pass through the epidermal and dermal layers and are absorbed systemically
(Gulson et al., 2010) and their hydrophobicity and persistence further raise concerns.
Promising work with plant extracts, e.g., green and white tea, as agents to
protect against UV-induced stress – suggests some possibility for use as
sunscreens, as measured by the presence of Langerhans cells and absence of
oxidative damage in skin cells in vivo (Camouse et al., 2009). Consumption of
extracts from the fruit Garcinia indica (also known as mangosteen) enhances
endogenous UV factors (Dike & Deodhar, 2015). More work is certainly needed to
identify safer alternatives, and it should not be assumed that “natural” products are
necessarily safe, or that high dose supplements of single compounds can replicate
the more complex effects of whole foods.
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2.7 Conclusions
Short, habitual exposure to the complex spectrum of sunlight has a multitude
of therapeutic effects. First, it effectively enables synthesis of vitamin D3 from a
cholesterol metabolite in the skin. Following several more conversions, the active
version of vitamin D is then responsible not only for absorption of calcium from the
diet, calcium and phosphate homeostasis, and bone metabolism, but also for arterial
health, and tumor prevention via inhibited inflammation and proliferation. While
supplementation with vitamin D has been heavily promoted (Wacker & Holick, 2013),
large epidemiological studies have shown no benefit compared to placebo against
several types of cancer or cardiovascular disease (JoAnn E Manson et al., 2019), no
effect on the quality of cartilage, bone, or pain in the joints of osteoporotic patients
(Jin et al., 2016), and no effect on bone and cartilage health in infants (Gallo et al.,
2013). Only in elderly populations does vitamin D supplementation reduce the risk of
hip and nonvertebrate fractures, but only after administration of doses twice the
recommended 400IU per day (Bischoff-Ferrari et al., 2005). Second, sunlight
increases nitride oxide in the skin and therefore naturally lowers blood pressure (D.
Liu et al., 2014), it increases levels of serotonin and dopamine (Lambert, Reid, Kaye,
Jennings, & Esler, 2002), and exposure to sunlight is associated with increased life
expectancy by lowering overall mortality (Lindqvist et al., 2014b). Conversely, long,
ad hoc exposures to sunlight are associated with acute damage of the skin,
accelerated skin aging, and skin neoplasias.
Considering the many benefits associated with sun exposure, as well as the
risks associated with excess exposure to UV light, humans have responded by
producing dozens of chemicals that can be used in sunscreen formulations. The
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incorporation of these chemicals into numerous personal care products, beyond
traditional sunscreens, has increased their release into the environment.
Furthermore, UV filters are no longer limited to use on human bodies; they are also
now added to numerous consumer products to provide protection against the
harmful effects of UV radiation. This expanded use of UV absorbing and UV
stabilizing chemicals has led to contamination of environmental matrixes, wildlife,
and the bodies of humans.
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CHAPTER 3

METHODS FOR MAMMARY GLAND ASSESSMENT

3.1 Assessing the Mammary Gland: Whole Mounts
My dissertation projects involve evaluations of the mouse mammary gland in
both sexes during several life stages. These approaches allowed for the assessment
of a set of well-established variables while developing several new ones. First, in
many of our studies, we examine the 4th inguinal mammary gland ductal network in
a “whole mount” preparation, i.e., the mammary fat pad is dissected in its entirety
and spread on a slide glass, processed and stained, and then visualized using a
dissection microscope at magnifications from about 10x to 35x.
In life stages prior to adulthood, we typically image the entire mammary gland
and measure in a 2-dimensional view the entirety of the epithelial ductal network.
The first quantification we perform is to measure the area subtended by ducts, an
endpoint known as the ductal area (FIGURE. 3.1A). The next measure of growth
tells us how far the ductal tree has grown relative to the centrally located lymph
node: the ductal extension (FIGURE 3.1.B). Growth of the mammary epithelium
during pubertal stages is dependent on the most distal structures of the mammary
ducts, the terminal end buds (TEBs), which are defined as bulb-like structures at the
tips of ducts that measure equal to or greater than 0.03mm2 (FIGURE 3.1C). These
are counted and individually measured.
The number of branching points is the fourth endpoint we measure in early life
stages in females and throughout the lifetime of male individuals. Branching points
occur because the actively proliferating cells of TEBs are guided not just straight
ahead but also to fork, creating secondary and tertiary branches from the primary
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stem. Further elongation brings about still more secondary and tertiary branching
and counting the forking events provides an estimation of the tree complexity
(FIGURE 3.1D). A simple counting method, however, is difficult to use to quantify
branching points in the more complex epithelial structures of females starting at
pubertal stages. Therefore, we have explored the possibility of using the Sholl
analysis, a software tool originally developed to measure the complexity of branching
in neurons, and adapted for the rodent mammary gland by our collaborators at
NIEHS (Stanko, Easterling, & Fenton, 2015; Stanko & Fenton, 2017). Evaluation of
the Sholl analysis was the topic of an undergraduate honors thesis by Gillian Szabo,
who used it to quantify the effects of several xenoestrogens on both male and
female mouse mammary glands. However, her analyses revealed that this complex,
time-consuming method was no better at quantifying effects of xenoestrogens on the
mammary gland than the more simplified quantification tools described above.

Figure 3.1: Evaluation of Whole Mounted Mammary Gland. A) Ductal Area. B)
Ductal Extension. C) Branching Points. D)Terminal End Buds. E) Grid Analysis. F)
Anomalies.
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Adult whole mount mammary glands in BALB/c female mice are generally too
large and too complex to be effectively assessed using most of the endpoints
described above. For two of my projects that assessed adult mammary tissues –
collected either from the F1 generation at 9-11weeks of age or from post-involution
pectoral mammary glands of F0 generation female mice up to 52 weeks old – we
applied so called “grid analysis”, a method of unbiased stereology used to quantify
the volume fraction of specific structures. We have also quantified mammary gland
parameters using optical density, which relies on the spectrophotometric tools of the
microscope to compare darkly stained structures (e.g., epithelium) between images
(FIGURE 3.1E).
Lastly, aged and disrupted mammary glands suffer from various structural
anomalies observable in the whole-mounted mammary glands with a dissection
microscope. Intraductal epithelial hyperplasia are a common abnormality with or
without malignant potential that may occur either due to a genetic precondition or
exposure to excessive endogenous or exogenous estrogens (Bocchinfuso, Hively,
Couse, Varmus, & Korach, 1999; K. Mandrup, Boberg, Isling, Christiansen, & Hass,
2016) (Vandenberg et al., 2008a). These structures appear as ducts with a beaded
appearance (FIGURE 3.1F). We typically report these kinds of hyperplasia as a
binary outcome (present/absent) within each whole-mount and also score their
severity. Hyperplastic alveolar structures can also be observed in whole-mounted
mammary glands; these appear as heavily stained, and sometimes overgrown,
lobular units.
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3.2 Assessing the Mammary Gland: Epithelium
The mammary gland is an organ comprised of an interacting collection of
tissue types, origins, functions, and regulation. The normal mammary gland has a
relatively rigorous organization of ductal epithelial cells compartmentalized by the
proteoglycans and a matrix of basal lamina from the surrounding stroma.
The mammary epithelium is a bilayer located ventral to the basal lamina.
Facing the ducts is a layer of luminal cuboidal cells connected firmly to an underlying
sheet of myoepithelial and/or basal cells in various stages of stemness (Cristea &
Polyak, 2018; Slepicka et al., 2021). Despite its rigorous structure, the epithelial
cellular environment is highly dynamic throughout the female’s lifetime and the cells
of both the epithelial layers display various phenotypes. For example, in the adult
murine mammary gland, the basal progenitor cells are abundant in nulliparous
females and during pregnancy; myoepithelial and protein c receptor basal cells are
detected almost exclusively during lactation; and fewer basal cells appear during
involution (Bach et al., 2017). The latest methods using large-scale single-cell
profiling underscore the complexity of the long- and short-term progenitor cells
during both rapid morphogenesis – puberty and pregnancy – and throughout the
“maintenance” periods (Fu, Nolan, Lindeman, & Visvader, 2020). Moreover, transient
intermediate phenotypes either between the luminal and basal cells during
embryonic development or two luminal types in the adult mammary gland were
identified (Pal et al., 2017; Trejo, Luna, Dravis, Spike, & Wahl, 2017).
In the mouse, during puberty, the ducts open into TEBs; these are stem-cell
enriched structures that drive branching and elongation of the ductal web (Paine &
Lewis, 2017). On the end most distant from the nipple, the TEBs are covered with a
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line of cap cells that will eventually become myoepithelial cells. The TEB itself is
filled with body cells that beget luminal cells. We evaluate TEBs for markers of
proliferation, which allows us to quantify the magnitude of ductal growth, and
apoptosis, the morphogenetic process responsible for ductal lumen formation. The
mammary gland maintains a balance between these two opposing processes and,
although it may seem counter-intuitive, estrogens are responsible for both ductal
growth and ductal patency; this balance is potentially disrupted due to abnormal
estrogen signaling induced by environmental contaminants (Humphreys, 1999; J.
Wang, Jenkins, & Lamartiniere, 2014).
Two types of luminal cells have been identified based on their relative
expression of hormone receptors – hormone receptor (HR) high or low. HR-high
cells, e.g., hormone sensing luminal cells, also belong to two groups: hormone
sensing progenitor cells (present in nulliparous tissues and in post-pregnancy
involution) or differentiated cells (identified in nulliparous animals, during involution
and pregnancy) (Bach et al., 2017). By using single-cell RNA sequencing, it was
discovered that the key genes characteristic for low-HR cells progenitor cells are
only expressed in nulliparous animals and in post-pregnancy involution while low-HR
alveolar – both progenitor and differentiated -are expressed during pregnancy and
lactation; and that high-HR luminal progenitors are present in nulliparous and
involuting mammary gland. Fifteen distinct epithelial mammary cells speak of a
complex cellular environment where cell populations are transient and commonly
express an intermediate phenotype (Bach et al., 2017; Fu et al., 2020).
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Figure 3.2: Expression of epithelial protein in the mammary gland.
A) Ki67-positive cells in a mammary duct (box: mitosis in a terminal end bud. B)
Expression of ERα in a mammary duct. C) Expression of PR in a mammary duct.

Many endocrine disruptors are known to alter the expression of hormone
receptors, either at the level of mRNA (typically measured with qRT-PCR or
RNAseq) or the number of hormone receptors (measured with western blots), or the
number of cells expressing hormone receptors (measured with
immunohistochemical evaluations) both in vivo and in vitro (La Merrill et al., 2020; H.
R. Lee et al., 2013). In the mammary gland, exposures to synthetic estrogens
increase the risk of cancer in females in at least two generations, and mammary
neoplasia in rodents of both sexes (Hilakivi-Clarke, de Assis, & Warri, 2013;
Sweeney, Hasan, Soto, & Sonnenschein, 2015). In our lab, we typically evaluate
expression of hormone receptors (including ERα and PR; TABLE 3.1.) in epithelial
cells using immunohistochemical methods. Briefly, tissues that have been fixed are
embedded in paraffin and sectioned to single-cell thickness, revealing the mammary
structures. Nuclear receptors are detected by incubating these tissues with
polyclonal rabbit antibodies generated against the receptor of interest; the antibodies
are diluted in blocking solution in concentrations optimized for the mammary gland
(usually 1:1000 for ERα, 1:500 for PR). The bound antibodies, and thus the hormone
receptor expressing cells, are then detected using tagged secondary antibodies and
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a colorimetric indicator. The immunohistochemistry method is also used to assess
the level of proliferation, which is usually reported as a percent of actively
proliferating epithelial cells (Ki67 marker, 1:1000).
Table 3.1: Antibodies

3.3 Assessing the Mammary Gland: Stroma
In the mouse mammary gland, stroma refers to any structure located outside
the ductal basal lamina. Directly adjacent to the lamina sits the periductal stroma,
consisting of collagen fibers and proteoglycans, fibronectin and matrix proteinases.
All of these components are produced by stromal fibroblasts (Unsworth, Anderson, &
Britt, 2014).
The first measure we typically take to evaluate the mammary stroma is to
quantify the width of the periductal stroma. Collagen fibers stain bright blue with
Masson’s trichrome stain while cytoplasm and muscle fibers are stained a
contrasting crimson red. Using the length tool in the ZEN Zeiss software, we take
eight measures (FIGURE 3.3A) from six ducts that are cut in a cross-sectional plane
per individual. These data are used to produce a single value representative of the
average width of the mammary periductal stroma for each individual.
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Moving outward from the densely packed periductal stroma stretches the
mammary fat pad. In the mouse mammary gland, adipocytes represent the most
abundant cells of mesenchymal origin. There are two types of adipose tissue
localized to the mammary gland, white and brown adipose cells, and both are crucial
for ductal morphogenesis and function. The white adipose cells serve the canonical
role of storing energy in the mammary gland while the brown adipocytes are quick to
burn it using their unique expression of mitochondrial uncoupling protein 1 (UPC1).
Despite what was once a textbook dogma (e.g., it was long believed that the adult
mammary gland was comprised only of white adipose tissue), brown fat persists into
adulthood with the potential of being mis-regulated due to environmental pollutants
(Di Gregorio et al., 2018; Gouon-Evans & Pollard, 2002). Based on their actions, a
new group of endocrine disruptors has been identified: metabolism disrupting
chemicals or, specifically to the metabolism of the adipose tissues, obesogenic
chemicals (Egusquiza & Blumberg, 2020; Heindel & Blumberg, 2019).
We have begun to evaluate animals exposed to estrogenic chemicals for
disruption to the mammary adipose tissue. Individual adipocytes of both white and
brown fat are assessed for their size/volume and measures of organization (e.g.,
number of neighboring cells) using formalin-fixed paraffin embedded tissues stained
with hematoxylin & eosin (FIGURE 3.3B). Moreover, expression of genes associated
with adipose tissue are also examined (see Chapter 5).
The third most abundant cell in the mouse mammary mesenchyme are
macrophages (MΦ). As scavengers, macrophages are essential cells of the immune
system that reside in the mammary gland throughout the entire life course (Stewart,
Hughes, Hume, & Davis, 2019). In fact, the origins of mammary gland macrophages
in adulthood can be tracked all the way to the embryonic sac and fetal liver
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(Jappinen et al., 2019), and their interaction with the epithelium is proving to be
important both in development and involution of the mammary gland (Dawson et al.,
2020; Gyorki, Asselin-Labat, van Rooijen, Lindeman, & Visvader, 2009). Two types
of MΦ can be distinguished based on their location in the mammary gland: ductal
macrophages that form a continuous network between luminal and basal layers
(Dawson et al., 2020); and stromal macrophages in close interaction with fibroblasts,
endothelial cells, and namely adipocytes (Schwertfeger, Rosen, & Cohen, 2006). In
the while fat, the classically activated M1 macrophages seem to promote

Figure 3.3: Evaluation of the Stromal Structures in the Mammary Gland.
A) Measuring the width of periductal stroma (trichrome stain). B) Adipose tissues
(brown patches encircled); TEB in the bottom left (H&E stain). C) Periductal
macrophages – arrows (F4/80 antibody). D) Mast cells in the periductal stroma –
arrows (toluidine blue stain)
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inflammation via secreting pro-inflammatory cytokines (Chawla, Nguyen, & Goh,
2011) while M2, the alternatively polarized macrophages recognized by the surface
receptor CD206, promote transformation of the white to beige type of adipocytes that
has been hypothesized as responding to environmental clues including the thyroid
hormones (Bertani et al., 2017; Francis et al., 2021; Nguyen et al., 2011). The
chemotactic and phagocytic roles are the primary task of macrophages, enabling
remodeling of the gland during post-lactation involution (O'Brien et al., 2012).
However, macrophages are not only involved in the destruction of mammary
structures, but are also involved in normal pubertal mammary development, stromal
homeostasis, and in the process of alveologenesis during the estrous cycle and in
late pregnancy (Chua, Hodson, Moldenhauer, Robertson, & Ingman, 2010; Dawson
et al., 2020; Pollard & Hennighausen, 1994; Y. Wang et al., 2020). Not surprisingly,
breast tumors are not devoid of macrophages and their dual and contested role is
discussed further in Chapter 8.
In our lab, we visualize macrophages using the F4/80 antibody and evaluate
their presence in the periductal stroma (FIGURE 3.3C). Evaluation of F4/80-stained
macrophages in induced mouse mammary tumors requires more complex methods
of quantification due to the abundance of macrophages in the tissue (FIGURE 8.5);
this became one of the topics of an undergraduate honors thesis by Shannon Silva.
Using a software named TissueQuant in FIJI, an open-source image processing
package by ImageJ, Shannon optimized a protocol that enabled us to isolate DABstained pixels (corresponding to the F4/80 signal) and quantify differences in
macrophage presence between chemical-exposed animals and controls.
Mast cells are phylogenetically old and phenotypically diverse cells that
mature and differentiate in peripheral tissues under paracrine control and regulation.
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In the mammary gland, both stromal fibroblasts and epithelial cells promote tissuespecific functional heterogeneity of mast cells. However, mast cells also act in
response to ad hoc needs of the tissue, producing a context-specific mixture of more
than 30 different cytokines (Crivellato, Beltrami, Mallardi, & Ribatti, 2004).
Granules in the cytoplasm of mast cells contain mostly heparin and histamine
associated with the primary role of the cells in innate immune responses to agents
causing allergic reaction. But the enzymes and cytokines produced by mast cells are
regarded as necessary for maintaining homeostasis and tissue repair in various
organs (Abe, Kurosawa, Ishikawa, & Miyachi, 2000; Noli & Miolo, 2001). In the
mammary gland, other enzymes such as tryptase, chymase, and carboxypeptidase
have been identified in mast cells granules and associated with normal development
(Galli & Tsai, 2008). During postnatal development, mast cells are well represented
in the periductal stroma and near blood vessels, and during puberty they are located
directly adjacent to the TEB residual basal lamina and cap cells, and are essential
for TEB growth and ductal elongation (Brisken & Ataca, 2015). Mice lacking mast
cells grow fewer TEBs, and have fewer proliferating cells within TEBs while their
periductal collagen remains intact (Lilla & Werb, 2010). Proliferation and repair are
not the only morphogenetic processes mast cells are involved in as they also
regulate apoptosis and mammary gland remodeling post-lactation via binding to
kallikrein in the plasma (Lilla, Joshi, Craik, & Werb, 2009).
Among other enzymes released from mast cells, tryptase and chymase have
been demonstrated to take part in angiogenesis, a multistep process that involves
migration of new endothelial cells, proliferation of muscle cells and fibroblasts and
hollowing of the new vessels via well-coordinated apoptosis (Blair et al., 1997)
(Saarinen, Kalkkinen, Welgus, & Kovanen, 1994). Mast cell pro-angiogenic factors
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include angiopoetine-1, IL-18, TNFα, and VEGF that may, indeed, contribute to
tumor promotion (Maltby, Khazaie, & McNagny, 2009) (Dyduch, Kaczmarczyk, &
Okon, 2012). In the case of breast cancer, mast cells are capable of re-directing the
migration and differentiation of T lymphocytes by secreting histamine, proteases,
TNF α and other chemokines (Galli, Grimbaldeston, & Tsai, 2008). Lastly, the
population of mast cells and serum histamine oscillate based on the stage of the
estrous cycle and positively correlate to 17β-estradiol blood concentrations in
ovariectomized Wistar rats (Jing, Wang, & Chen, 2012). Collectively, their complex
role in proliferation, immunity, and angiogenesis allows mast cells to contribute to
breast cancer initiation and progression (E. Z. da Silva, Jamur, & Oliver, 2014).
For their part in normal mammary tissue and neoplasia, we assess the
abundance of mast cells in the developing mammary gland, mammary tumors, and
in the surrounding stroma (FIGURE 8.5). Due to the content of their intracellular
granules, mastocytes stain metachromatically, i.e. toluidine blue stains the cells
bright purple with granules clearly recognizable (Ribatti, 2018).

3.4 qRT-PCR
In addition to microscopic evaluation of receptors, cells, and tissue
compartments, we evaluate expression of the genes of interest from mammary
tissue samples that are snap frozen and stored at -80°C. First, we extract RNA using
Trizol reagent and a BeadBug microtube homogenizer, examine the RNA purity as
the A260/A280 ratio, and quantify the concentration of RNA in the sample using
Nanodrop UV spectrophotometry. 1 mg of RNA from each sample is transcribed to
cDNA using reverse transcription. Lastly, 2 µL of cDNA is combined with forward and
reverse primers for each target gene (TABLE 3.2) and SYBR green master mix to
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amplify and detect the gene of interest (thermal prolife cycles are set as follows: 10
minutes at 95°C, 40 cycles of 15 seconds at 95°C, 30 seconds at 60°C, and 15
seconds at 72°C). A melting-curve analysis is conducted to identify nonspecific
products. Finally, quantification of the target gene is evaluated relative to reference
genes determined using the ΔΔCt method. Every sample is run in triplicate for each
target gene. We use two reference genes for the mammary gland analyses: β actin
and β2 microglobulin (TABLE 3.2).

Table 3.2: Primer sequences
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CHAPTER 4

EFFECTS OF PERINATAL OXYBENZONE EXPOSURES ON THE MALE AND
FEMALE MOUSE MAMMARY GLAND
This chapter was previously published as:
Matouskova, K., Jerry, D. J., & Vandenberg, L. N. (2020). Exposure to low doses of
oxybenzone during perinatal development alters mammary gland morphology in
male and female mice. Reproductive Toxicology, 92, 66-77.

4.1 Abstract
Oxybenzone (benzophenone 3) is an ultraviolet radiation filter commonly used in
personal care products including sunscreens, textiles and inks, and food and
beverage containers, among others. Due to its widespread use, human exposures to
oxybenzone are widespread. Oxybenzone is considered an endocrine disrupting
chemical due to its antiestrogenic and antiandrogenic properties. We evaluated the
effects of oral exposures to oxybenzone on the growth and morphology of the
mammary gland, body weight and anogenital distance in BALB/c mice exposed to
30, 212 or 3000 μg/kg/day in utero and during lactation. Developmental exposures to
oxybenzone reduced the size and growth of mammary gland in males prior to and
during puberty. In exposed females, oxybenzone reduced mammary cell
proliferation, decreased the number of cells expressing estrogen receptor α, and
altered mammary gland morphology in adulthood. These results suggest that even
low doses of oxybenzone can disrupt hormone sensitive organs during critical
windows of development.
Keywords: 2-hydroxy-4methoxybenzophenone, endocrine disruptor; sunscreen;
xenoestrogen; anogenital distance
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4.2 Introduction
Oxybenzone is a synthetic compound used to protect people and consumer
products from solar irradiation. It is added to many personal care products and found
at high concentrations in many commercially available sunscreens. Although it was
once thought that oxybenzone applied in a sunscreen remains on the skin surface,
both animal (R. Jiang et al., 1999) and human studies (Janjua et al., 2004)
demonstrate that it penetrates the skin (C. Fernandez et al., 2002; R. Jiang et al.,
1999), enters the blood stream (Hayden et al., 1997), and is excreted via urine and
feces (Kadry et al., 1995).
In addition to dermal exposure, the growing use and production of
oxybenzone has increased its prevalence in consumer goods, resulting in exposures
via the oral route as well. Oxybenzone-enhanced glass and plastics protect food,
beverages, and other consumer goods from degradation caused by sunlight
("Packaging gets active: Additives lead the way," 2004). Moreover, many textiles
include oxybenzone for color stability, and industrial inks contain oxybenzone as a
wetting agent and photo-initiator (Danish Environmental Protection Agency, 2015).
Finally, oxybenzone is added to perfumes to enhance the fragrance of musk, and to
candies and other foods as a flavoring agent. As a result of high production of
oxybenzone and only partial ability to remove it from drinking water (Rodil et al.,
2012), it has also been detected in surface water (Fent et al., 2010), wastewater and
drinking water (C. P. da Silva et al., 2015; Loraine & Pettigrove, 2006b).
Oxybenzone has recently received significant attention as an environmental pollutant
suspected to contribute to coral bleaching across the worlds’ oceans (Downs et al.,
2016).
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Greater than 98% of the U.S. general population has detectable urinary
concentrations of oxybenzone, and exposures appear to be increasing; in samples
collected between 2003-4, the mean concentration was 22.9 μg/L (Calafat et al.,
2008) while six years later the mean concentration was 36.3 ng/L (Meeker et al.,
2013). The urinary concentration of individuals who report “always” using sunscreen
is more than two times higher than in those who report only “sometimes” using
sunscreens and both are strikingly higher from those who reported “never” using
sunscreens (Ferguson et al., 2017). Besides urine, oxybenzone has been detected
in blood (T. Zhang et al., 2013), semen (Leon et al., 2010), and in amniotic fluid and
cord blood, suggesting that the compound can cross the placenta (Krause,
Frederiksen, Sundberg, Jorgensen, Jensen, Norgaard, Jorgensen, Ertberg, Juul, et
al., 2018). Neonates are further exposed via human milk (Molins-Delgado et al.,
2018; Rodriguez-Gomez et al., 2015); concentrations as high as 121 ng/g of lipid
were measured in three different cohorts in Switzerland (Schlumpf et al., 2010).
Oxybenzone affects hormone signaling in animals, including humans
(Ghazipura et al., 2017; Maipas & Nicolopoulou-Stamati, 2015). Several studies
have demonstrated that oxybenzone acts as an estrogen receptor (ER) agonist in
yeast assays (Balazs et al., 2016; Kunz & Fent, 2006a), human cell cultures
(Schlumpf et al., 2001; Suzuki et al., 2005) and fish (Bluthgen et al., 2012). There is
also strong evidence that oxybenzone acts as an ER antagonist in yeast reporter
assays (Kunz & Fent, 2006a) and fish (Balazs et al., 2016; Bluthgen et al., 2012).
Although the concept of a single compound having both agonist and antagonist
activities for a single receptor seems contradictory, this is a common characteristic of
other selective ER modulators (often called SERMs) like tamoxifen (Jensen & Khan,
2004). Further, a number of studies point to oxybenzone’s potent anti-androgenic
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effects in in vitro reporter cell lines (R. Ma et al., 2003), in yeast reporter assays
(Balazs et al., 2016; Kunz & Fent, 2006b), and in fish (Bluthgen et al., 2012). Some
of these actions may be due to the endocrine disrupting properties of oxybenzone’s
metabolites as well (Watanabe et al., 2015).
Estrogens, progesterone and testosterone play a pivotal role in the
development of hormone-sensitive organs including the mammary gland. Although it
is generally held that the mammary gland in both males and females develops
independent of hormones prior to puberty, and only the female hormones produced
during the estrous cycle promote epithelial growth (Brisken & O'Malley, 2010), the
mammary mesenchyme expresses both ER and androgen receptor (AR) during
prenatal development. Further, exposures to ER and AR agonists and antagonists
during this critical window of development can affect the growth of the mammary
gland, its function and risk of disease (Fenton, 2006). Importantly, the mammary
gland is a sexually dimorphic structure, therefore male and female glands not only
develop differently, they are affected by endocrine disruptors differently. In both male
and female mouse embryos, the mammary band of ectodermal cells begins to form
around embryonic day 10.5 and is observed on both the left and right sides,
stretching from the upper to lower limb (Stephens, 1982). In female mice, the
ectoderm invaginates into the underlying mesenchyme, forming an epithelial cord
that branches into the developing fat pad and forms a nipple (five pairs in mice)
attached to the skin. Yet, in male mice, the production of testosterone from the fetal
testis causes an AR-dependent condensation of the mesenchyme around the stalk
of the epithelial cord, ultimately detaching it from the overlying epidermis; the slightly
branched epithelial cord does not open to the surface and nipples do not form
(Topper & Freeman, 1980). Numerous studies have shown that anti-androgenic
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chemical exposures during this critical window of mammary gland development lead
to nipple retention in males (Christiansen et al., 2014; C. Wolf, Jr. et al., 1999), and
other studies have shown that perinatal exposures to estrogenic chemicals can
increase the growth of the male epithelium even when nipples are not present (Kolla,
Pokharel, & Vandenberg, 2017; Pokharel et al., 2018; Skarda, 2002; Vandenberg et
al., 2013). Other effects of antiandrogenic and estrogenic compounds on the male
reproductive system have been reviewed by Hejmej et al. (Hejmej, Kotula-Balak, &
Bilińska, 2011).
In this study, we investigated the endocrine-disrupting potential of
oxybenzone on male and female BALB/c mice exposed during gestation and the
perinatal period. We evaluated offspring at three different life stages: prior to
puberty, at puberty and in adulthood. Our results suggest that developmental
oxybenzone exposures alter growth parameters in the mouse mammary gland,
findings consistent with what would be expected if oxybenzone was a hormonally
active endocrine disruptor.

4.3 Methods
Animals
6-8-week-old BALB/c female mice (UMass colony, D.J.J. laboratory, Amherst,
MA) were randomly assigned to one of four treatment groups using SPSS statistical
software Version 24 (IBM Inc, Armonk, NY) to distribute them evenly according to
their body weight. Females were mated and housed in polysulfone cages with
bedding and food (LabDiet Chow 5058; LabDiet, St. Louis, MO) and tap water (in
polysulfone bottles with rubber stoppers and metal tops) provided ad libitum.
Animals were maintained at the University of Massachusetts, Amherst Morrill Animal
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Facility, in temperature- and light-controlled conditions (12-hour cycles of light and
dark). After weaning, offspring were housed under the same conditions as their
mothers, with 4-5 same-sex (and same-treatment) animals per cage. All
experimental procedures were approved by the University of Massachusetts
Institutional Animal Care and Use Committee.

Chemical administration
From pregnancy day zero (when a sperm plug was observed) until the day
before weaning (on lactational day 21), females were weighed and orally dosed daily
by pipet with either tocopherol-stripped corn oil or oxybenzone dissolved in
tocopherol-stripped corn oil. As a result, the offspring evaluated in this study were
exposed in utero and during the first 21 days of postnatal life via the mother. Three
doses of oxybenzone were used: 30 μg/kg/day, 212 μg/kg/day, and 3000 μg/kg/day.
All three doses chosen for our study are below the doses used in traditional
toxicological studies (μg vs mg) (Tyl, 2009), and the two lowest doses are likely
relevant to human intake based on back-calculations of urinary concentrations in
pregnant women (Woodruff et al., 2011). Dams were allowed to deliver naturally and
litters were not culled. Sample sizes for the treatment groups were: controls,11
litters; 30μg/kg oxybenzone, 10 litters; 212 μg/kg oxybenzone, 11 litters; 3000 μg/kg
oxybenzone, 9 litters. Only one female and one male from each litter was selected
for each endpoint to avoid litter bias, but sample sizes for each endpoint vary based
on litter size. Characteristics of litters are reported in (LaPlante et al., 2018) and the
litter sizes (mean ± standard deviation) by treatment group were controls: 4.4 ± 1.6;
30 µg/kg/day: 5.0 ± 1.6; 212 µg/kg/day: 3.6 ± 2.9; 3000 µg/kg/day: 3.9 ± 2.6.
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Pups were weaned on postnatal day (PND) 21 and co-housed with same-sex
animals of the same treatment group for the remainder of the experiment. Animals
were ear-tagged upon weaning for identification.

Euthanasia and tissue collections
At weaning, we determined the sex of each offspring and assigned them to
one of the three age groups: one male and one female from each litter was
euthanized prior to the onset of puberty (at PND21), in puberty (PND32-35), or in
adulthood (postnatal week 9-11). Results from the dams (the F0 generation) are
described in LaPlante et al., 2018 (LaPlante et al., 2018).
On the day of sacrifice, animals were euthanized with CO2 inhalation followed
by cervical dislocation to ensure death. Timing of euthanasia was not limited to
specific stages of the estrous cycle. The weight of each animal was recorded and
anogenital distance was measured with calipers. Anogenital index (AGI) was
calculated as the anogenital distance divided by body weight to account for
differences in body size. From every male animal we collected both the left and right
fourth inguinal mammary glands, spread both on a glass slide (Thermo Fisher
Scientific, Waltham, MA), and fixed them overnight in 10% neutral-buffered formalin
(Thermo Fisher Scientific). From every female animal we dissected the right fourth
inguinal mammary gland, spread it on a glass slide (Thermo Fisher Scientific,
Waltham, MA) and fixed it overnight in 10% neutral buffered formalin. The left
mammary gland was fixed in 10% neutral buffered formalin overnight before being
washed, dehydrated, and embedded in paraffin for histology and
immunohistochemistry.
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Whole mounted mammary gland processing and morphometric evaluation
Whole mounted mammary glands were processed and stained according to
standard protocols (Markey, Luque, Munoz De Toro, Sonnenschein, & Soto, 2001;
Stanko & Fenton, 2017). Briefly, glands were moved through a graded series of
ethanols (70%, 95% and 100%, for one hour each) followed by two washes of
toluene (one hour the first wash, at least two hours in the second wash) to remove
fat from the tissue, rehydrated through a series of ethanols (100%, 95%, 70%) and
stained overnight with carmine. Carmine stains all nuclei but allows the ducts to be
distinguished because of the close proximity of the epithelial cells to each other
compared to the size of the adipose cells in the stroma. Finally, the samples were
dehydrated through a series of alcohols (70%, 95% and 100%, one hour each) and
xylene for two hours, and sealed in individual k-pax heat-sealed pouches (Fisher
Scientific) containing 5ml methyl-salicylate (Acros Organics, Morris Plains, NJ).
The whole mounted mammary glands were imaged with a Zeiss AxioImager
dissection microscope (Carl Zeiss Microscopy, Jena, Germany) and a Zeiss highresolution color camera. All measurements were made with ZEN software (Carl
Zeiss Microscopy, Jena, Germany).
In the PND21 and pubertal female mammary glands, and in the PND21,
pubertal and adult male mammary glands, measurements included the mammary
gland ductal area (e.g., the area subtended by ducts), ductal extension (e.g., the
furthest growth of ducts relative to the center of the lymph node, a centralized
landmark), number and area of terminal end buds (TEBs, defined as bulb-shaped
structures at the end of ducts measuring at least 0.03 mm 2). Details about these
measurements are provided in (Vandenberg et al., 2006) for females and
(Vandenberg et al., 2013) for males. For ductal extension, negative values are
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assigned to ductal trees that have not yet reached the midpoint of the lymph node,
and positive values are given to ductal trees that have grown past the midpoint of the
lymph node; in groups where all animals had negative ductal extensions, the
absolute values (positive) are graphed for ease of interpretation. In males at all ages,
the number of branching points in the entire ductal tree were counted as well.

Whole mounted mammary gland evaluation in adult female mice
The adult female mammary gland is large and complex, so different
measurements were made using methods described previously (Vandenberg et al.,
2008b). In brief, we imaged the area just anterior to the central lymph node at 30x
magnification. Using ZEN software, we placed a 15 by 12 grid on the picture and
characterized the ductal structures at each of the 180 crosshairs (e.g. ducts, terminal
ends, and alveolar buds). The volume fraction of each structure was calculated by
dividing the number of crosshairs hitting each structure by the total number of
crosshairs hitting mammary tissue using standard methods from unbiased
stereology (Howard & Reed, 2004; Vandenberg et al., 2008b).

Tissue embedding, sectioning and histological staining
Fixed mammary glands were washed in 1x phosphate buffered saline,
dehydrated through a series of alcohol and embedded with paraffin (Leica
Biosystems, Richmond, IL) under vacuum. Paraffin blocks were cut into five
micrometer sections on a rotary microtome (Fisher Scientific) and mounted on
positively charged slides (Fisher Scientific) for histological evaluation and
immunohistochemistry.
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For histological evaluations, slides were deparaffinized with xylene and a
series of alcohols, stained with Harris’ hematoxylin and eosin (Fisher Scientific),
dehydrated, and mounted with permanent mounting media (Fisher Scientific). Digital
images were collected using a Zeiss Axio Observer.Z1 inverted microscope, a 10X
objective, and a high-resolution color camera (Carl Zeiss Microscopy).

Immunohistochemistry
Expression of three markers was evaluated using standard methods for
immunohistochemistry and commercial antibodies including rabbit anti-ERα (EMD
Millipore, Cat# 06-935, Temecula, CA; diluted 1:1000); rabbit anti-Ki67 (Fisher
Scientific, Cat# RM-9106-S1; diluted 1:1000), a marker of proliferation; and rabbit
anti-progesterone receptor (PR; Abcam, Cat# ab131486, Cambridge, MA; diluted
1:500). Briefly, sections were deparaffinized, hydrated through a series of alcohols,
microwaved in 10 mM citrate buffer (pH 6) for antigen retrieval, and treated with
hydrogen peroxide to quench endogenous peroxidases. Non-specific binding was
blocked with 1% milk protein in 5% normal goat serum (Cell Signaling Technology,
Danvers, MA).
Sections were incubated with primary antibodies (diluted in blocking solution)
at 4°C for 14-16 h. They were then washed and incubated with secondary antibody
(goat anti-rabbit, Abcam, Cat# ab64256) followed by streptavidin peroxidase
complex (Abcam, Cat# ab64269). Diaminobenzidine chromogen (Abcam, Cat#
ab64238) was used to visualize reactions. Sections were counterstained with
hematoxylin (Fisher Scientific). Each immunohistochemical run included a negative
control in which the primary antibody was replaced with 5% normal goat serum.
Images were collected of each sample for ERα, Ki67, and PR at 40X
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magnification with a Zeiss Axio Observer.Z1 inverted microscope. The fraction of
cells expressing ERα or PR was evaluated by counting at least 500 epithelial cells in
2-4 separate fields. Fraction of cells expressing Ki67 was evaluated by counting at
least 1000 epithelial cells in 3-5 separate fields. Different numbers of fields were
observed to ensure that sufficient cells were available for evaluation; the epithelial
structures in PND21 females are limited, so typically all fields with epithelium were
evaluated whereas in pubertal and adult females, fields were selected at random. All
epithelial cells were evaluated in each field that was imaged. Expression of ERα,
Ki67 and PR were expressed as a percent ratio of the total number of epithelial cells
evaluated.

Statistical analysis
SPSS Version 24 (IBM Inc, Armonk, NY) was used to analyze all data. First,
data were tested for linearity by regression analysis with treatment dose (0, 30, 212
or 3000 µg/kg/day) as the independent variable and the various outcomes
(mammary gland morphometric measurements, expression of markers, etc.) as the
dependent variable. A Pearson correlation is reported in the text when statistical
significance (p<0.05) or a possible statistical trend (p<0.1) was observed.
Next, normally distributed data were evaluated with one-way ANOVA (with
oxybenzone treatment as the independent variable) followed by Fisher’s LSD posthoc tests. For body weight measurements, number of pups in the litter was treated
as a covariate as weight has been shown to be affected by litter size (Suvorov &
Vandenberg, 2016). Mammary gland parameters were not corrected for litter size. A
p-value <0.05 was considered statistically significant.
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All data are graphed as mean ± standard error. All samples were collected,
and all analyses were conducted by experimenters blind to treatment group.

4.4 Results
Oxybenzone alters anogenital distance in males at PND21 and puberty but does not
affect male body weight
At all three ages, pups were weighed at the time of necropsy. In males, no
effect of oxybenzone was observed on body weight at any age (FIGURE 4.1A), even
when litter size was treated as a covariate to control for differences in growth
parameters (Suvorov & Vandenberg, 2016).
Anogenital distance (AGD), the length between the anus and the genitals, is a
sexually dimorphic measure that is known to be affected by prenatal exposures to
hormonally active agents. Typically, AGD is longer in males than females due to
production of androgens by the fetal testis. We adjusted AGD for the weight of the
animal (to calculate anogenital index, AGI) because body size and weight can
influence AGD (Swan, 2006). In males, AGI was reduced after exposures to 30μg
and 212μg doses (FIGURE 4.1C, ANOVA, p<0.05, Fisher’s posthoc p<0.05) at
PND21 and in puberty. In adult males, no differences in AGI were observed.

Oxybenzone alters body weight in females at puberty and in adulthood and
decreases female AGI at puberty
In females, developmental exposure to oxybenzone did not affect body
weight at PND21 (FIGURE 4.1B). However, at puberty, when litter size was treated
as a covariate, females exposed to 3000 µg/kg/day oxybenzone were heavier
compared to controls (ANCOVA, p<0.05, Fisher’s posthoc p<0.05). Furthermore,
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females exposed to 212 µg/kg/day oxybenzone were heavier in adulthood compared
to controls (ANCOVA, p<0.05, Fisher’s posthoc p<0.05).
In females, AGI was unaffected at PND21, but decreased by exposure to 212
μg/kg/day when measured at puberty (FIGURE 4.1D, ANOVA, p<0.05, Fisher’s
posthoc p<0.05). No effects of developmental oxybenzone exposure were observed
on female AGI in adulthood.

Figure 4.1 Oxybenzone alters body weight and anogenital
index in a sex- and dose-specific manner. A) Perinatal exposure
to oxybenzone did not affect male body weight at any age. B)
Measurements of anogenital index (AGI; anogenital distance
divided by body weight) in males at all three ages. C) Heavier body
weights were measured in females exposed to 3000 µg/kg/day
oxybenzone in puberty, and in females exposed to 212 µg/kg/day
oxybenzone in adulthood, compared to controls. D) Measurements
of AGI in pubertal females reveal lower AGI in females exposed to
212 µg/kg/day oxybenzone. In all panels, different letters indicate
significant differences, Fisher’s LSD posthoc after significant 1-way
ANOVA.
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Exposure to low doses of oxybenzone alters male mammary gland morphology
Like other strains of mice, even in the absence of nipples, male BALB/c mice
have a small mammary rudiment (FIGURE 4.2A). Our prior work demonstrated that
males of this strain also have left-right asymmetric mammary gland development,
with a right mammary ductal tree that is typically larger than the left at specific
stages (e.g., in puberty and in adulthood) (Pokharel et al., 2018). For this reason, we
evaluated the effects of oxybenzone on both the left and right mammary glands.
At PND21, developmental exposure to oxybenzone significantly reduced the
size of the male mammary gland epithelium on both the left and right sides (Figure
4.2B, ANOVA, p<0.05, Fisher’s posthoc p<0.05). At puberty, there were no
statistically significant effects of oxybenzone. Finally, we examined mammary gland
morphology in males in early adulthood (FIGURE 4.2D). There were no statistically
significant differences after oxybenzone exposure.
We also examined total branching points (a combined sum for the left and
right glands), a measure of mammary gland complexity in each male. At PND21,
mammary glands from all three oxybenzone treatment groups had significantly fewer
branching points compared to controls (FIGURE 4.2E, ANOVA, p<0.05, Fisher’s
posthoc p<0.05). By puberty and in adulthood, the control glands were less complex
in their branching, and there were no longer significant differences based on
oxybenzone treatment (FIGURE 4.2E).
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Figure 4.2: Perinatal exposures to oxybenzone alter growth parameters of the male
mammary gland. A) Left and right mammary glands from control BALB/c male mice at
PND21, in puberty, and in early adulthood. Dotted boxes outline the ductal trees. Scale bar
= 0.5 mm. B) Quantification of total ductal area in the left and right epithelial trees in
control and oxybenzone-exposed males at PND 21. C) Quantification of ductal area in
males at puberty. D) Quantification of ductal area in adulthood. E) Total branching points
were calculated (from left + right ductal trees) and evaluated at each of the three ages. In
all panels, different letters indicate significant differences, Fisher’s LSD posthoc after
significant 1-way ANOVA.

Perinatal exposure to oxybenzone induces modest alterations in growth of the
female mammary gland prior to and at puberty.
We next evaluated growth and development patterns in whole mounted
mammary glands collected from females. At PND 21, females exposed to the
highest dose of oxybenzone had modestly larger ductal areas compared to controls
(ANOVA, p<0.05, Fisher’s posthoc p<0.05) but no significant effects were observed
for the extent of growth into the fat pad (ductal extension) (FIGURES 4.3A,B,C).
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TEBs were observed in a few animals, with no significant differences in number or
size based on oxybenzone treatment (FIGURE 4.3A and data not shown).

Figure 4.3: Perinatal oxybenzone exposure induces modest changes to
the prepubertal and pubertal female mammary gland. A) Representative
whole mounted mammary glands from females from the four treatment groups
at PND21. Dotted boxes outline the ductal tree. Scale bar = 2 mm. B)
Quantification of ductal area and C) ductal extension in females at PND21.
Although not indicated in the graph, ductal extension for all females at PND21
has a negative value because the ductal tree has not yet reached the lymph
node. D) Representative whole mounted mammary glands from females from
the four treatment groups at puberty. Arrowheads indicate select TEBs. Scale
bar = 2 mm. E) Quantification of ductal area and F) ductal extension in females
at puberty. G) Quantification of TEB number and H) total TEB area in females
at puberty. In all panels, different letters indicate significant differences,
Fisher’s LSD posthoc after significant 1-way ANOVA.

At puberty, the females exposed to 30 and 3000 μg oxybenzone/kg/day had a
modest increase in the size of the ductal tree and a significant increase in the extent
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of growth into the mammary fat pad (FIGURES 4.3D,E,F). There was also a
significant increase in the number of TEBs in females exposed to 3000 μg
oxybenzone/kg/day (FIGURE 4.3G, ANOVA, p<0.05, Fisher’s posthoc p<0.05) as
well as a trend toward significance for a linear increase in number of TEBs by
oxybenzone dose (Pearson correlation 0.324, p = 0.058). There were no significant
differences in total TEB area between oxybenzone treated groups and controls
(FIGURE 4.3H) although there was a trend toward significance for a linear increase
in TEB area by oxybenzone dose (Pearson correlation 0.304, p = 0.075).

Developmental exposure to oxybenzone alters mammary morphology in female mice
in adulthood.
To determine if developmental exposures to oxybenzone have lasting effects
on the female mammary gland, we next quantified mammary gland morphology in
young adults. Analysis of adult mammary glands showed a decreased fraction of the
mammary gland comprised of ducts as the dose of oxybenzone increased
(FIGURES 4.4A,B). The opposite pattern was observed for the fraction of the gland
comprised of alveolar buds, with a significant increase observed in females from the
3000 μg oxybenzone/kg/day group (FIGURE 4.4B, ANOVA, p<0.05, Fisher’s
posthoc p<0.05); on average, females from this high dose group have more than
twenty times more alveolar buds compared to controls. There was also a trend
toward significance for a linear increase in volume fraction of alveolar buds by
oxybenzone dose (Pearson correlation -0.306, p = 0.065). There were no significant
differences in volume fraction of terminal ends based on treatment (data not shown).
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Figure 4.4:
Perinatal
exposure to
oxybenzone
increases
alveolar buds in
females at
adulthood. A)
Representative
whole mounted
mammary glands
from females from
the four treatment
groups in
adulthood.
Arrowheads
indicate alveolar
buds. Scale bar =
0.5 mm. B)
Quantification of
ducts, terminal
ends, and alveolar
buds in adult
female mammary
glands. Different
letters indicate
significant
differences,
Fisher’s LSD
posthoc after
significant 1-way
ANOVA.

Developmental exposure to oxybenzone alters expression of hormone receptors in
the mammary gland
ERα is expressed in the mammary epithelium starting just before birth and
allows the epithelial cells to respond to estrogens produced in the ovaries
(Bocchinfuso et al., 2000), although the role of ER in the prepubertal mammary
gland is not clear; ERα is essential for growth and branching of the epithelial ducts at
and after puberty (Mallepell et al., 2006a). Interestingly, we observed a decrease in
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the fraction of cells positive for ERα in the mammary gland of females exposed to
oxybenzone. The decreased fraction of ERα-positive cells was only significant in
adult females after developmental exposures to 30 or 212 μg/kg/day (FIGURES
4.5A,B, ANOVA, p<0.05, Fisher’s posthoc p<0.05).
Several previous studies revealed an antagonistic effect of oxybenzone on
progesterone receptor in cell cultures (R. H. Schreurs, E. Sonneveld, J. H. Jansen,
W. Seinen, & B. van der Burg, 2005), yet the effects of this compound on
progesterone receptor expression have not yet been examined. Progestins are
important for growth and epithelial branching of the mammary gland via inducing
growth hormone secretion (Lombardi et al., 2014). We found no significant effects of
oxybenzone on fraction of cells expressing progesterone receptor in mammary
glands at PND21 or in adulthood, but a significant decrease in progesterone
receptor-positive epithelial cells at puberty in females exposed to 212 μg
oxybenzone/kg/day (FIGURES 4.5C,D, ANOVA, p<0.05, Fisher’s posthoc p<0.05).
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Figure 4.5: Oxybenzone alters expression of hormone receptors in an age- and
dose-specific manner. A) Photomicrograph illustrating expression of ERα (brown cells,
indicated by an arrow). Blue cells (indicated by arrowheads) are negative for ERα,
counterstained with hematoxylin. Scale bar = 50 µm. Inset is a representative negative
control. B) Quantification of epithelial cells expressing ERα in the mammary gland at
PND21, puberty, and in adulthood. C) Photomicrograph illustrating expression of
progesterone receptor (brown cells, indicated by an arrow). Blue cells (indicated by
arrowheads) are negative for progesterone receptor, counterstained with hematoxylin.
Scale bar = 50 µm. Inset is a representative negative control. D) Quantification of
epithelial cells expressing progesterone in the mammary gland at PND21, puberty, and
in adulthood. In all panels, different letters indicate significant differences, Fisher’s LSD
posthoc after significant 1-way ANOVA.

Developmental exposures to oxybenzone reduce cell proliferation in the mammary
gland epithelium
We next examined the effect of oxybenzone on expression of Ki67, a marker
of cell proliferation. In controls, approximately 4% of ductal cells are Ki67-positive at
PND21 and at puberty; cells within the highly proliferative TEBs were not included in
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these measures. At both ages, developmental exposure to oxybenzone reduced the
fraction of proliferating cells, although only the females from the 30 µg/kg/day group
were significantly different from controls at PND21 (FIGURES 4.6A,B, ANOVA,
p<0.05, Fisher’s posthoc p<0.05). There was, however, a significant linear
relationship between oxybenzone dose and fraction of cells positive for Ki67
(Pearson correlation 0.447, p = 0.006). In adulthood, proliferation in the mammary
epithelium was not affected by developmental oxybenzone exposure (FIGURE 4.6).
Figure 4.6:
Quantification of
proliferation index
in mammary
epithelial cells. A)
Photomicrograph
illustrating
expression of Ki67
(brown cells,
indicated by an
arrow). Blue cells
(indicated by
arrowheads) are
negative for Ki67,
counterstained with
hematoxylin. Scale
bar = 50 µm. Inset is
a representative
negative control. B)
Quantification of
epithelial cells
expressing Ki67 in
the mammary gland
at PND21, puberty,
and in adulthood.
Different letters
indicate significant
differences, Fisher’s
LSD posthoc after
significant 1-way
ANOVA.
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4.5 Discussion
In this study we have examined the effects of perinatal, low-dose exposure to
oxybenzone on the growth and morphology of the mammary gland in male and
female BALB/c mice at three life stages. To date, studies of oxybenzone on
mammals remain limited, and we believe this is the first study to show that perinatal
exposures to this compound disrupt development of hormone-sensitive organs.
Several broad conclusions may be drawn from our study. First, based on the growth
parameters we measured, oxybenzone appears to affect young males more than
females, although the effects observed on the adult female mammary morphology
(e.g., increases in alveolar buds) were striking. Second, we observed more effects
induced by 30 and 212 μg oxybenzone/kg/day than the higher dose of 3000 μg /kg;
these two lower doses are relevant to human exposures based on back-calculations
of urinary concentrations in pregnant women (Woodruff et al., 2011). Although it is
difficult to draw definitive conclusions about dose response shape with only three
treated groups, these results may be consistent with non-monotonic effects of many
endocrine disrupting chemicals (Vandenberg et al., 2012). Finally, our results stress
an urgent need to focus on the consequences of perinatal exposure throughout the
life course, from early to adulthood, and on patterns rather than isolated
measurements.
The male mouse mammary gland is distinguishable from the female starting
from approximately E14, when androgen production in the fetal testis causes a
detachment of the mammary tree from the overlying epidermis. Although the male
gland fails to develop a nipple, it remains responsive to estrogenic stimuli
(Vandenberg et al., 2013). Here we found that when exposed to oxybenzone, the
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male mammary gland was initially smaller than in controls; but by adulthood,
significant differences were no longer observed between treatment groups. These
findings suggest that oxybenzone can produce different effects on the male gland
depending on when the animals are evaluated. At this time, we are uncertain of the
significance of a smaller mammary gland like those we observed in oxybenzonetreated males. Unlike the female, where ducts are an essential part of the tissue and
are responsible for the delivery of milk from lobuloalveolar units to the nipple during
lactation, the mammary ducts are a vestigial structure in males. From the
perspective of developmental biology, any change in morphology has the potential to
be deleterious, and this change might signal effects on other hormone-sensitive
outcomes. Considering the responsiveness of the male gland to environmental
insults, and the fact that males can develop breast cancer, the vestigial nature of the
male mammary ducts does not mean they should be ignored. However, from the
perspective of toxicology, we are unaware of any disease condition associated with
the disruptions we observed to the male mammary gland after oxybenzone
exposures.
In females, the most remarkable effects of perinatal oxybenzone exposure
were the high fraction of alveolar buds in adult glands, countered by the decreased
rate of proliferation in mammary epithelium at early ages. Alveolar buds are epithelial
pouches that form all over the ductal tree in the mid- and late stages of pregnancy in
anticipation of milk production. Their presence during non-pregnant adulthood is
atypical and suggests an organizational disruption to the tissue. Similar effects on
alveolar bud formation have been reported after perinatal exposure to the estrogenic
chemicals bisphenol A (Markey et al., 2001), bisphenol S and 17α-ethinyl estradiol
(SriDurgaDevi Kolla, Mary Morcos, Brian Martin, & Laura N. Vandenberg, 2018) in
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mice, or exposures to a mixture of estrogenic and anti-androgenic chemicals in rats
(K. R. Mandrup et al., 2015). Formation of alveolar buds depends primarily on
orchestrated action of prolactin and progesterone (Neville, McFadden, & Forsyth,
2002), suggesting the possibility that these environmental chemicals may be acting
at the level of the pituitary; additional work is needed to evaluate this hypothesis. We
did not control for stage of the estrous cycle stage in these females, and it may have
increased variability in the responses we have observed; future studies should also
evaluate whether perinatal exposures to oxybenzone alter estrous cyclicity in adult
females.
Oxybenzone is hydrophobic (partitioning coefficient, logPow = 3.64) and
accumulates in adipose tissue. This has been demonstrated in fish in their native
environment (Gago-Ferrero et al., 2013) and under laboratory conditions (Schlumpf
et al., 2010). In humans, oxybenzone has been detected in the adipose tissue of
female breasts and its concentration positively correlates with the incidence of tumor
in the lateral region of the breast (Barr et al., 2018); the possibility that oxybenzone
could be stored in mouse mammary tissue should be evaluated in future studies. We
did not attempt to measure oxybenzone in the blood of these pups because they
were never directly exposed and, with the exception of the pre-pubertal animals,
they were evaluated long after they would have been exposed via mothers’ milk.
Based on toxicokinetic data available, we anticipate that the circulating levels in the
pups’ blood would always be below the limits of detection in analytical chemistry
assays. In tissues and the environment, oxybenzone undertakes two metabolic
pathways: demethylation and hydroxylation. Oxybenzone demethylates into
benzophenone-1 (BP1, also called 2,4-dihydroxybenzophenone), which further
hydroxylates to 2,3,4- trihydroxybenzophenone (2,3,4 THB) or 2,4,5 113

trihydroxybenzophenone (2,4,5 THB). Oxybenzone is hydroxylated on either of its
rings forming several different metabolites, e.g. benzophenone-8 (BP-8, also called
2,2’ dihydroxy-4-4-methoxybenzophenone), 3-hydroxy-benzophenone-3 or 5hydroxy-benzophenone-3 (Cheng, 2014). These transformations require human
cytochrome P450 (CYP) 1A and 2D6 (Watanabe et al., 2015), enzymes that are
expressed in the adult liver, small intestine and other tissues. CYP expression and
activity may change during the life course, with levels that are often lower during
fetal development (de Wildt et al., 1999; Sadler et al., 2016). Therefore, exposure of
the fetus to the parent compound is likely, and exposure to the major metabolites is
likely to occur due to maternal metabolism. BP1, the major metabolite, is also
occasionally used in consumer products (S. Kim & Choi, 2014) and it is more
hydrophilic than the parent compound, allowing it to be detected in surface waters
(Jeon et al., 2006). BP1 is a potent estrogen agonist in yeast assays (Kunz & Fent,
2006a) and a mixture of oxybenzone and BP1 had an additive estrogenic effect on
human MCF-7 cells (Heneweer et al., 2005). Because of its metabolism and the
biological activity of its metabolites, administering oxybenzone is essentially a test of
a chemical mixture. For this reason, the effects of oxybenzone are likely to be
complex and to change as the metabolic potential of the individual changes
throughout the life course. This is one challenge of mixture studies, although they
are likely to be better representative of real-world exposures (Kassotis, Tillitt, Davis,
Hormann, & Nagel, 2014; Sapouckey, Kassotis, Nagel, & Vandenberg, 2018).
At different periods of development, the mammary gland is responsive to
numerous hormones including estrogens, progestins, prolactin, androgens, growth
hormone, IGF, and others (Brisken & Ataca, 2015). As noted above, we observed
changes in the fraction of epithelial cells expressing ERα in oxybenzone-treated
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females in adulthood. Other effects were observed on the fraction of epithelial cells
expressing PR, but only at puberty. We cannot determine if specific effects we
observed on the mammary gland were caused by the estrogenic, anti-estrogenic, or
anti-androgenic actions of the parental compound or the estrogenic properties of the
oxybenzone metabolites, or even non-hormonal pathways. However, many of the
effects we observed in the female mammary gland are consistent with those
observed after perinatal exposures to estrogenic compounds. Prior studies of
xenoestrogens including ethinyl estradiol, diethylstilbestrol, bisphenol A and
bisphenol S have shown similar increases in alveolar bud density in young adulthood
after perinatal exposures (SriDurgaDevi Kolla et al., 2018; Macon & Fenton, 2013;
Markey et al., 2001; Vandenberg et al., 2008b); bisphenol S exposure also
decreased Ki67-expression in prepubertal females (SriDurgaDevi Kolla et al., 2018),
like we observed here with oxybenzone. Yet, ethinyl estradiol increased the fraction
of epithelial cells expressing ERα in adulthood (SriDurgaDevi Kolla et al., 2018), and
BPA increased the expression of PR at puberty (Munoz-de-Toro et al., 2005), both of
which contrast with what we have observed here for oxybenzone. Further, the
effects we observed in the male mammary gland are inconsistent with the effects we
have observed after exposures to several ER agonists including ethinyl estradiol,
bisphenol A or bisphenol S (Kolla, McSweeney, Pokharel, & Vandenberg, 2019;
Pokharel et al., 2018; Vandenberg et al., 2013); in fact, we are not aware of any
studies that report smaller, less elaborated ductal trees in males after exposures to
hormonally active agents.
One hint at the endocrine properties of administered oxybenzone might come
from our measures of AGI. Anogenital distance measures about twice as long in
males than in females and depends on androgen action in utero (Salazar-Martinez et
115

al., 2004). Perinatal exposure to 212 μg/kg oxybenzone induced a lower AGI in both
males and females. In males, such reduction suggests an anti-androgenic effect of
oxybenzone (Fisher et al., 2016; Swan et al., 2005; C. J. Wolf et al., 2000), while in
females a shorter AGI cannot be easily explained. In females, xenoestrogens such
as diethylstilbestrol can lengthen anogenital distance (Honma et al., 2002) as do
prenatal exposures to testosterone (Rhees, Kirk, Sephton, & Lephart, 1997)
although other studies have shown that the xenoestrogen BPA can shorten female
anogenital distance, consistent with what we have seen here for oxybenzone
(Barrett et al., 2017). Thus, our results suggest that oxybenzone alters numerous
hormone-sensitive outcomes, consistent with the effects expected after exposure to
an endocrine disrupting chemical with pleiotropic actions. However, the exact
mechanism by which it acts remains unclear, and in fact it likely acts via several
hormone pathways. Future studies using pharmacologically active positive controls
may assist in determining the mechanism by which oxybenzone acts. However, the
number of different groups needed to evaluate as positive controls for oxybenzone is
large (e.g., an estrogenic, anti-estrogenic, and anti-androgenic positive control as
well as mixtures of these positive controls to evaluate pleiotropic effects). While
evaluating this range of positive controls is an important endeavor, it was not
feasible in the current study.
Finally, the results of this study shed light on the effects of oxybenzone on the
mammary gland at different vulnerable periods of development. Our prior study,
examining the effects of oxybenzone on the mothers of the mice used in this study,
revealed that oxybenzone altered mammary gland morphology and cell proliferation
in dams, even weeks after exposures had ceased (LaPlante et al., 2018). Those
results suggested long-term or perhaps even permanent effects of exposures during
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pregnancy and lactation. Here, our results similarly suggest that the sons and
daughters, exposed during perinatal development, are also permanently affected by
oxybenzone exposures, with effects that manifest at different periods of postnatal
development. Although the specific outcomes between exposed mothers and
offspring differ, these studies provide new evidence that exposures to endocrine
disrupting chemicals during pregnancy can affect the mammary gland in at least two
generations. Future studies are needed to understand the mechanism by which
oxybenzone acts on the mammary gland, especially considering its multiple modes
of action and its metabolites. Additionally, further studies should address whether
oxybenzone alters development of the mammary stroma, and whether these
disruptions might play a role in the health or pathology of the mammary gland.

4.6 Conclusion
In this study, we exposed BALB/c mice orally to oxybenzone in utero and
through lactation and examined males and females at three different stages: prior to
puberty, in puberty, and in early adulthood. Exposures to low doses of oxybenzone
altered AGI in both males and females, decreased the size and complexity of the
mammary ductal epithelium in males, and increased the appearance of alveolar
buds in adult females. Oxybenzone altered the expression of hormone receptors in
the female mammary gland in an age- and dose-specific manner and disrupted
proliferation in the mammary epithelium.
Recent studies have raised alarm over the use of oxybenzone in sunscreens
because of the ability of this compound to penetrate the dermal layer and enter the
bloodstream. Human biomonitoring studies confirm that humans are widely exposed
to this chemical, that exposures are enhanced after the use of personal care
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products containing UV filters, and that exposures are especially high in pregnant
women. The results of this study indicate that even low doses of oxybenzone can
disrupt hormone-sensitive outcomes in male and female offspring and suggest that
more caution is needed when using these products.
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CHAPTER 5

EXPOSURE TO LOW DOSES OF OXYBENZONE DURING PERINATAL
DEVELOPMENT ALTER MAMMARY GLAND STROMA IN FEMALE MICE

5.1 Abstract
Mammary stroma is a prominent modulator of epithelial development, and its
complex network of interactions is either permissive or restrictive in tumor initiation
and progression. Exposures to oxybenzone, a common UV filter and environmental
pollutant and endocrine disruptor, during perinatal development induce alterations in
mammary epithelium. Our earlier research indicates that oxybenzone alters
mammary epithelial structures at puberty (i.e. more TEBs and a longer ductal
extension) and in adulthood (e.g., a higher volume fraction of alveolar buds). We had
also previously observed changes in the expression of hormone receptors at puberty
(e.g., oxybenzone induced a decrease in the number of PR-positive epithelial cells)
and in adulthood (e.g., oxybenzone induced a decrease in the number of ER-positive
epithelial cells), and increased body weight in adulthood. Here, we investigated
stromal changes in BALB/c animals exposed during gestation and perinatal
development to 0, 30, or 3000 μg oxybenzone/kg/day. In response to exposure to 30
µg/kg/day, we observed morphological statistically significant changes in adulthood
(the periductal stroma was thicker and adipocytes were considerably larger). And
observed increased number of mast cells in the mammary stroma at puberty may
represent a transient influence of oxybenzone exposure. These results provide
additional evidence that even low doses of oxybenzone can disrupt hormone
sensitive organs during critical windows of development and that developmental
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exposure to low doses of oxybenzone can induce abnormalities that manifest in later
life.

5.2 Introduction
The etymology of the word stroma comes from the Greek for a “bed” or
“layer”. In the mammary gland, the stroma is classified as a “connective tissue” type
but neither the role of a “bed” or “connector” portrays the importance of the stroma
as it is understood today. Beginning during prenatal development, the mammary
gland is established from an interplay between the dermal epithelium and underlying
mesenchyme (stroma) (Sakakura, Nishizuka, & Dawe, 1976). In fact, transplantation
of mammary epithelium into salivary stroma (and vice versa) indicates the
importance of the stroma for establishing the morphology of the epithelium; when
such transplantations occur using fetal tissues, the epithelium takes on the
morphological characteristics associated with the stroma where it is transplanted.
The same is true in carcinogenesis, where changes in the stroma are no longer
considered a side effect of epithelial loss of order. Epithelial cells exposed to a
carcinogen develop mammary neoplasia only if the stroma was also primed with
carcinogen and conversely, normal stroma can prevent a carcinogen-exposed
epithelium from tumorigenesis (Maffini, Soto, Calabro, Ucci, & Sonnenschein, 2004).
During normal development, stromal extracellular matrix both stimulates
epithelial side-branching via induction of Wnt pathways and suppresses excessive
branching via MMPs and TGFβ (Wiseman & Werb, 2002). Beyond para- and
autocrine signaling, the stroma may modulate endocrine responses in estrogennonresponsive epithelium (Haslam & Counterman, 1991). Other regular mediators of
the hormonal crosstalk among the two tissue compartments in the mammary gland
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include PTHrP and IGF-1, which is induced by growth hormone (see Chapter 1).
Lastly, adipose tissue, vasculature, and immune cells of the stroma can act as either
permissive or restrictive towards spreading of tumor cells, and therefore these
stromal cells modulate the metastatic potential of epithelial tumors via a complex
network of interactions (Hussain et al., 2020; Khamis, Sahab, & Sang, 2012).
Endocrine disrupting chemicals (EDCs) have been investigated for their
impact on the mammary stromal structures and components. A new class of
chemicals, the metabolism disrupting chemicals, can affect energy balance and fat
deposition. This suggests that many EDCs act directly on adipocyte differentiation,
or indirectly on central and peripheral organs with a downstream influence on
metabolism, storage of triglycerides, and signaling altering hunger and satiety
(Heindel & Blumberg, 2019). In various organs, EDCs induce dysfunction in white
adipose and brown adipose tissue (Francis et al., 2021). Many of these chemicals
are also deposited in lipids, and their presence in adipose cells may contribute to
continued dysfunction in the stromal compartment.
As an example, it has been proposed that the primary target for BPA, a
common xenoestrogen, in the mammary gland is the stroma. During prenatal
development, estrogen receptors are not expressed in the epithelium, thus, during
this period of exposure, BPA is most likely acting via receptors expressed in the fetal
mesenchyme (Vandenberg et al., 2007). Furthermore, the transcriptomal profile of
BPA, compared to ethinyl estradiol (EE2, an estrogenic positive control), also
pointed to its effects predominantly located in the stromal compartment (Wadia et al.,
2013).
There is also evidence that many estrogenic EDCs can act via the immune
cell populations that reside in the mammary stroma. Many of these immune cells
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express estrogen receptors and are therefore sensitive to environmental chemicals
acting via these signaling pathways. Specifically in macrophages, EDCs decrease
phagocytosis in a THP-1 cell culture possibly via ERK1/2 MAPK pathways
independent of ERα (Couleau et al., 2015).
In this study, we examined the effects of perinatal exposure to oxybenzone
on the stromal structures and cells in the mouse mammary gland. Our study
suggests that there are structural impacts of early exposures to oxybenzone that
persist to adulthood while effects on immune cells might be transient.

5.3 Methods
Animals
BALB/c mice [UMass colony, D.J.J. laboratory, Amherst, MA, described and
analyzed in (LaPlante et al., 2018)] were housed in polysulfone cages, with at
maximum of five mice of the same sex per cage, and provided food (soy-free chow,
ProLab IsoDiet, Brentwood, MO) and tap water (in polysulfone bottles with rubber
stoppers and metal tops) ad libitum. Animals were maintained at the University of
Massachusetts, Amherst Morrill Animal Facility, in temperature- and light-controlled
conditions (12-hour cycles of light and dark). All experimental procedures were
approved by the University of Massachusetts Institutional Animal Care and Use
Committee.

Chemical administration
From the first day of gestation (GD0 when a sperm plug was observed) until
the day before weaning (on lactational day 21), the mothers were weighed and orally
dosed daily by pipet with either tocopherol stripped corn oil or oxybenzone dissolved
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in stripped corn oil. As a result, the offspring evaluated in this study were exposed in
utero and during the first 21 days of postnatal life via the mother’s milk. Two doses of
oxybenzone were used: 30 μg/kg/day and 3000 μg/kg/day (FIGURE 5.1.).
Depending on the region, season, and individual use of oxybenzone-based personal
care product, the lowest dose is likely relevant to human exposures based on backcalculations of urinary concentrations NHANES studies (Han et al., 2016; Woodruff
et al., 2011).

Figure 5.1: Study Design.

Dams were allowed to deliver naturally, and litters were not culled. Sample
sizes for the treatment groups were: controls,11 litters; 30μg/kg oxybenzone, 10
litters; 3000 μg/kg oxybenzone, 9 litters. Pups were distributed into separate cages
upon weaning and kept until the peak of puberty (PND 32-35) or adulthood (PND 6575). One female from each litter was selected for each endpoint to avoid litter bias,
but sample sizes for each endpoint vary based on litter size. Animals were eartagged upon weaning for identification.
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Euthanasia and tissue collections
One female from each litter was euthanized at the peak of puberty (PND3235), or in adulthood (PND 65-75). Results from the dams (the F0 generation) are
described in (LaPlante et al., 2018). Characteristics of the F1 females including
morphology of the whole mount mammary gland and epithelial endpoints were
described in (K. Matouskova et al., 2019).
On the day of sacrifice, animals were euthanized with CO2 inhalation followed
by cervical dislocation to ensure death. From every animal we dissected the right
fourth inguinal mammary gland, spread it on a glass slide (Thermo Fisher Scientific,
Waltham, MA) and fixed it overnight in 10% neutral buffered formalin. The left
mammary gland was fixed in 10% neutral buffered formalin overnight before being
washed, dehydrated, and embedded in paraffin for histology and
immunohistochemistry. The 3rd pectoral mammary glands were collected (avoiding
the lymph node), flash frozen on dry ice, and stored at -80°C for qRT-PCR analyses.

Tissue embedding, sectioning and histological staining
Fixed mammary glands were washed in 1x phosphate buffered saline,
dehydrated through a series of alcohols and embedded with paraffin (Leica
Biosystems, Richmond, IL) under vacuum. Paraffin blocks were cut into five
micrometer sections on a rotary microtome (Fisher Scientific) and mounted on
positively charged slides (Fisher Scientific) for histological evaluation and
immunohistochemistry.
For histological evaluations, slides were deparaffinized with xylene and a
series of alcohols, stained with Harris’ hematoxylin and eosin (Fisher Scientific),
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dehydrated, and mounted with permanent mounting media (Fisher Scientific). Digital
images were collected using a Zeiss Axio Oberserver.Z1 inverted microscope, a 10X
objective, and a high-resolution color camera (Carl Zeiss Microscopy).
For quantification of periductal collagen fibers, sections were stained with
Gomori’s Trichrome Stain (Richard-Allen Scientific/Thermo Fisher Scientific, REF
87020). In short, deparaffinized samples were fixed with Bouin’s fluid (REF# 88038),
and stained with Weigert’s Iron Hematoxylin (REF#s 88028 and 88029) and
Gomori’s Trichrome Stain (REF# 88030). Individual dyes in the kit stain the collagen
fibers blue, cell nuclei are stained black, while cytoplasm and muscle fibers appear
red.

Mast cells staining and analysis.
One section from each animal was stained using toluidine blue stain (1%
RICCA, Arlington, TX USA). The cover-slipped slides were analyzed using a Zeiss
Axio Oberserver.Z1 inverted microscope, a 10X objective, and a high-resolution
color camera. Each age group required a slightly modified approach as the
mammary gland differs at puberty and in adulthood. For adult animals, ten to twelve
images of ducts comprised of 20 to 100 epithelial cells were chosen. For each
image, we counted the number of ducts and number of mast cells associated with
ducts. For each animal, the ratio of total number of mast cells divided by the total
number of ducts was calculated.
The epithelial compartment of the mammary gland is less developed in
pubertal mice. Therefore, the ducts selected for analysis were practically all the
ducts present in the section. Terminal end buds were excluded from analysis due to
their specific character. Also, extra care was taken to not include blood vessels in
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the analysis as they often appear near mammary ducts and their walls contain
higher numbers of mast cells.

Immunohistochemistry
Expression of two markers, Ki67 and F4/80, was evaluated using standard
methods for immunohistochemistry and commercial antibodies including rabbit antiKi67 (Fisher Scientific, Cat# RM-9106-S1), a marker of proliferation, and F4/80 (a
macrophage marker). Briefly, sections were deparaffinized, hydrated through a series
of alcohols, microwaved in 10 mM citrate buffer (pH 6) for antigen retrieval, and treated
with hydrogen peroxide to quench endogenous peroxidases. Non-specific binding was
blocked with 1% milk protein in 5% normal goal serum (Cell Signaling Technology,
Danvers, MA).
Sections were incubated with primary antibodies (typically diluted 1:500 or
1:1000 in blocking solution) at 4°C for 14-16 h. They were then washed and incubated
with secondary antibody (goat anti-rabbit, Abcam, Cat# ab64256) followed by
streptavidin peroxidase complex (Abcam, Cat# ab64269). Diaminobenzidine
chromogen (Abcam, Cat# ab64238) was used to visualize reactions. Sections were
counterstained with hematoxylin (Fisher Scientific). Each immunohistochemical run
included a negative control in which the primary antibody was replaced with 5% normal
goat serum.

qRT-PCR
Total RNA was extracted from the mammary glands using Trizol reagent and
a BeadBug microtube homogenizer. We then examined the RNA purity as the
A260/A280 ratio and quantified the concentration of RNA in the sample using
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Nanodrop UV spectrophotometry. 1 mg of RNA from each sample was transcribed to
cDNA using reverse transcription. Lastly, 2 µL of cDNA was combined with forward
and reverse primers for each target gene (TABLE 3.2.) and SYBR green master mix
to amplify and detect the gene of interest (thermal prolife cycles were set as follows:
10 minutes at 95°C, 40 cycles of 15 seconds at 95°C, 30 seconds at 60°C, and 15
seconds at 72°C). A melting-curve analysis was conducted to identify nonspecific
products. Finally, expression of each target gene was quantified using the ΔΔCt
method, which allows each target to be evaluated relative to reference genes. Every
sample was run in triplicate for each target gene. Two reference genes were used
for the mammary gland analyses: β actin and β2 microglobulin (TABLE 3.2.). These
were averaged for the ΔΔCt quantification.

Statistical analysis
GraphPad (Prism version 9.1.1) was used to analyze categorical and
continuous variables. Normally distributed continuous data were evaluated with oneway ANOVA followed by Tukey post-hoc tests. Categorical variables were evaluated
using contingency tables with Chi-square and Fisher’s exact tests and graphed as
percent fraction of each experimental group and endpoint.
For all evaluations, a p-value of less than 0.05 was considered statistically
significant. All continuous data are graphed as a mean ± standard error. Categorical
data are graphed as percentages of each treatment group assigned to each
category. All analyses were conducted by experimenters blinded to treatment group.
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5.4 Results
5.4.1

The periductal stroma is wider in animals exposed perinatally to

oxybenzone when evaluated in adulthood

We began by measuring the width of the loose stroma that typically surrounds
the mammary ducts. Of the two doses of oxybenzone tested, 30 µg/kg/day induced
the expansion of the periductal stroma in both age groups, although this was only
statistically significant in adult animals (FIGURE 5.2 A and B; ANOVA, p values =
0.32 and 0.035 resp, Tukey posthoc = 0.028).

Figure 5.2: Periductal stroma, collagen and fibronectin. A) The width of periductal
stroma at puberty. B) The width of periductal stroma in adulthood. C) Relative mRNA
expression of Col1a1 mRNA at puberty. D) Relative mRNA expression of Col1a1
mRNA in adulthood. E) Relative mRNA expression of Fn7_1 mRNA at puberty. F)
Relative mRNA expression of Fn7_1 mRNA in adulthood. * indicates significance <
0.05: ANOVA, Tukey posthoc test. All qRT-PCR expression data were normalized using
the ΔΔCt method.
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The loose stroma has a cellular component, the fibroblasts, and a matrix
comprised of collagens, glycoproteins, and proteoglycans. We assessed the
expression of the gene for type I collagen – its pro-α1(I) chain (Col1_1), the most
abundant collagen type. The fold change was slightly greater for both tested doses
of oxybenzone in pubertal animals and adults exposed to 3000µg/kg/day, but neither
of the differences were statistically significant (FIGURE. 5.2 C and D; ANOVA, p
value= 0.835 and 0.879 in pubertal and adults resp.). We also evaluated the
expression of fibronectin, the matrix glycoprotein. There was no effect on fibronectin
expression in either of the age or treatment groups (FIGURE 5.2 E and F, ANOVA p
values = 0.954 and 0.273).

5.4.2

Adipocytes in the mammary stroma

Next, we assessed the size of adipocytes in the mammary stroma. In the
white adipose tissue, we observed that adult adipocytes were on average more than
two times larger in response to oxybenzone (30µg/kg/day) compared to controls
(FIGURE 5.3B, ANOVA, p value = 0.0084, Tukey posthoc = 0.077). Furthermore,
between puberty and adulthood, the adipocytes in control mammary glands
decreased in size by about 1/3 (from an average of 1677 µm2 to 1218 µm2). In
contrast, white adipose cells from oxybenzone-exposed animals increased in size in
the mammary gland from 1502µm2 to 2023 µm2 in the 30 µg/kg/day group, and from
1473 µm2 to 1736 µm2 in the 3000 µg/kg/day group. At puberty, the white adipocytes
were not significantly different in size between the treatment groups (FIGURE 5.3A,
p value = 0.641, ANOVA).
To determine if oxybenzone treatment altered other aspects of adipocyte
biology, we also examined the number of cell neighbors for adipocytes, which is a
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measure of the organization and packing of adipocytes in the tissue. There was a
modest but statistically significant difference between the two oxybenzone treated
groups at puberty, suggesting that the higher dose of oxybenzone might be
producing subtle effects on the organization of the cells in the fat pad. Although there
were modest shifts in this measure, overwhelmingly the adipocytes are organized in
hexagons similar to other cells like hepatocytes (FIGURE 5.3C and D; ANOVA, p
values = 0.041 at puberty, Tukey posthoc = 0.0491, and 0.6 in adulthood).

Figure 5.3: White Adipose Tissue. A) Size of a while adipocyte at puberty. B) Size of
a white adipocyte in adulthood. C) Number of an adipocyte adjacent cells at puberty.
D) Number of an adipocyte adjacent cells in adulthood. E) Relative mRNA expression
of PPARγ mRNA at puberty F) Relative mRNA expression of PPARγ mRNA in
adulthood. G) Relative mRNA expression of Plin2 mRNA at puberty H) Relative mRNA
expression of Plin2 mRNA in adulthood I) Relative mRNA expression of Fas mRNA at
puberty J) Relative mRNA expression of Fas mRNA in adulthood. * indicates
significance < 0.05: ANOVA, Tukey posthoc test. All qRT-PCR expression data were
normalized using the ΔΔCt method.

We next selected three genes representing different aspects of adipocyte
function and evaluated their expression. The transcription factor and abundant fat
protein PPARγ is critical for adipogenesis. Although we saw PPARγ downregulation
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following exposure to 30µg/kg/day oxybenzone, this difference was not statistically
significant (FIGURE 5.3 E and F). Adiponectin is an adipocyte-released cytokines
mediating metabolism; adiponectin stimulates β oxidation of fatty acids while fatty
acid synthase (Fas) takes part in the opposite process, i.e., the biosynthesis of fatty
acids. Again, we saw a non-significant downregulation of Fas in adult animals from
the 30µg/kg/day oxybenzone exposure group (FIGURE 5.3J).
In addition to its white adipose tissue, the pubertal mammary gland bears
occasional areas of brown fat. Brown adipocytes are smaller than white fat cells
(averaging 900 µm2 vs 1677 µm2). In our analyses of the brown fat cells in the
pubertal mammary gland, we saw a trend toward smaller brown fat cells in
mammary glands collected from the 30µg/kg/day group (FIGURE 5.4A; ANOVA, p
value = 0.54). In all three treatment groups, the brown adipocytes maintained their
hexagonal arrangement (FIGURE 5.4.B).
Lastly, we investigated 5 non-overlapping regions of the mammary gland and
compared the proportions of white vs brown adipocytes. Perinatal oxybenzone
exposure does not alter the proportion of the fat pad that is comprised of white
adipose cells (FIGURE. 5.4.C). In all treatment groups, the pubertal mammary gland
in BALB/c female mice is comprised of about 90% of white and 10% of brown
adipocytes.
Figure 5.4: Brown
adipose tissue at
puberty. A) Brown
adipocyte: size. B)
Number of neighboring
cells in the brown
adipose tissue. C) Per
cent of white adipocyte
tissue compared to
brown fat.
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5.4.3

Macrophages and Mast Cells in the Oxybenzone-treated Mammary Gland

Scattered throughout the stromal matrix are immune cells that are
responsible for maintaining the health of the tissue. In our study, we first focused on
quantifying the number of macrophages. Using slides stained with F4/80 antibody,
we quantified the number of macrophages present. Macrophages are ample in the
periductal stroma in both ages, averaging about 30 per duct at puberty and 19 per
duct in adult animals. The number of macrophages in the periductal stroma was not
altered by perinatal oxybenzone exposure at either of the ages we evaluated
(FIGURES 5.5A and B; ANOVA, p value 0.672 at puberty, and 0.854 in adulthood).

Figure 5.5: Macrophages, Mast Cells, Proliferation in TEB. A) Number of
macrophages in periductal stroma at puberty. B) Number of macrophages in
periductal stroma in adulthood. C) Number of mast cells in periductal stroma at
puberty. D) Number of mast cells in periductal stroma in adulthood E) Ratio of Ki67
positive cells to cells total in terminal end buds at puberty. F) Ratio of Ki67 positive
cells to cells total in terminal end buds in adulthood. ANOVA, Tukey posthoc test.
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We also evaluated the number of mast cells localized to the periductal
stroma. Mast cells were less abundant than macrophages, with an average of 0.51
per mm2 at puberty and 1.12 per mm2 in adult animals. We observed an almost
doubling of the number of mast cells in females from the 30µg/kg/day group when
the evaluation was conducted at puberty (FIGURE. 5.5.C; ANOVA, p value = 0.033,
Tukey posthoc = 0.047); however, this effect appears to be transient because no
differences were observed in adulthood (FIGURE 5.5.D; ANOVA, p value = 0.73).

5.4.4

Proliferation in the Terminal End Bud Structures

Earlier studies suggest that mast cells are required for normal proliferation in
the epithelium as well as in the TEBs specifically (Lilla and Werb, 2010). After seeing
the number of mast cells increase in response to a 30µg/kg/day oxybenzone, we
next quantified proliferation specifically in the TEB structures in the pubertal
mammary gland. The number of cells in the TEB expressing Ki67, a marker of
proliferation, was not affected by perinatal oxybenzone exposure (FIGURE. 5.5.E,
ANOVA p value = 0.64). These results are consistent with the lack of an effect of
oxybenzone on the size of the average TEB in the pubertal mammary gland (data
not shown, ANOVA, p value = 0.97).

5.5 Discussion & Conclusion
In this study, we extended our prior work, where we reported on the epithelial
features in the first generation (F1) of BALB/c mice exposed to oxybenzone during
gestation and the perinatal period (K. Matouskova et al., 2019). In that study, we had
observed effects of oxybenzone on the morphology of the epithelial structures at
puberty (e.g., more TEBs and a longer ductal extension) and in adulthood (e.g., a
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lower volume fraction of alveolar buds). We had also observed changes in the
expression of hormone receptors at puberty (e.g., oxybenzone induced a decrease
in the number of PR-positive epithelial cells) and in adulthood (e.g., oxybenzone
induced a decrease in the number of ER-positive epithelial cells). The results of the
current study establish further connections between these effects in the epithelium
and alterations to the stroma, and provide additional areas to probe the mechanisms
by which oxybenzone alters mammary gland development. Furthermore, the current
study provides additional evidence of later-life manifestations (e.g., delayed effects)
of developmental exposures to low doses of oxybenzone.
On the cellular and tissue levels, exposure to 30 µg/kg/day of oxybenzone
during gestation and perinatal development induced two important alterations to the
organization of the stroma in adulthood: hypertrophy in white adipocytes and
expansion of the periductal stroma. Despite the larger adipocytes that were
observed, the adult body weight of female offspring was not altered by oxybenzone
exposure (Matouskova et al., 2019). These results might suggest that the effects of
oxybenzone are specific to mammary adipocytes, rather than adipocytes more
generally. There is evidence that other estrogenic chemicals have distinct effects on
adipocytes isolated from different parts of the body; for example, the effects of
bisphenols on the transcriptome of omental fat cells differs significantly from their
effects on the transcriptome of subcutaneous adipose cells (Peshdary et al., 2020).
Future studies are needed to determine if the effect of low doses of oxybenzone on
fat cell size are specific to subcutaneous (mammary) fat.
Similar effects as seen here (hypertrophy of adipocytes in adulthood) have
also been shown to be induced by low doses of ERα agonists including EDCs such
as dioxins and PCBs, and also high-fat diet (Davis et al., 2013; Le Magueresse134

Battistoni, 2020). Therefore, we also explored several molecular mediators of
adipose cell size. PPARγ is described as both a necessary and sufficient factor of
adipogenesis in mammals and fish (Wafer, Tandon, & Minchin, 2017) due to its
ability to stimulate differentiation of pre-adipocytes to adipocytes. PPARγ is a
mediator of adipocyte hypertrophy (Kubota et al., 1999). For this reason, we
anticipated that the expression of PPARγ would be altered following perinatal
exposures to oxybenzone. However, our data do not demonstrate that PPARγ or
adiponectin are mediators of oxybenzone-related adipocyte hypertrophy. Similarly,
we observed no significant change in the expression of a gene involved in fatty acids
biosynthesis, fatty acid synthase, another theoretical mediator of these effects. It has
been suggested that unlike hyperplasia (an increase in the number of adipocytes),
hypertrophy is a sign of dysfunctional development of the adipocyte cells. Moreover,
expanded adipocytes can lead to cellular hypoxia and chronic sub-inflammation
along with an increased influx of immune cells and local increase of reactive oxygen
species (Bokobza et al., 2021). Therefore markers of inflammation, and possibly, the
mechanisms by which inflammation in the mammary stroma affect the long-term
health of the epithelium should be evaluated in future research studies.
The periductal stroma was wider in adult animals exposed to the lower dose
of oxybenzone. However, two additional endpoints – gene expression of collagen
type 1 and fibronectin - we chose to explore the change in greater detail have not
yielded any significant insights. We may conclude that a type of collagen fibers other
than collage 1 mediates the change, or that oxybenzone (at the timepoints or doses
we investigated) does not alter expression of fibronectin. Several other glycoproteins
in the mammary extracellular matrix such as laminin and tenascin, as well as TGFβ
and hepatocyte growth factors mediate growth of the matrix (Schedin, Mitrenga,
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McDaniel, & Kaeck, 2004). It has also been revealed that activation of fibroblasts
leads to increased extracellular collagen, fibronectin, and laminin deposition and
ultimately to alterations in the periductal stroma (Vafaizadeh et al., 2010).
Follow-up experiments should also evaluate matrix metalloprotease (MMPs),
a group of proteases stored in the periductal stroma. In the mammary gland, the
mRNAs for MMPs (MMP2, MMP3, and MP9, gelatinase A, stromelysis, and
gelatinase B) are upregulated during involution suggesting their role in physiological
healing-like processes, while MMP2 mRNA detected in virgin animals and
throughout pregnancy hints at its role acting in physiological maintenance (Schedin
et al., 2004). Degradation of MMPs through MMP inhibitors (TIMP1) leads to
restricted ductal outgrowth while loss of TIMP1 and MMP upregulation reduces ECM
integrity and less restricted TEBs (Fata, Leco, Moorehead, Martin, & Khokha, 1999).
In late puberty, MMP2 null mice show delayed ductal outgrowth but increased lateral
branching (Wiseman et al., 2003). Evaluating the effects of oxybenzone exposure on
MMP expression may elucidate other potential mechanisms by which oxybenzone
interferes with the mammary epithelium.
We observed an increase in the number of mast cells at puberty associated
with oxybenzone exposure, but this increase was no longer observed in adulthood,
suggesting that this effect may be transient. The pubertal increase in the number of
mast cells in the periductal stroma might be a consequence of the increased area of
the periductal stroma however, we observed no effect on the population of
macrophages in the same tissue compartment. Future studies should expand these
evaluations to other immune cell populations. Unpublished work from the Schneider
lab suggests that oxybenzone can affect the health of several different kinds of
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immune cells, but additional work is still needed to determine if these effects are also
transient, or can persist long after exposures end.
The doses used in this study are not high doses but instead were selected to
be relevant to human real-life exposures. While we have seen most effects at the
lower dose (30 µg/kg of body weight, administered daily to the mothers of the
offspring in our experiment throughout pregnancy and lactation), other studies such
as those conducted by the National Toxicology Program have administered much
higher doses (e.g., concentrations of 1000 – 50000 ppm of oxybenzone in feed)
(Mutlu et al., 2017; Nakamura et al., 2015). It is difficult to determine based on the
two dose groups that we have evaluated whether the effects we have observed are
consistent with non-monotonic dose responses, e.g., effects that are greater at lower
doses than at higher doses. However, it has been previously demonstrated for other
endocrine disruptors that effects observed after exposures to low doses cannot be
extrapolated from high exposures and vice versa. However, the effects we have
observed in the lower dose group should not be dismissed because of the absence
of effects after exposures 100x higher; endogenous hormones produce profound
effects in nano- and picomolar concentrations that are also not observed at higher
concentrations (Vandenberg et al., 2012).
The effects of environmental chemicals on the mammary gland are often
poorly evaluated, if they are evaluated at all, in traditional toxicology studies used by
regulatory agencies (Cardona & Rudel, 2020). Unfortunately, the mammary gland
stroma is not evaluated as an adverse effect in toxicological studies and in the
absence of those data, chemicals causing subtle but consequential effects on this
tissue compartment might be falsely concluded as having no negative effect on
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human health. Improving evaluations of mammary gland health in regulatory studies
will likely have an important effect on public health protections.
In conclusion, we have demonstrated here that the stroma of the mammary
gland is a sensitive target of oxybenzone, a UV filter commonly used as a sunscreen
in personal care products, packaging of perishable foods and drinks, and in paints,
textiles, and plastics. Our data suggest that perinatal exposure to low doses of
oxybenzone induces adipocyte hypertrophy and expands the periductal stroma in
adulthood. Perinatal exposures to oxybenzone also affect mast cell populations in
the mammary gland at puberty, but not in adulthood, suggesting these effects may
be transient. Additional work is needed to fully elucidate the mechanisms
responsible for these alterations and to better understand their possible correlations
with adverse clinical conditions.
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CHAPTER 6

THE IMPACT OF EARLY LIFE EXPOSURE TO OXYBENZONE ON RESPONSES
TO A 17 ALPHA-ETHINYL ESTRADIOL PERIPUBERTAL CHALLENGE
Klara Matouskova, Anna Schmidt, Jennifer Bugos, Laura N. Vandenberg

6.1 Abstract
Early-life exposures to environmental chemicals can contribute to later-in-life
susceptibility to hormonally active chemicals. Oxybenzone (benzophenone 3) is an
estrogen receptor (ER) agonist and antagonist, and androgen receptor antagonist
that has been shown to interfere with development of the mammary epithelium
following perinatal exposure. Here, we evaluate the effects of exposures during two
vulnerable periods of development: the perinatal and prepubertal periods. We also
evaluated the effect of perinatal exposure to oxybenzone on a prepubertal exposure
to 17α-ethinyl estradiol (EE2), a pharmaceutical estrogen. We observed effects of
perinatal oxybenzone exposure on female offspring including an increase in
anogenital distance and in the number of epithelial cells expressing ERα. Contrary to
expectations, the female mammary gland did not respond to prepubertal exposure to
EE2 in its growth parameters, and perinatal oxybenzone exposure had no effect on
EE2 responsiveness. The male mammary gland decreased in both area and
complexity in response to prepubertal EE2 but perinatal oxybenzone exposure
prevents this effect. Collectively, these results suggest that perinatal exposure to
oxybenzone interferes with tissue-specific endpoints in the female, but this exposure
has no influence on responsiveness to prepubertal estrogen exposure. Further,
oxybenzone interferes with the actions of EE2 in the male mammary gland. These
data contribute to the body of evidence suggesting that in vivo oxybenzone exposure
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during sensitive periods alters development of the mammary gland and other
hormone-sensitive outcomes.

Keywords: 2-hydroxy-4methoxybenzophenone, BP 3, endocrine disruptor;
sunscreen; xenoestrogen; anogenital distance, two-hit, mice pups, perinatal,
prepubertal

6.2 Introduction
The perinatal period, which includes the development that occurs in utero and
the first weeks (in mice) or years (in humans) of postnatal development, is arguably
the most critical period in the life of the individual. During this period, all tissues and
organs of the body are established in both structure and function, following the
instructions of the individual’s genotype. Yet phenotype results from both the genes
and the environment and hormone-sensitive tissues such as the mammary gland are
prone to disorganization due to environmental contaminants with endocrine
disrupting potential.
Regarding the genotype, the direction of perinatal development of the
mammary gland depends on the presence or absence of SRY, a sex-determining
gene located on the Y chromosome. In its presence, testes are formed, and the male
mouse experiences the first surge of testosterone at about embryonic day (ED)13. In
response to this testosterone surge, between ED13 and 16 the mesenchyme
surrounding the budding mammary epithelium, which temporarily expresses
androgen receptor, condenses around the invaginating mammary epithelium,
detaching the epithelial bud from its epidermal placode (Kratochwil & Schwartz,
1976). Following the detachment of the epithelial bud, the male mouse fails to form
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nipples and the fetal mammary epithelium does not grow beyond two or three
primary ducts and a few secondary branches. In CD1 mice, a relatively uncomplex
epithelial network is observed in the male a few days after birth – with an average of
10 branching points and a ductal area up to 0.5mm2 at postnatal day (PND)5. At
puberty, the ductal area of the male mammary epithelium has increased about ten
times in size (to approximately 5 mm2), with the epithelium later regressing to about
half of its pubertal area in adulthood (Pokharel, Kolla, Matouskova, & Vandenberg,
2018; Vandenberg, Schaeberle, Rubin, Sonnenschein, & Soto, 2013). Similar
patterns have been observed in other mouse strains, even when the relative size of
the mammary epithelium differs significantly. For example, BALB/c males have a
total ductal area of about 0.2-0.25 mm2 (the right mammary gland being consistently
larger than the left) at PND21, which increases to approximately 0.35mm 2 at puberty
and in early adulthood (Matouskova, Jerry, & Vandenberg, 2019).
Because of the actions of androgens in the male, the female mouse
mammary gland becomes visibly distinct from its male counterpart about halfway
through gestation. At ED14, as the epithelial anlage invaginates into the underlying
mesenchyme, the absence of testosterone in the female allows the epithelium to
remain attached to the overlying epidermis (Hogg, Harrison, & Tickle, 1983). The
mammary epithelium sprouts at ED16; at ED18, the epithelium has formed a ductal
lumen and a well-differentiated nipple along with 10-15 secondary branches in an
early differentiated fat pad (Robinson, 2007). In contrast to the response of the male
mouse mammary gland to testosterone, embryonic development of the female
mouse mammary gland does not depend on ovarian or pituitary hormones, as
evidenced by the absence of a mammary phenotype prior to puberty in mice
genetically altered to lack hormone receptors (Hens & Wysolmerski, 2005). Yet
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prenatal exposure to a number of well-established xenoestrogens is associated with
abnormal growth of the gland, as well as increased later-in-life breast cancer risk
(Calaf, Ponce-Cusi, Aguayo, Munoz, & Bleak, 2020), suggesting that while
estrogens are not necessary for perinatal development of the mammary gland, they
are able to disrupt its development (Soto, Vandenberg, Maffini, & Sonnenschein,
2008). A number of mechanisms have been proposed or demonstrated for these
effects including increased numbers of estrogen-responsive cells, increased ductal
proliferation, altered stromal-epithelial interactions, activation of oncogenes and/or
repression of critical tumor suppressing genes, and alterations in the epigenome,
among others (Hilakivi-Clarke, de Assis, & Warri, 2013; Soto, Brisken, Schaeberle, &
Sonnenschein, 2013).
Ultimately, the growth of female mammary gland is promoted by ovarian
estrogens along with progesterone via signaling through estrogen receptor (ER)α
and progesterone receptors, respectively. However, the hypophysis-pituitary axis is
dormant until just prior to puberty, and at that time both hormones produce a 4- to 5fold increase in epithelial proliferation (Haslam, 1989). Just prior to the onset of
puberty (at approximately PND24), the female CD-1 mammary epithelium is
approximately 30-35 mm2 and it grows quickly to reach approximately 120 mm2 by
mid-puberty (PND32-35) (Kolla, Morcos, Martin, & Vandenberg, 2018). Again, similar
features are seen in other mouse strains although there are quantitative differences:
the female BALB/c ductal network at PND 21 extends to about 5 mm 2 and grows to
approximately 50 mm2 by PND32-35 (K. Matouskova et al., 2019). In this strain,
terminal end buds (TEBs), the highly proliferative epithelial structures that advance
the growth of the ductal network that represent the hallmark of puberty, are not
typically seen at PND21, whereas an average of seven TEBs per ductal tree are
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observed in BALB/c females at puberty. Compared to the ~20 TEBs that are typical
of the CD-1 mouse at puberty, it is evident that there are strain differences in the
quantitative features of the mammary gland.
The mammary gland is highly susceptible to hormone signaling throughout
life, but especially vulnerable during perinatal development, puberty, and pregnancy
& lactation. Throughout these periods, the organ undergoes re-organization,
proliferation, induction, and differentiation while relying on a host of molecular
signaling (Slepicka, Somasundara, & Dos Santos, 2021). A number of studies
suggest that early life exposures to xenoestrogens can alter the response of the
mammary gland to subsequent hormone or carcinogen exposures. For example,
male mice exposed to bisphenol S (BPS), an estrogenic chemical, have mammary
glands that are hyper-responsive to 17α-ethinyl estradiol (EE2), a pharmaceutical
estrogen, when it is provided at puberty (Kolla, McSweeney, Pokharel, &
Vandenberg, 2019). Furthermore, several studies have demonstrated that female
rodents exposed to bisphenol A (BPA) during perinatal development have mammary
glands that are hyper-responsive to 17β-estradiol after ovariectomy (Munoz-de-Toro
et al., 2005; Wadia et al., 2007).
In this study, we pursued a study design that allowed us to investigate the
effects of a “double” environmental insult on the mouse mammary gland, e.g., the
first exposure occurred during perinatal development, and the second occurred
during the prepubertal period. Here, mice were exposed during perinatal
development to oxybenzone, a chemical that has gained popularity as an effective
UVA and UVB filter. Initially used as a sunscreen ingredient and in other personal
care products, oxybenzone is now also used to stabilize dyes, inks, flavors and
fragrances and it pollutes the tissues of both aquatic and terrestrial species including
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humans (Calafat, Wong, Ye, Reidy, & Needham, 2008; Downs et al., 2016; EPA,
2015; Molins-Delgado et al., 2017). Oxybenzone is considered an endocrine
disruptor because it possesses both ER agonist and ER and AR antagonist activities
(Balazs et al., 2016; Kunz & Fent, 2006; Watanabe et al., 2015). Next, during the
prepubertal period, mice were exposed to either oxybenzone or to EE2, a synthetic
pharmaceutical estrogen commonly used in contraceptives (Stanczyk, Archer, &
Bhavnani, 2013).
This study design allowed us to pursue two distinct aims: In the first (see
FIGURE 6.1A, “Effects of Oxybenzone”), the mice were exposed to oxybenzone
either 1) during the perinatal period or 2) the five-day period just prior to puberty or
3) over both the perinatal and prepubertal periods. A fourth group was unexposed to
oxybenzone at all times. This aim allows us to determine which period of life
(perinatal vs prepubertal) is most sensitive to oxybenzone.
In the second approach (see FIGURE 6.1B, “Oxybenzone & EE2”), mice
were exposed to either vehicle or oxybenzone during the perinatal period, and then
administered EE2 during the 5 days prior to puberty. This study design allowed us to
determine whether perinatal exposure to oxybenzone might potentiate the effects of
xenoestrogens administered later in life. This second study involved three
experimental groups: 1) controls unexposed to either oxybenzone or EE2 or 2) mice
exposed to EE2 during the prepubertal period (but unexposed during the perinatal
period) or 3) a group of mice exposed to oxybenzone during the perinatal period
followed by EE2 exposure during the prepubertal period.
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Figure 6.1: Study Designs: A) “Effects of Oxybenzone”. B)”EE2 & Oxybenzone”.

6.3 Methods
Animals
BALB/c mice were kept in polysulfone cages with bedding, fed soy-free chow
(ProLab IsoDiet, Brentwood, MO) and tap water (in polysulfone bottles with rubber
stoppers and metal tops) provided ad libitum. Animals were maintained at the
University of Massachusetts Amherst Animal Facility in temperature-, humidity-, and
light-controlled conditions. All experimental procedures were approved by the
University of Massachusetts Institutional Animal Care and Use Committee.

Chemical administration
Female BALB/c mice were mated and then exposed to either tocopherolstripped corn oil (negative control) or 3000 μg/kg/day of oxybenzone dissolved in
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corn oil from pregnancy day 0 through lactational day 21. Each day, the mothers
were weighed and orally dosed daily by pipet. As a result, the offspring evaluated in
this study were exposed in utero and during the first 21 days of postnatal life via the
mother (e.g., throughout the perinatal period). At weaning, one male and one female
pup from each litter was randomly assigned to a prepubertal experimental group to
avoid litter bias. The animals were ear tagged for identification and co-housed with
the same-sex and same prepubertal treatment peers.
Prepubertal exposure ensued on the five days following weaning – from
PND21 to 25. The pups were weighed and orally dosed daily by pipet with stripped
corn oil, 2.5 μg/kg/day EE2, or 3 mg/kg/day oxybenzone. Sample sizes were 10-12
animals per treatment group including the control group.

Euthanasia and tissue collections
One day after the last administered prepubertal dose (e.g., on PND26),
animals were euthanized with CO2 inhalation followed by cervical dislocation to
ensure death. The weight of each animal was recorded and anogenital distance was
measured with calipers. Females were inspected to determine whether there was an
opening in their vagina, a sign of the onset of puberty.
From every male animal, we collected both the left and right fourth inguinal
mammary glands, spread both on a glass slide (Thermo Fisher Scientific, Waltham,
MA), and fixed them overnight in 10% neutral-buffered formalin (Thermo Fisher
Scientific). We also dissected and weighed the seminal vesicles. From every female
animal, we dissected the right fourth inguinal mammary gland, spread it on a glass
slide (Thermo Fisher Scientific, Waltham, MA) and fixed it overnight in 10% neutral
buffered formalin. The left mammary gland was fixed in 10% neutral buffered
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formalin overnight before being washed, dehydrated, and embedded in paraffin for
histology and immunohistochemistry. Finally, from each female, the uterus was
carefully dissected and weighed.

Whole mounted mammary gland processing and morphometric evaluation
Whole mounted mammary glands were processed through a graded series of
alcohols followed by two washes of toluene to remove fat from the tissue. Whole
mounted glands were rehydrated through a series of alcohols and stained overnight
with carmine. Finally, the samples were dehydrated through a series of alcohols and
xylene and sealed in individual k-pax heat-sealed pouches (Fisher Scientific)
containing 5ml methyl-salicylate (Acros Organics, Morris Plains, NJ).
The whole mounted mammary glands were imaged with a Zeiss AxioImager
dissection microscope (Carl Zeiss Microscopy, Jena, Germany) and a Zeiss highresolution color camera. All measurements were made with ZEN software (Carl
Zeiss Microscopy, Jena, Germany). In females, the mammary gland measurements
included the mammary gland ductal area (e.g., the area subtended by ducts), ductal
extension (e.g., the furthest growth of ducts relative to the center of the lymph node,
a centralized landmark), number and area of TEBs (defined as bulb-shaped
structures at the end of ducts measuring at least 0.03 mm 2). Images of female
mammary glands were captured at 15x magnification. In males, the number of
branching points in the entire ductal tree in both the right and left mammary gland
were measured along with the ductal area and TEB-like structures (not limited by
their true size but based on the ratio of the diameters in their center and the
respective duct). Images of male mammary glands were captured at 18x
magnification.
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Tissue embedding, sectioning and histological staining
Fixed mammary glands were washed in phosphate buffered saline,
dehydrated through a series of ethanols and embedded with paraffin (Leica
Biosystems, Richmond, IL) under vacuum. Paraffin blocks were cut into five
micrometer sections on a rotary microtome (Fisher Scientific) and mounted on
positively charged slides (Fisher Scientific) for histological and immunohistochemical
analyses.
For histological evaluations, slides were deparaffinized with xylene and a
series of alcohols, stained with Harris’ hematoxylin and eosin (Fisher Scientific),
dehydrated, and mounted with permanent mounting media (Fisher Scientific). Digital
images were collected using a Zeiss Axio Oberserver.Z1 inverted microscope, a 10X
objective, and a high-resolution color camera (Carl Zeiss Microscopy). Periductal
collagen fibers were stained with Gomori’s Trichrome Stain (Richard-Allen
Scientific/Thermo Fisher Scientific, REF 87020). In short, deparaffinized samples
were fixed with Bouin’s fluid (REF# 88038), stained with Weigert’s Iron Hematoxylin
(REF#s 88028 and 88029), and Gomori’s Trichrome Stain (REF# 88030). Individual
dyes in the kit stain the collagen fibers blue, cell nuclei are stained black, while
cytoplasm and muscle fibers appear red.

Immunohistochemistry
Expression of three markers was evaluated using standard methods for
immunohistochemistry and commercial antibodies including rabbit anti-ERα (EMD
Millipore, Cat# 06-935, Temecula, CA); rabbit anti-Ki67 (Fisher Scientific, Cat# RM9106-S1), a marker of proliferation; and rabbit anti-progesterone receptor (PR; Abcam,
Cat# ab131486, Cambridge, MA). Briefly, sections were deparaffinized, hydrated
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through a series of alcohols, microwaved in 10 mM citrate buffer (pH 6) for antigen
retrieval, and treated with hydrogen peroxide to quench endogenous peroxidases.
Non-specific binding was blocked with 1% milk protein in 5% normal goal serum (Cell
Signaling Technology, Danvers, MA).
Sections were incubated with primary antibodies (typically diluted 1:500 or
1:1000 in blocking solution) at 4°C for 14-16 h. They were then washed and incubated
with secondary antibody (goat anti-rabbit, Abcam, Cat# ab64256) followed by
streptavidin peroxidase complex (Abcam, Cat# ab64269). Diaminobenzidine
chromogen (Abcam, Cat# ab64238) was used to visualize reactions. Sections were
counterstained with hematoxylin (Fisher Scientific). Each immunohistochemical run
included a negative control in which the primary antibody was replaced with 5% normal
goat serum.
Images were collected of each mammary sample for ERα, Ki67, and PR at
400X magnification with a Zeiss Axio Observer.Z1 inverted microscope. Expression of
ERα and PR were evaluated by counting at least 500 epithelial cells in 2-4 separate
fields. Expression of Ki67 was evaluated by counting at least 1000 epithelial cells in
3-5 separate fields. Expression of ERα, Ki67 and PR were expressed as a percent
ratio of the total number of epithelial cells evaluated.

Statistical analysis
GraphPad Prism statistical software (version 9.1.1.) was used to perform
statistical analyses. One-way ANOVA tests were used to determine the variance of
the means among the treatment groups (using perinatal + postnatal treatment
groups as the independent variables), and Tukey’s post hoc test was used to
evaluate the between-groups significance, correcting for multiple comparisons.
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When needed, the Kruskal-Wallis ANOVA test was utilized for non-normally
distributed outcomes. Categorical data were analyzed using a Chi-square test for
trend. A p-value less than 0.05 was considered significant. Graphs represent means
± standard error unless indicated otherwise.

6.3 Results

EFFECTS OF OXYBENZONE
6.3.1

Oxybenzone does not alter animal weight but modestly changes

endocrine sensitive endpoints in both males and females

We started by quantifying the effects of oxybenzone on growth and overt
signs of endocrine activity in the male. Neither perinatal nor prepubertal exposures
to oxybenzone affected the body weight of the male at PND26 (FIGURE 6.2A).
However, there was a trend observed in the oxybenzone exposure groups, which
showed an increased anogenital index compared to controls (FIGURE 6.2B, Kruskal
Wallis test, p value = 0.0834). The weight of seminal vesicles (corrected for body
weight) was not significantly changed by oxybenzone treatment (FIGURE6.2C,
ANOVA, p value = 0.2434).
We next evaluated growth and overt endocrine endpoints in the female at
PND26. The body weight of female pups was not altered due to exposure to
oxybenzone at either stage of development (FIGURE 6.2D, ANOVA, p value = 0.74).
On the other hand, we observed a significant increase in the female anogenital
distance in response to perinatal exposure to oxybenzone (FIGURE 6.2E, ANOVA, p
value = 0.0517). Uterine weight was not changed following either perinatal or
prepubertal exposure to oxybenzone (FIGURE 6.2F, ANOVA, p value = 0.5665).
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Finally, females exposed to oxybenzone during prepubertal development were less
likely to have the vaginal aperture open at PND26 compared to controls, although
this effect was not statistically significant (FIGURE 6.2G, Chi-square test for trend, p
value = 0.2793).

Figure 6.2: “Effects of Oxybenzone” Male and Female morphometrics at PND26. A)
Male animal weight. B) Male anogenital index. C) Weight of seminal vesicles relative to
the body weight (arrows on the inserted icon indicate seminal vesicles in the male
reproductive system in the mouse). D) Female animal weight. E) Female anogenital
index (ANOVA, p value = 0.0517; Tukey posthoc p value = 0.0302); F) Uterus to body
weight ratio (inserted icon of a mouse uterus without ovaries). G) Vaginal opening.
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6.3.2

Female mammary gland growth parameters at pubertal onset are not

affected by perinatal or prepubertal exposure to oxybenzone

We next evaluated the effect of oxybenzone on the female mammary gland,
measuring several growth parameters at PND26. We observed no significant effects
of oxybenzone treatment, regardless of the period of administration, on ductal area
(FIGURE 6.3A), ductal extension (FIGURE 6.3B), number of TEBs (FIGURE 6.3C),
average TEB size (FIGURE 6.3D), total TEB area (FIGURE 6.3E), or TEB density
(FIGURE 6.3F). These results suggest that oxybenzone treatment alone does not
affect these aspects of mammary gland morphology at this age.

Figure 6.3: “Effect of Oxybenzone” Female Whole Mounts Mammary Gland
Analyses at PND26. A) Ductal area. B) Ductal extension. C) Average number of
terminal end buds (TEBs). D) Average TEB area. E) Area of TEBs total. F) TEB density.
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6.3.3

The male mammary gland exhibits consistent asymmetry, but neither the

left nor the right gland are affected by oxybenzone exposure alone

We next turned our attention to the morphology of the male mammary gland.
Prior studies of the male mouse mammary gland revealed a distinct left – right
asymmetry both after exposure to a synthetic estrogen and in controls (Pokharel et
al., 2018). The right mammary gland has been reported to be larger than the left,
and more sensitive to ER agonists administered either during the perinatal or
peripubertal period. Consistent with those findings, we observed that the right
mammary gland was more likely to have epithelial structures present and the
epithelial network was larger, more branched and had modestly higher number of
TEB-like structures compared to its left counterpart (FIGURES 6.4A, ANOVA test, p
value <0.001; 6.4B-D vs 6.4E-G).
For the remainder of our analyses of the male mammary gland, all variables
were evaluated separately for the right and left glands. In the right mammary gland,
ductal area was decreased with prepubertal and perinatal exposure to oxybenzone
although this difference was not statistically significant (FIGURE 6.4.B ANOVA, p
value = 0.1910). Other parameters in the right mammary gland followed similar
patterns after oxybenzone exposure (e.g., fewer branching points and fewer TEBlike structures, see FIGURES 6.4C,D). These responses are not statistically
significant but are consistent with our previous findings (Matouskova et al., 2019).
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Figure 6.4: “Effect of Oxybenzone”: Male Whole Mount Mammary Gland
analyses at PND26. A) Ductal tree presence in the right vs left male mammary
gland (MG). B) Ductal area in the right MG. C) Number of branching points in the
right MG. D) Number of pre-terminal end buds in the right MG. E) Ductal area in
the left MG. F) Number of branching points in the left MG. G) Number of preterminal end buds in the left MG.
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As for the left mammary gland, nearly half of the males were lacking an
outgrowth on the left side, therefore the statistical power is diminished, making
interpretation of the results less reliable than in the right mammary gland. In spite of
this limitation, we observed that the effect of oxybenzone on ductal area, branching
points, and TEB-like structures follows a similar pattern as we observed for the
ductal tree on the right (FIGURES 6.4E,F,G).

EE2 and OXYBENZONE
6.3.4

Five days of exposure to EE2 during prepuberty does not alter male body

weight, anogenital distance, or weight of the seminal vesicles in BALB/c mice

The next step we took was to examine the effect of prepubertal EE2 exposure
on growth and endocrine endpoints in the male. We found that this short-term
exposure to EE2 does not affect body weight (FIGURE 6.5A) or anogenital distance
(FIGURE 6.5B). We were surprised to find no effect of prepubertal EE2 exposure on
the relative weight of the seminal vesicles (FIGURE 6.5C).

6.3.5

Five days of exposure to EE2 during prepuberty does not alter female body

weight, anogenital distance, uterine weight, or the timing of vaginal opening in
BALB/c mice

Prior studies have documented numerous effects of prepubertal EE2
exposure on the female mouse, so we next turned our attention to the female pups
at PND26. Not surprisingly, there was no effect of prepubertal EE2 on body weight
(FIGURE 6.5D) or anogenital index (FIGURE 6.5E); this was expected because this
parameter is established during prenatal development. Interestingly, where we saw
that perinatal exposure to oxybenzone altered anogenital index (see FIGURE 6.2E),
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when these animals were administered a postnatal estrogen challenge, the effect of
perinatal exposure to oxybenzone was no longer observed (FIGURES 6.2E. vs
6.5E).
Perhaps most surprising is the absence of an effect of EE2 on uterine weight.
The uterotrophic response has been well documented in prepubertal female mice at
lower doses of EE2 than what we administered here. We observed that the mean
weight of the uterus was higher in females perinatally exposed to oxybenzone and
later to EE2 (0.1725g) than in controls (0.1336g), but this difference was not
statistically significant (FIGURE 6.5F, ANOVA, p value = 0.38). Vaginal opening also
did not significantly differ among the treatment groups (FIGURE 6.5G, Chi square =
0.2116, p-value = 0.6455).

Figure 6.5: “Oxybenozne & EE2” Male and Female Morphometrics at PND26. A)
Male body weight. B) Anogenital index (anogenital distanced divided by body weight) in
males. C) Seminal vesicles weight related to the body weight. D) Female body weight.
E) Female anogenital index. F) Uterine weight related to the body weight. G) Vaginal
opening
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6.3.6

Modest evidence that perinatal exposure to oxybenzone diminishes the

effects of prepubertal EE2 treatment on the female mammary gland

Prior studies have demonstrated that the mammary gland responds to
estrogenic stimulation at prepubertal stages with quantifiable changes (usually
increases) in morphological parameters. Transient prepubertal exposure to EE2
increased growth parameters of the mammary gland as measured in the whole
mount, but we were once again surprised to find that these effects were not
statistically significant. These included effects on ductal area, (FIGURE 6.6A,
ANOVA test, p value = 0.1897), ductal extension (FIGURE 6.6B, ANOVA test, p

Figure 6.6: “Oxybenzone & EE” Female Mammary Gland Whole Mount
Analyses. A) Ductal area. B) Ductal extension. C) Average number of terminal
end buds (TEBs). D) TEB average area. E) TEB area total. F) TEB density.
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value = 0.6009), number of TEBs (FIGURE 6.6C, ANOVA test, p value = 0.0938)
and average size of the TEBs (FIGURE 6.6D, ANOVA test, p value = 0.6414). There
was some indication that perinatal oxybenzone exposure interferes with the modest
estrogenic stimulation; ductal area (and number of TEBs) in females exposed
perinatally to oxybenzone followed by prepubertal EE2 treatment was smaller than in
females stimulated with EE2 alone (FIGURES 6.6A,C).

6.3.7

Effect of perinatal oxybenzone and postnatal EE2 on histological

parameters of the female mammary gland

In response to perinatal exposure to oxybenzone, female luminal cells
express ERα in proportionally greater numbers than controls (FIGURE 6.7A,
ANOVA, p value = 0.0023); this effect was more pronounced in females exposed to
oxybenzone during both the perinatal and prepubertal periods (FIGURE 6.7A,
ANOVA p value = 0.0267). Interestingly, a short-term prepubertal exposure to EE2
alone does not significantly alter the number of ERα expressing luminal cells
whereas a combined exposure (perinatal oxybenzone plus prepubertal EE2)
increases the number significantly (FIGURE 6.7B, ANOVA, p value = 0.0017).
We next used Ki67 as a marker to evaluate proliferation in luminal cells. We
observed no effect of oxybenzone at either period of development on the number of
cells in mitosis (FIGURE 6.7C). There was also no statistically significant effect of
perinatal oxybenzone exposure combined with a short term prepubertal exposure to
EE2 on measures of mitosis (FIGURE 6.7D).
Finally, we examined the effect of oxybenzone and/or EE2 on the width of the
loose connective tissue located around mammary ducts (also known as the
periductal stroma). In females, exposure to EE2 during the prepubertal period does
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not significantly alter periductal stromal width. This was observed regardless of
perinatal exposure to oxybenzone (FIGURE 6.7F, ANOVA test, p value = 0.7169).

Figure 6.7: Immunohistochemistry analyses in the female mammary gland at PND 26.
A) “Effect of oxybenzone” Expression of ERα. B) “Oxybenzone&EE2” Expression of
ERα. C) “Effect of Oxybenzone” Expression of Ki67. D)“Oxybenzone&EE2”
Expression of Ki67. E) “Oxybenzone & EE2” Width of periductal stroma.
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6.3.8

The right, but not the left, male mammary gland is responsive to postnatal

exposure to EE2, and this effect is abrogated by perinatal exposure to
oxybenzone.

Consistent with our earlier findings and studies [FIGURES 6.4A-G and
(Pokharel et al., 2018)], the right male mammary gland is present more often and is
more sensitive to exposure to oxybenzone compared to the left (FIGURE 6.8A).
However, peripubertal exposure to EE2 lessens the naturally occurring right-left
asymmetry in the male mammary gland. Contrary to what was observed in controls,
the left mammary gland exhibits no difference in ductal tree occurrence once
stimulated with EE2.
When exposed to EE2 during peripubertal development, the right male
mammary gland is smaller (FIGURE 6.8B, ANOVA, p value 0.0599), with a
significant reduction in complexity as measured by the number of branching points
(FIGURE 6.8C, ANOVA, p value = 0.033) compared to controls. Yet, males exposed
to oxybenzone during perinatal development are insensitive to a peripubertal
estrogen challenge, with no effect on number of branching points compared to
untreated males (FIGURE 6.8C). The number of TEB-like structures were decreased
after EE2 exposures (with or without perinatal oxybenzone exposure), but these
effects were not statistically significant (FIGURE 6.8D).
In contrast, we observed no significant effects of prepubertal EE2 treatment
on the left mammary gland, regardless of whether the male was exposed to
oxybenzone during the perinatal period, although the trends were similar as in the
right (FIGURES 6.8E,F,G). The absence of a left mammary ductal tree in a number
of the samples likely contributed to the lower statistical power for measures of the
left gland.
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Figure 6.8: “Oxybenzone & EE2” Male Whole Mount Mammary Gland
analyses at PND26. A) Ductal tree presence in the right vs left male mammary
gland (MG). B) Ductal area in the right MG. C) Number of branching points in the
right MG. D) Number of pre-terminal end buds in the right MG. E) Ductal area in
the left MG. F) Number of branching points in the left MG. G) Number of preterminal end buds in the left MG.
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6.5 Discussion
In this study, we observed that a small number of outcomes were altered in
animals exposed to oxybenzone during the perinatal period, consistent with its
actions as an endocrine disruptor. For example, anogenital distance was longer in
females exposed to oxybenzone during the perinatal period compared to controls.
Also, expression of ERα in the female mammary gland was significantly increased in
animals exposed to oxybenzone. These results are consistent with several prior
studies that investigated the reproductive toxicity and endocrine-disrupting effects of
oxybenzone in rodents. An NTP study aimed at evaluating the toxicity of oxybenzone
showed that high doses (up to 50000 parts per million in feed) lowered sperm
concentration, increased the frequency of sperm abnormalities, and increased the
length of the estrous cycle in female mice and rats (French, 1992). Reproductive
abnormalities observed in a later toxicological study included decreased anogenital
index in the male rat at PND 23, reduced weight of testes and the number of
spermatocytes, decreased weight of the ovaries and uterus, and decreased numbers
of antral follicles following exposure to 25000 and 50000ppm (in feed) of
oxybenzone during development (Nakamura et al., 2015). Recent work also from our
laboratory revealed that short-term oxybenzone exposure in adult female mice
increased the expression Esr1 at doses that had no effect on uterine weight
(LaPlante, Bansal, Dunphy, Jerry, & Vandenberg, 2018). Hormone-sensitive
outcomes are not limited to rodents, as studies in zebrafish have also revealed that
oxybenzone exposures alter vitellogenin expression in fish (Kariagina et al., 2020).
Collectively, the results of the current study, together with the results of these prior
studies, suggests that oxybenzone meets at least four of the ten key characteristics
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of an endocrine disrupting chemical: it is a hormone receptor agonist, a hormone
receptor antagonist, it alters expression of hormone receptors, and it alters the fate
of cells in hormone-responsive organs (La Merrill et al., 2020).
The effects of oxybenzone have now been demonstrated in several studies
specifically examining the mammary gland. In human breast epithelial cells and in
the mammary epithelium of mice treated with oxybenzone, 1 µM and 5µM
concentrations or 3000µg/kg/day respectively, increased DNA damage as measured
by a double-strand break assay and in the quantification of R-loops, a threedimensional structure that is associated with DNA damage (Majhi et al., 2020). The
damage was ERα-dependent and analogous to adverse effects on DNA caused by
endogenous estrogens (e.g., 17β-estradiol). Yet, in a toxicological study that
evaluated the carcinogenic potential of oxybenzone in the Sprague-Dawley rat, the
incidence of mammary gland fibroadenomas and carcinomas were decreased in
females administered food containing 10,000ppm oxybenzone compared to
unexposed controls (NTP, 2020). These results suggest that, at this high dose,
oxybenzone might prove to be protective against some kinds of mammary tumors.
Our own work has shown that developmental exposure to oxybenzone is associated
with greater ductal growth and number of TEBs in the female pubertal mammary
gland, and an increase in the number of alveolar buds in the female adult mammary
gland (K. Matouskova, Vandenberg, L.N., 2022). In contrast, males exposed to
oxybenzone during development had smaller and less elaborated mammary
epithelial networks compared to controls at PND21.
The study design used in the “EE2 & Oxybenzone” experiment was devised
based on our hypothesis that exposure to xenoestrogens during early organ
development would increase susceptibility of the mammary tissue to pre-neoplastic
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changes later in life. The suggested mechanisms of augmented susceptibility include
interference with the number of nuclear and non-classical membrane receptors,
enhanced activation of these receptors, as well as non-genomic epigenetic
alterations – specifically DNA methylation of estrogen-sensitive genes (Prins, Tang,
Belmonte, & Ho, 2008). For example, perinatal exposure to bisphenol A (BPA)
enhances responses to estradiol in the mammary gland – exposures to 25 or 250
ng/kg/day BPA potentiated the number and size of TEBs when estradiol was
administered at puberty to ovariectomized females (Munoz-de-Toro et al., 2005). In
another study, mice were administered bisphenol S (BPS) during early development
and then given an additional EE2 challenge at puberty. Whereas control females
responded to the EE2 challenge as expected, e.g., with increases in the number of
ovarian follicles in all stages, this estrogen-induced stimulation was not observed in
females that had been exposed to BPS (Hill, Sapouckey, Suvorov, & Vandenberg,
2017). These studies suggest that early life exposures to xenoestrogens can
enhance, or abrogate, the effects of estrogens administered around puberty.
We were surprised to find that early life exposure to oxybenzone enhanced the
responses of the mammary gland to a peripubertal estrogen challenge in females, as
measured by an increased expression of ERα (FIGURE 6.7B). This was especially
surprising because there were no significant effects on the morphology of the
mammary gland in the females of any treatment groups (FIGURE 6.6). However, we
did note that EE2 exposure alone had no effect on morphology of the mammary
gland, or weight of the uterus (FIGURE 6.5F, Figure 6). These results suggest that
the female BALB/c mice used in this study may be unusually insensitive to
estrogenic stimuli either because of a genetic- or age-specific factor. This
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insensitivity has been observed previously for BALB/c mice, in contrast to other
strains (Haslam & Counterman, 1991; Kleinstreuer et al., 2016)
EE2 is a well-accepted positive control for estrogenicity, and its inclusion is
suggested as a routine practice. The inclusion of such a positive control in studies of
potential endocrine disruptors is necessary to distinguish between “true negative”
effects of test chemicals and negative effects that are observed because the test
system is unresponsive or insensitive to stimulation (vom Saal & Welshons, 2006).
Animal models should have demonstrated sensitivity to low doses of positive control
chemicals, e.g. EE2 (vom Saal et al., 2010). As our results suggest, such
responsiveness cannot be assumed. Lasty, doses of test chemicals should be
chosen based on knowledge of the relative receptor binding affinity whenever
possible. For example, if the test chemical has a receptor binding affinity that is 100
to 1000 times lower than the positive control, then doses of the test chemical should
be administered at least 100 to 1000 times higher than those that elicit a response in
the positive control (Timms et al., 2005). To illustrate the point, an extensive, multilaboratory effort failed to consistently detect effects of BPA on uterine weight at
doses below 300 mg/kg/day (Kanno et al., 2003). However, the rat strains that were
used are not appropriate for such studies because, based on their relative binding
affinities and the absence of uterotrophic responses to 0.1 µg/kg/day EE2, doses in
the range of 1000µg/kg/day BPA are predicted to alter uterine weight (Kanno et al.,
2001).
Our results provided additional evidence on the left-right asymmetry of the male
mammary gland that is consistent with previous findings in the same and other
mouse strains. We found that the mammary epithelium was present in significantly
greater numbers of male mice on the right side compared to the left fat pad. Our
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prior studies revealed that the right mammary gland is also consistently more
commonly affected by exposure to endocrine-disrupting chemicals (Pokharel, Kolla,
Matouskova, & Vandenberg, 2018). Here, we found that perinatal oxybenzone
exposure altered the response of the right male mammary gland to a prepubertal
EE2 challenge. In the males, both ductal area and complexity of the right gland were
significantly reduced upon prepubertal exposure to EE2, but these effects were no
longer observed in the males exposed to oxybenzone (FIGURE 6.8B,C). No effects
of either oxybenzone or EE2 were observed in the left male mammary gland. These
results suggest that early life oxybenzone exposure stunts the response of the right
male mammary gland to estrogens administered later in life.

6.6 Conclusion
The results in this study reveal modest but significant effects of perinatal
exposure to oxybenzone, a common active ingredient in sunscreens and personal
care products and UV-resisting agent in packaging, textiles, and industrial paints and
coatings. Female mice exposed to oxybenzone in utero and during lactation had a
longer anogenital distance. Perinatal exposure to oxybenzone also increased the
ratio of cells expressing ERα by 25% compared to controls. In males, short-term
prepubertal exposure to EE2 reduces both the area and complexity of the right
mammary ductal tree. Interestingly, perinatal exposure to oxybenzone reduces the
effects of EE2 in the male mammary gland as well. This study contributes to an
existing body of evidence suggesting that oxybenzone is an endocrine disruptor, and
suggests that disruptions during perinatal development can persist beyond the
period of exposure, and that the right mammary gland in the male is a sensitive
target of endocrine disruption.
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CHAPTER 7

A BRIEF OVERVIEW OF BREAST CANCER AND THE ENVIRONMENT

7.1 Breast Cancer Incidence and Trends
Worldwide, breast cancer is the leading cause of female neoplasia in 154 out
of 185 countries; of all cancers diagnosed in women, 24 percent occur in the breast
(Bray et al., 2018). Furthermore, despite advances in diagnostics and treatment,
breast cancer leads female cancer mortality in more than 100 countries around the
world.
In the United States, according to the database of Surveillance Epidemiology
and End Results (SEER), which includes data from patients with tumors dating back
to 1975, breast cancer in women in all age categories has increased over the past
four decades – by an average annual percentage change in 55-69 year old women
of 0.14% (95% CI = -0.18% to 0.46%) and 0.93% (95% CI= 0.48 % to 1.41%) in
women 70-89 years old at the time of diagnosis (Kehm, Yang, Tehranifar, & Terry,
2019). Population-based incidence data from the Connecticut Tumor registry offer
data dating back to the 1930s. This registry documents a shocking increase in
incidence of breast cancer from 16.5 cases per 100 000 women in 1935 to 38.5
cases per 100 000 women in 2015 (Lima et al., 2020); this is equivalent to an
increased relative rate of 2.4. Importantly, the authors accounted for parity trends
and concluded that changes in parity explain no more than 4% of the variability in
breast cancer incidence over the 80 years that have been studied.
7.1.1

Disparity in Breast cancer Incidence and Mortality

As a disease with multiple causative factors, breast cancer incidence varies
across age, race and ethnicity, but also depends on social, economic, and
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environmental determinants of health. In the period of 2012-16, incidence of breast
cancer in non-Hispanic white and black women was reported as 130.8 and 126.7
cases per 100 000 women respectively (DeSantis et al., 2019). These rates are
much higher than that of American Indian/Alaska Native, Asian/Pacific Islander, and
Hispanic female populations, which are reported as 94.7, 93.2, and 93.7 cases per
100 000 women, respectively.
Similarly, race, ethnicity, and social, economic and environmental
determinants of health also impact breast cancer mortality rates in the US. Mortality
ratio rates collected between 2013 and 2017 identified 42 states with breast cancer
mortality rate disparities based on ethnicity, and in all 42, non-Hispanic black women
are more likely to die from breast cancer than non-Hispanic white women. The
District of Columbia (relative risk = 1.83), Louisiana (relative risk = 1.63), and
Mississippi (relative risk = 1.59) rank as the top three states with ethnicity-driven
disparities in women’s death from breast cancer. Overall, during this same period of
time, breast cancer mortality rates were 20.3 deaths per 100 000 women in nonHispanic white populations and 28.4 cases per 100 000 women in non-Hispanic
black populations; this compares to 14.6, 11.5. and 14.0 deaths per 100 000 women
in American Indian/Alaska Native, Asian/Pacific Islander and Hispanic female
populations respectively (DeSantis et al., 2019).

7.2 Protective Effect of Parity
The mammary gland of a parous adult female rodent is distinct from that of a
nulliparous animal. Similarly, breast tissues of women who have had a full-term birth
deviate from tissues of those who have not. As discussed below, these changes can
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include the types of differentiated epithelial cells and structures, the composition and
characteristics of the periductal stroma, and the immune cell populations, among
others. Thus, on a microscopic and molecular level, both the mammary epithelia and
stromal structures bear signs of post-partum involution if full-term pregnancy
occurred in the body. These differences suggest that pregnancy is a critical period
for long term protection against breast pathology. Yet estrogen levels that increase
to nearly a hundred times higher compared to regular ovarian cycles pose a
paradox: on the one hand, the high levels of estrogen associated with pregnancy
induce protective changes in the breast, but on the other hand, in the treatment of
breast cancer, lowering the circulating level of estrogens is typically the first line of
defense. This paradox has been investigated at least since Sir Beatson published an
observation of a breast cancer in his patient regressing in response to removal of her
ovaries (Beatson, 1896).
Early epidemiological data clearly showed that pregnancy, especially at
younger ages, lowers the long-term risk of breast cancer (MacMahon et al., 1970).
Later still, data began to show that the long-term benefit takes some time to be
achieved because pregnancy first conveys a 2 to15 year long period of increased
risk (Albrektsen, Heuch, Hansen, & Kvale, 2005). Using more sophisticated
statistical analyses, the latest large collaborative “pooled” evaluation to examine the
relationships between age, parity, and breast cancer concluded that parous women
do acquire significant protection against the disease but only after about 20 years of
slightly higher risk of breast cancer (2.2% in women who had given birth vs 1.9% in
those who had not); the period of increased risk is longer, the later in life her
pregnancy has occurred (Nichols et al., 2019).
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Hypotheses proposed on the underlying cellular and molecular mechanisms
of the protection afforded by parity have focused on the two mammary
compartments: the epithelium and stroma. In the epithelium, parity induces
permanent changes consistent with lower susceptibility to carcinogenesis such as
decreased epithelial proliferation, fewer undifferentiated epithelial cells (J. Russo &
Russo, 1997), and also fewer luminal progenitor cells (Bach et al., 2017). ERαpositive epithelial cells tend to become less common following postpartum involution,
but the number of ERβ-expressing cells increase in older parous animals compared
to age-matched nulliparous controls (Dall et al., 2018). Further, parous animals have
lower PR expression in the mammary epithelial cells, as well as downregulated
expression of genes in the Wnt/β-catenin pathway (Muenst et al., 2017), and higher
expression of other genes involved in cell adhesion, DNA repair, and apoptosis
compared to age-matched nulliparous controls (Incassati, Chandramouli, Eelkema,
& Cowin, 2010; J. Russo, Balogh, & Russo, 2008).
The crucial role of stroma in carcinogenesis has been described in classic
experiments in the 1970s and 1980s: normal or carcinogen-treated mesenchyme
were transplanted with normal or carcinogen-treated epithelium in various organs,
revealing that the treatment of the stroma dictated the disease phenotype in the
epithelium (Sakakura et al., 1976). Thus, treatment of the stroma alone with a
carcinogen was sufficient to induce epithelial-derived tumors in the crosstransplanted samples.
Considering this essential role of the stroma, further experimentation has
worked to identify which features of the stromal compartment are responsible, at
least in part, for the protection afforded by parity. The changes, before all else, seem
highly conserved amongst rat strains; there is a conserved signature in the stroma,
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including alterations in activity of Tgf-β, immune cells, and extracellular matrix
(Blakely et al., 2006). Interestingly, a parity-associated gene expression signature
revealed conserved effects of parity in the epithelium, including downregulation of
amphiregulin and the GH/Igf-1 axis. In human breast tissue, a recent study revealed
286 genes that were differentially expressed – mostly upregulated - in women who
experienced full-term pregnancy compared to nulliparous women, although the study
did not discern in which effects were attributed to the epithelium or stroma(SantucciPereira et al., 2019).
Experimentally, the extracellular matrix from parous rodents – specifically its
protein components and enzymes - restricts ductal elongation and bifurcation more
than matrix isolated from nulliparous females, and in 3D organoid cultures it
suppresses development of alveolar structures (Schedin et al., 2004). Pregnancyassociated changes in the immune cell populations including macrophages,
lymphocytes, and mast cells are addressed in Chapter 8, however, the mammary
stromal compartment also includes adipose tissue and vascular systems where
potential targets of parity-related changes are largely still to be investigated.
Of note, beyond effects that are directly observed in the mammary tissue,
parity in the rat animal model is associated with other effects that can indirectly
impact mammary gland health. For example, parity permanently decreases the
levels of growth hormone (GH) in the pituitary, and GHRH in both the hypothalamus
and hypophysis; parity also permanently alters the levels of prolactin in the pituitary
which can be induced by lower THR and higher dopamine levels in the
hypothalamus (Subramani et al., 2021). Both of these hormones (prolactin and GH)
are key regulators of mammary gland morphogenesis (see Chapter 1). The role of
prolactin in regulating the morphology and function of the gland is observed for the
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most part during late pregnancy and lactation. In contrast, GH, which can bind to
prolactin receptors in addition to growth hormone receptors, acts throughout the
lifetime and can influence mammary carcinogenesis (X. Chen, Wu, Zheng, Liu, &
Wang, 2020; Katz, 2016; Subramani, Nandy, Pedroza, & Lakshmanaswamy, 2017).

7.3 Genes Associated with Breast Cancer
Like the organ itself, breast cancer risk is strongly sexually dimorphic, with
much higher risk observed in the female sex. Lifetime risk for women in the U.S. is
approximately 1 in 8 (13%) and more than 280,000 women are expected to be newly
diagnosed with breast cancer in 2021. The lifetime risk of the disease in men in the
U.S. is 1 in 833, corresponding to 2650 male patients that will receive the diagnosis
of breast cancer annually (SEER, 2021a).
Age is the next most critical risk factor for breast cancer, and age has been
associated with damage to the genome because somatic mutations accumulate over
time. This relationship between age and accumulation of mutations does not appear
to hold true for stem cells, which means that older age is not the only factor that can
influence the frequency of mutations in the cells that may participate in
carcinogenesis (Brazhnik et al., 2020). Interestingly, in addition to the number of
age-related mutations, the number of mutations calculated in tumors are predictable
and can be seen as a clock for tumor development and progression (S. Jones et al.,
2008). Thus, genomic instability appears to be a common feature of tumors, and
because these mutations accumulate in a stereotypical manner, they can be used to
calculate the time since the initiation of the tumor.
Although much work has been done to identify genes known to be tumor
suppressors or oncogenes, it is now understood that a single mutation, either

172

somatic or germline, will not produce a neoplasia (Hanahan & Weinberg, 2011). It is
instead estimated that somewhere between two and eight – and in some cases as
many as twenty - mutations in respective genes must be altered for a tumor to
manifest clinically (Vogelstein et al., 2013). The smorgasbord of available genes is
abundant: an extensive collaborative study identified 990 cancer-associated
mutations in 51 distinct genes mutated in the twelve most common types of cancer
(Pan et al., 2014); over 400 unique mutations in the tumor suppressor gene Tp53
alone are listed in the IARC database (Bouaoun et al., 2016).
In breast cancer, 10% of cases are associated with inherited germline
mutations. 6% of those are due to mutations in the alleles of the major breast
cancer susceptibility genes, BRCA 1 and BRCA2 (Tung et al., 2016). Mutations in
BRCA1 and BRCA2 increase the risk of breast cancer for the carriers from 13%
seen in the general population to 55-65%, and 45% respectively (S. Chen &
Parmigiani, 2007). After these genes are accounted for, the next most common
breast cancer related mutations occur in TP53. The frequency of TP53 germline
mutations has been estimated from as high as 1 in 5000 to 1 in 23,000 (Gonzalez,
Noltner, et al., 2009; Lalloo et al., 2003), and the likelihood of a mutation is increased
in individuals with a family history of early onset Li-Fraumeni syndrome related
cancers. Additional research quantifying the frequency of somatic TP53 mutations
suggests a role for ethnicity in individual risk of breast cancer. High profile genetic
profiling of populations in different parts of the world revealed that mutated TP53
accounts for 46% of somatic mutations in triple negative breast tumors isolated in
African American patients, 27% of tumors collected from Caucasian patients, 39% of
Saudi Arabian patients, and 19% of tumors from Chinese patients (Ademuyiwa, Tao,
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Luo, Weilbaecher, & Ma, 2017; Al-Tamimi, Bernard, Shawarby, Al-Amri, & Hadi,
2009; Lin et al., 2009).
Other genes that increase the likelihood of breast cancer to a more modest
degree include PTEN, PIK3C, ATM or CHEK2. Once again, the frequency of
mutations in these genes is highly dependent on ethnicity and tracking their origin
might be challenging (H. A. Yu et al., 2014). These low/moderate-penetrance genes
often have a role as a modifier of cancer manifestation, or a larger number of
mutations in those genes may produce a higher lifetime risk of breast cancer
compared to a smaller number of mutations in high penetrance genes (Thier et al.,
2003; Weber & Nathanson, 2000).
The risk of breast cancer risk has increased over time in both the general
population and in women carrying germline mutations. Ashkenazi Jewish females
are carriers of several ancient BRCA1/2 mutant alleles specific to this population and
therefore their risks and cancer manifestation can be studied with unique precision.
Comparing the risks of breast cancer between women born before and after 1940,
i.e. before the boom of the petrochemical industry and after, revealed that nongenetic factors have significantly increased the penetrance of the high-risk,
BRCA1/2, mutations in Ashkenazi Jewish women (King, Marks, Mandell, & New
York Breast Cancer Study, 2003). These results suggest that there is a substantial
influence of non-genetic, environmental factors superimposed on the genotype.
In conclusion, awareness of the genetic factors that contribute to increased
risks of cancer allow sensitive populations to be identified. De novo mutations in
BRCA1/2 are rare but testing for the presence of familial mutations in these genes is
common. Furthermore, testing for somatic mutations in TP53 may be beneficial as
de novo mutations in these genes can be present in up to 20% early onset cancers
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(Gonzalez, Buzin, et al., 2009). Individuals who are carriers of these mutations might
be the first in their family diagnosed with Li-Fraumeni syndrome, an autosomal
dominant disease manifesting in early-onset tumors, often even in childhood, as well
as breast cancers that develop before the age of 30 (Ruijs et al., 2010).
Because an individual cannot change their genetic risk factors, it has been
widely discussed amongst environmental health scientists that more effort is needed
to identify modifiable risks for cancers. Yet, there is increasing understanding that
genetics and environment should be viewed in concert. Certainly, there is evidence
that some genetic backgrounds can increase the sensitivity of individuals to
environmental carcinogens and other environmental risks (Colletti et al., 2014; Jerry
et al., 2018). Genetic screening is important because it offers the opportunity for
earlier interventions. Cancers diagnosed in early stages can usually be treated more
effectively, therefore identification of vulnerable individuals using modern methods of
genetic testing represents a highly consequential effort toward secondary prevention
attributed to advances in medical science and technology.

7.4 Environmental Chemicals Associated with Breast Cancer
The origin of as many as 80% of breast cancers does not rely on genetic
mutations. The argument that the culprits of increasing incidence of hormonesensitive cancers are likely environmental is constructed from three clues: 1/ the
incidence of hormone-sensitive cancers has increased over just two or three
generations, therefore a profound genetic shift is unlikely; 2/ human exposure to
environmental chemicals including many endocrine disruptors has increased
enormously over the past three or four generations; and 3/ the available evidence
from experimental in vitro and in vivo studies, well as mechanistic research and
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epidemiological studies, builds a strong case of environmental causes of endocrine
cancers.
As noted above, estrogens pose a paradox pertaining to breast cancer;
women are exposed to fluctuating levels of endogenous estrogens during ovarian
cycles reaching as high as 700pg/mL mid cycle (compared to serum levels less than
16pg/mL and 10pg/mL prior to puberty and after menopause respectively), and even
higher levels are measured during late pregnancy (up to around 7000pg/mL)
(Gardner, 2018); however, 87% of women in the general U.S. population remain
breast cancer-free throughout their lifetime. In spite of the high estrogen levels
associated with parity, pregnancy and lactation are long-term protective factors
against the risk of breast cancer (Nichols et al., 2019). On the other hand, women
who enter menopause later in life, and those who start menstruating earlier in life,
experience increased risk for breast cancer; these results suggest that lifetime
exposures to estrogens, including natural ones, are a major risk factor for mammary
cancer (Soto, Vandenberg, Maffini, & Sonnenschein, 2008). Furthermore, exposures
to various xenoestrogens have recently been associated with higher risks of breast
cancer and a wider range of adverse reproductive outcomes (Rodgers, Udesky,
Rudel, & Brody, 2018). Evidently, estrogens alone are “necessary but insufficient”
players in breast cancers and a number of modifying and contributory factors must
also be considered (Cohn, 2011).
The first indication that exogenous estrogens could contribute to breast
cancer risk came from the iatrogenic exposures of countless expectant mothers to
diethylstilbestrol (DES) between 1940s and 1971 (in the U.S.). The DES cases
represent a tragic probe into the effects induced by a potent synthetic nonsteroidal
estrogen in human populations. Mothers exposed to one dose or more of DES
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during pregnancy experience a long-term increased risk of breast cancer (TitusErnstoff et al., 2001); their offspring, both daughters and sons, exposed in utero are
more likely to be diagnosed with a range of uterine and vaginal malformations;
ovarian, uterine, breast and testicular cancers as well as other benign tumors in
these tissues compared to unexposed individuals (Al Jishi & Sergi, 2017). Animal
experiments have supported the epidemiological data pertaining to DES (Kawaguchi
et al., 2009; Newbold, Padilla-Banks, & Jefferson, 2006). While clinicians have
learned that “more estrogens” during the estrogen-rich time of pregnancy contradicts
the desired outcome, the effects of environmental estrogens have largely been
unexplored in females exposed during adulthood (including during pregnancy)
because of assumptions that adults would be less sensitive to hormone disruption.
Common environmental xenoestrogens linked to mammary cancer in rodents
or humans include the well-studied plasticizer bisphenol A (BPA) (Keshavarz-Maleki
et al., 2021; Vom Saal & Vandenberg, 2021), organochlorine pesticides such as
DDT, non-organochlorine pesticides such as atrazine, industrial persistent pollutants
such as polychlorinated biphenyls (PCBs), and dominantly air-bound contaminants
such as dioxins and polycyclic aromatic hydrocarbons (PAHs) (Gore et al., 2015).
The group of environmental chemicals associated with breast cancer is diverse in
molecular structure and most lack the typical 4-ring configuration associated with
endogenous steroid receptor ligands. Yet all of them interfere with estrogen action
either via binding to or by activating estrogen receptors through genomic or nongenomic pathways, or they alter the synthesis of endogenous estrogens; several of
these chemicals also induce epigenetic modifications in the cells that produce
estrogens or respond to them (La Merrill et al., 2020).
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Prolonged exposure to estradiol (E2) initiates tumorigenesis in human breast
epithelial cells via structural and genomic changes: the exposed epithelium no longer
differentiates or forms duct-like structures. Rather, it aggregates into spherical
masses and proliferates rapidly (J. Russo & Russo, 2006). These changes are
accompanied by genomic transformations including both gains in 1p and 5q and
deletions in 3p, 8p, and 18q. Formation of reactive estrogen metabolites are another
path towards cancer initiation. Endogenous estrogens transform into catechol
estrogens, and these are oxidized into quinones. Upon reaction with DNA, the
quinones form depurinating adducts capable of initiating cancer because DNA with
apurinic sites is prone to errors in repairs, and thus likely to mutate and eventually,
form cancers (Cavalieri & Rogan, 2016). The formation of DNA adducts has been
previously shown as a tumorigenic effect of DES (Saeed, Rogan, & Cavalieri, 2009).
There is additional evidence that estrogens are involved in the initiation of
breast tumors. An imbalance in estrogen metabolism, largely due to dysregulation of
CYP enzymes, has been demonstrated in tumors of ERKO mice (Devanesan et al.,
2001) and breast tissue of carcinoma patients (Rogan et al., 2003). Furthermore,
endogenous estrogens and other ER agonists may induce direct DNA damage via
interaction with chromatin and the formation of R loops, the three-stranded hybrid
DNA-RNA structures formed by cellular RNAs that are normally removed in a timely
manner and carefully regulated (Majhi et al., 2020; Niehrs & Luke, 2020; Stork et al.,
2016).
A number of indirect mechanisms, sometimes referred to as epigenetic or
non-genomic effects, enhance susceptibility to carcinogenesis and enable tumor
progression. In a truly epigenetic manner, exposure of epithelial cells to E2 or BPA
induced hypermethylation of several genes involved in branching processes and
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enhanced their invasion and migration capacity (S. V. Fernandez & Russo, 2010).
BPA was also demonstrated to increase the number of proliferating cells and
stimulate abnormal cell proliferation, and produce pre-neoplastic lesions in the
mammary gland (Bosquiazzo, Varayoud, Munoz-de-Toro, Luque, & Ramos, 2010;
Murray, Maffini, Ucci, Sonnenschein, & Soto, 2007). Further, endogenous estrogens
and other ER agonists interfere with apoptosis in breast cancer cells (Bailey, Shin,
Westerling, Liu, & Brown, 2012; J. Wang et al., 2014). Based on the role of the
mammary stromal components discussed above, these components are likely one of
the indirect mechanisms that permit cancer progression. Experimental therapies that
suppress aromatase in the adipose tissue have been used in obese women based
on a theory that estrogens can induce adipokines in the adipose tissue, leading to
increased risk of breast cancer (O'Flanagan, Bowers, & Hursting, 2015;
Subbaramaiah et al., 2011).
Much work still remains to be done to understand how xeno/estrogens
contribute to susceptibility to breast cancer. What is clear from recent work by breast
cancer advocates is that the current methods that have been used to evaluate
environmental chemicals for their contributions to breast cancer risk are insufficient,
and even when there is evidence that xenoestrogens disrupt mammary gland health,
these findings are often ignored by regulatory agencies (Cardona & Rudel, 2020).
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CHAPTER 8

EXPOSURE TO OXYBENZONE DURING PREGNANCY AND LACTATION
ALTERS TUMOR CHARACTERISTICS IN A TP53-/- MURINE MODEL OF
BREAST CANCER
Klara Matouskova, Amy Roberts, Jackie Cao, Carol Bigelow, Shannon Silva, Karen
A. Dunphy, Sallie S. Schneider, D. Joseph Jerry, Laura N. Vandenberg

8.1 Abstract
Background: Oxybenzone is a UV filter commonly used in sunscreens, and
countless consumer and industrial products. Prior studies indicate that oxybenzone
is an estrogen receptor (ER) agonist, and it can induce ER-dependent DNA damage.
In vivo studies demonstrate that exposures during sensitive periods of development
increase proliferation and expression of ERα. Based on these findings, we
hypothesized that oxybenzone would increase the susceptibility of the mammary
gland to develop cancer in a genetically susceptible mouse model, either by
decreasing tumor latency or increasing tumor severity.
Methods: We transplanted Tp53 -/- epithelial cells into cleared mammary fat pads
of BALB/c mice, and exposed the females to either 0 (control) or 3000 µg/kg/day
oxybenzone throughout pregnancy and lactation. We surveilled these mice until they
reached 52 weeks of age to investigate tumor latency. Follow-up analyses examined
tumor characteristics in the Tp53-/- tissues, and mammary gland characteristics in
wild type tissues.
Results: Exposure to oxybenzone during pregnancy and lactation modestly
decreased the latency of mammary neoplasia in a Tp53-/- model. In the tumors,
oxybenzone exposure enhanced tumor vascularization and macrophage infiltration.
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Evaluation of the morphology of the wildtype (non-transplanted) glands confirmed
that exposures to oxybenzone during pregnancy and lactation produce permanent
alterations in the morphology of the mammary gland.
Conclusions: Exposures to oxybenzone during pregnancy and lactation may pose
an additional challenge to mammary gland health in genetically vulnerable
individuals. Mutations in the tumor suppressor gene Tp53 in the mammary
epithelium combined with exposures to oxybenzone, an endocrine disrupting
chemical, elicit modest but significant changes in tumorigenesis outcomes that may
be consistent with worse clinical prognosis.

Keywords: 2-hydroxy-4methoxybenzophenone, endocrine disruptor; sunscreen;
xenoestrogen; parity

Figure 8.1: Study Design.
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8.2 Introduction
Pregnancy and breastfeeding provide a unique set of protections to the
mother including a decreased incidence of metabolic syndrome and cardiovascular
diseases as well as a much-discussed protection against breast cancer (Gunderson
et al., 2010). Initially observed in large human datasets in 1970 and followed up with
epidemiological cohort studies, early pregnancy and multiple parity reduce later-inlife risk of breast cancer (MacMahon et al., 1970). Yet even though pregnancy
provides significant protection during the post-menopausal period, the risk of breast
cancer in parous women peaks six years after giving birth (Albrektsen et al., 2005).
According to a recent meta-analysis, childbirth increases the risk for breast cancer
for 20 years postpartum, regardless of the length of lactation (Nichols et al., 2019).
Many studies evaluating the molecular mechanisms involved in breast cancer
have revealed the role of germline mutations, somatic mutations and/or epigenetic
alterations in three central groups of genes: proto-oncogenes [e.g., HER2
(Krishnamurti & Silverman, 2014)], DNA repair genes [e.g., BRCA 1 and BRCA 2
(Winter et al., 2016)], and tumor suppressor genes [e.g., the classic Rb, colorectal
cancer associated APC, or the master regulator Tp53 (Sherr, 2004)]. As
investigation of these genes continues to progress, understanding of their
specializations has revealed that their actions can be pleiotropic, e.g., the products
of Tp53 or BRCA can both suppress malignant growth of tumor cells and repair
damaged DNA (Boutelle & Attardi, 2021; Matsuda et al., 2020).
It is also becoming more widely appreciated that development of breast
cancer is a multiple step process that is more complicated than an event involving a
single gene mutation. For example, among BRCA1 and BRCA2 mutation carriers,
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46% and 52% of women respectively will develop breast cancer at some point in
their lives, indicating that about half of women with these mutations will not develop
the disease (Rebbeck et al., 2015). The prevalence of BRCA1 and BRCA2
mutations in the U.S. population is estimated as occurring in 1:300 to 1:500 women
(Moyer & Force, 2014), leaving approximately 99% of all breast cancer diagnoses
unexplained by these specific prototypical inherited mutations (Tung et al., 2016).
Twin studies conducted in Scandinavian countries found that 27% of breast cancers
can be attributed to inherited causes (Lichtenstein et al., 2000), providing additional
evidence that most cases of the disease occur due to accumulated mutations in
moderate and low penetrance genes, epigenetic alterations, and other
environmental risk factors. Furthermore, women in two different cohorts were
investigated for frequency of germline or somatic mutations in BRCA and other high
penetrance genes; in both cohorts, those mutations were estimated to be
responsible for about 10% of breast cancer cases (Cybulski et al., 2019; Tung et al.,
2016). The relatively modest role of mutations in prototypical cancer genes
contributes to a renewed interest to identify environmental determinants that can
either promote breast cancer outright or interact with genetic susceptibility factors to
increase cancer risk indirectly.
Commonly recognized environmental factors involved in breast cancer
etiology include obesity, lack of physical activity, and use of tobacco or alcohol (Hiatt
& Brody, 2018). Other environmental exposures associated with increased risk of
breast cancer include nitrogen oxides from air pollution, industrial chemicals such as
congeners of polychlorinated biphenyls (PCBs), and legacy pesticides like
dichlorodiphenyltrichloroethane (DDT) and its metabolites (Andersen et al., 2017;
Cohn et al., 2015; Cohn, Terry, Plumb, & Cirillo, 2012). Further, both endogenous
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and exogenous estrogens are associated with an increased risk for breast cancer as
seen in women who enter puberty earlier and menopause later (Soto et al., 2008),
as well as in women administered some hormone therapies at menopause (J. E.
Manson et al., 2013). The tragic story of increased breast cancer risk observed in
women exposed to pharmaceutical estrogens such as diethylstilbestrol (DES) during
organizational periods of mammary gland development similarly highlights the
sensitivity of the breast to exogenous hormonally active agents (Palmer et al., 2006;
Titus-Ernstoff et al., 2001).
Studies of women exposed to DES led scientists to hypothesize that other
endocrine disrupting chemicals, including chemicals found in everyday consumer
products, contribute to the mixture of quotidian estrogenic exposures and thus may
increase risk for breast cancer as well (Hiatt & Brody, 2018; Macon & Fenton, 2013;
Schwarzman et al., 2015; Soto & Sonnenschein, 2010). PCBs, DDT, and DDT
metabolites, all chemicals associated with increased breast cancer risk, are
hormonally active agents, and their endocrine disrupting properties are suspected to
be responsible for their actions (Gore et al., 2015; Rodgers et al., 2018; Rudel,
Fenton, Ackerman, Euling, & Makris, 2011). Importantly, several xenoestrogens
have been described as “epigenetic carcinogens” because of their ability to promote
uncontrolled growth of breast cells via estrogen receptor (ER) mediated processes
and formation of estrogen-DNA adducts (Cavalieri & Rogan, 2016).
Oxybenzone (benzophenone 3) is an ultraviolet filter used commonly in
personal care products, fabrics, resins, and plastics. Because of its widespread use,
it has been documented to pollute a number of environmental matrices, and it has
been repeatedly measured in human biological samples including urine, blood,
semen, amniotic fluid, and breast milk (Hines et al., 2015; Krause, Frederiksen,
184

Sundberg, Jorgensen, Jensen, Norgaard, Jorgensen, Ertberg, Petersen, et al., 2018;
Leon et al., 2010; Woodruff et al., 2011). Oxybenzone is an ER agonist and
androgen receptor antagonist, and its metabolites, namely benzophenone 1 and
2,4,4’ trihydroxybenzophenone, are also ER agonists, making its effects on the
mammary gland important to evaluate (K. Matouskova, Vandenberg, L.N., 2022). In
our previous study, we found that mice exposed to oxybenzone during pregnancy
and lactation had significantly higher proliferation rates in their post-involution
mammary epithelium, even several weeks after exposures had ceased (LaPlante et
al., 2018). We also found that oxybenzone induced ER-dependent DNA damage in
the mammary glands of exposed mice, as well as in T47D breast cancer cells (Majhi
et al., 2020). Collectively, these results led us to hypothesize that exposures to
oxybenzone would alter the risk of mammary cancer in a mouse model with an
unfavorable genetic background, e.g., mice with mammary epithelium lacking Tp53.
Here, we transplanted BALB/c mice with Tp53-/- epithelial cells, and then
exposed these females to 0 or 3000 µg/kg/ body weight oxybenzone during
pregnancy and lactation. The mice were observed for tumor development until the
females reached 52 weeks of age. Once tumors emerged, they were investigated for
clinically relevant characteristics. We found that oxybenzone modestly shifted the
latency to develop tumors and altered some but not all aspects of tumor biology
(e.g., necrosis and macrophage infiltration). Oxybenzone also permanently altered
the morphology of the BALB/c wildtype (non-transplanted) mammary epithelium.
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8.3 Materials and Methods
Animal Model
BALB/c female mice were raised in the UMass colony and housed under
standard conditions, e.g., in polysulfone cages with sanitary bedding. Chow (ProLab
IsoDiet, Brentwood, MO) and tap water (in polysulfone bottles with rubber stoppers
and metal tops) were provided ad libitum. Animals were maintained in temperatureand light-controlled conditions (12-hour cycles of light and dark) throughout the
study. All experimental procedures were approved by the University of
Massachusetts Institutional Animal Care and Use Committee.
At 3 weeks of age, female mice were anesthetized and epithelium from the
left and right 4th mammary glands was removed, and the cleared fat pads were
injected with mammary epithelial tissue fragments previously collected from animals
lacking Tp53 [see FIGURE 8.1] (Yan et al., 2010). The genotype of the transplanted
cells was verified with PCR.
At 6 weeks of age, each female was randomly assigned to a treatment group
using statistical software to distribute them evenly according to their body weight; 22
females were assigned as controls (CTRL) and 20 female mice formed the
oxybenzone-treated group (OXY). The females were then paired with untreated
breeder males. The control females were orally administered tocopherol stripped
corn oil and the oxybenzone group was exposed to 3000 μg/ kg body weight/ day
(dissolved in tocopherol stripped corn oil) via pipette feeding throughout pregnancy
and 21 days of lactation (approximately 42 consecutive days).
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Tumor Surveillance
After weaning at 21 days post-partum (at approximately 12 weeks of age),
female mice were palpated for mammary tumors and their general condition was
examined. This occurred every two weeks for the first 24 weeks of surveillance, and
then every week from 24 weeks post-transplant until tumors were detected, or 52
weeks of age. When tumors were detected, they were closely surveilled and
surgically removed before they reached a diameter of 1 cm in any dimension. The
animals continued in the experiment if tumors were observed unilaterally. Tumor
regrowth or identification of bilateral tumors required the females to be euthanized.

Euthanasia and Tissue Collection
Animals were euthanized with CO2 inhalation followed by cervical dislocation
to ensure death and tumor location was recorded. For each animal, remaining
mammary tissue from the 4th inguinal gland was collected along with the tumor, as
well as the 3rd pectoral pair of mammary glands, which were comprised of wildtype,
non-transplanted epithelium.
Pectoral and remnants of inguinal mammary glands were spread on glass
slides (Thermo Fisher Scientific, Waltham, MA), and fixed overnight in 10% neutralbuffered formalin (Thermo Fisher Scientific, Waltham, MA) for whole mount analysis.
Tumor tissue collected for histopathological analysis was fixed overnight in 10%
neutral buffered formalin before being washed, dehydrated, and embedded in
paraffin.
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Whole mounted mammary gland processing and morphometric evaluation
Whole mounted mammary glands were processed through a graded series of
alcohols followed by two washes of toluene to remove fat. They were then
rehydrated through a series of alcohols and stained overnight with carmine. Finally,
the samples were dehydrated through a series of alcohols and xylene and preserved
in individual k-pax heat-sealed pouches (Fisher Scientific) containing methyl
salicylate (Acros Organics, Morris Plains, NJ).
Whole mounted mammary glands were imaged with a Zeiss AxioImager
dissection microscope (Carl Zeiss Microscopy, Jena, Germany) and a Zeiss highresolution color camera, to verify a successful outgrowth of the Tp53 -/- transplants.
All outgrowths were examined for possible tumors and other gross abnormalities.
When observed, aberrant tissues were excised from the whole mounted gland,
embedded in paraffin, and sectioned for histopathological analysis.
For analysis of mammary gland morphology in the unmodified gland, wholemounted pectoral mammary glands were imaged at 30x magnification, and the
optical density was measured in both glands using ZEN software (Carl Zeiss
Microscopy); optical density is inversely correlated with the amount of mammary
epithelium present. Whole-mounted glands were also evaluated for the presence of
intraductal hyperplasias [observed as ducts with a beaded appearance (Vandenberg
et al., 2008a)] and hyperplastic alveolar buds. Each gland was assigned an
“abnormality” score based on the presence and extent of these abnormalities in the
unmodified glands.
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Tissue embedding, sectioning and histological staining.
Fixed mammary glands were washed in 1x phosphate buffered saline,
dehydrated through a series of alcohols and embedded with paraffin (Leica
Biosystems, Richmond, IL) under vacuum. Paraffin blocks were cut into five
micrometer sections on a rotary microtome (Fisher Scientific) and mounted on
positively charged slides (Fisher Scientific) for histological and
immunohistochemistry evaluation.
For histological evaluations, slides were deparaffinized with xylene and a
series of alcohols, stained with Harris’ hematoxylin and eosin (H&E) (Fisher
Scientific) or toluidine blue, then dehydrated, and mounted with permanent mounting
media (Fisher Scientific). Digital images were collected using a Zeiss Axio
Observer.Z1 inverted microscope, a 40x objective, and a high-resolution color
camera (Carl Zeiss Microscopy).

Histopathological Analyses
Tumor type and Grade
H&E-stained tumor sections were evaluated by a trained pathologist. The
tumor type and grade were determined according to the consensus criteria from the
Annapolis expert pathologists meeting (Cardiff et al., 2000). In brief, tumors were
classified as carcinoma, carcinosarcoma, or sarcoma based on their tissue origins.
Morphological descriptors (e.g., acinar, cribriform, papillary, solid, and squamous)
were used when appropriate. While both carcinoma and adenocarcinoma represent
a type of neoplasm originating from epithelium and glandular epithelium with proven
malignant behavior, adenocarcinoma contains both glandular and squamous types
of differentiation. Tumors described as carcinosarcoma are comprised of two tissue
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type components, epithelial and mesenchymal, with malignant behavior. Lastly,
some lesions were described as mammary intraepithelial neoplasia (MIN), e.g.,
lesions with intraluminal epithelial proliferation with cytologic atypia including
carcinoma in situ.
Tumor grade was assigned based upon histological and cytological criteria,
mitotic rate and necrosis. Low-grade carcinomas are characterized by the presence
of well-organized glandular patterns without significant pleomorphism, such as
acinar carcinoma, which is composed of small clusters of tumor cells forming glands
with small lumens. High-grade carcinomas have less differentiation, more solid
growth, more nuclear pleomorphism and a higher mitotic rate. Solid carcinomas,
adenocarcinomas, and carcinosarcomas were scored as grade 1, 2, 3, or 4. MIN
were graded as “low” or” high” grade and for the purpose of statistical analyses were
attributed grade 1 or 4, respectively.
Necrosis and Angiogenesis
H&E-stained tumor sections were qualitatively assessed for the presence and
degree of necrosis by two independent investigators. Each sample was graded as
“no necrosis”, “low degree”, “medium”, or “high degree” of necrosis. The degree of
angiogenesis was similarly scored in H&E-stained tumor sections by two
independent investigators. Because all samples had at least some blood vessels
present, scoring categories included “low degree”, “medium”, and “high degree” of
angiogenesis. For both measures, when samples were heterogeneous for measures
of necrosis or angiogenesis, the highest degree was selected as indicative for the
sample.
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Lymphocyte presence in the tumor and peri-tumor stroma
H&E-stained tumor sections and stroma surrounding the tumor were
qualitatively assessed for the presence and degree of tumor-infiltrating lymphocytes
(TILs) (Salgado et al., 2015). Within the tumor, TILs were scored as “absent”, “low
numbered”, “moderate numbered” or “high numbered”. In the stromal regions
surrounding the tumor, the presence of lymphocytes in the stroma (sTILs) were
scored as “low”, “moderate” or “high”. Scoring was performed by two independent
observers; if no consensus could be reached a third observer was consulted.
Quantification of mast cells
To quantify the distribution of mast cells in and around tumors, the total
number of mast cells were counted within the tumor and in the stroma surrounding
the tumor in Toluidine blue-stained sections. Mast cell distribution in the tumor and
stroma was reported as number of mast cells per area.
Immunohistochemistry
Immunohistochemical analyses of four markers were evaluated using standard
methods and commercial antibodies including rabbit anti-ERα (EMD Millipore, Cat#
06-935, Temecula, CA); rabbit anti-Ki67 (Fisher Scientific, Cat# RM-9106-S1), a
marker of proliferation; rabbit anti-progesterone receptor (PR; Abcam, Cat# ab131486,
Cambridge, MA); and rabbit anti-F4/80 (Cell Signaling Technology, Cat#70076), a cell
surface antigen expressed on macrophages. Briefly, sections were deparaffinized,
hydrated through a series of alcohols, microwaved in 10 mM citrate buffer (pH 6) for
antigen retrieval, and treated with hydrogen peroxide to quench endogenous
peroxidases. Non-specific binding was blocked with 1% milk protein in 5% normal goal
serum (Cell Signaling Technology, Danvers, MA).
Sections were incubated with primary antibodies (typically diluted 1:500 or
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1:1000 in blocking solution) at 4°C for 14-16 h. They were then washed and incubated
with secondary antibody (goat anti-rabbit, Abcam, Cat# ab64256) followed by
streptavidin peroxidase complex (Abcam, Cat# ab64269). Diaminobenzidine
chromogen (Abcam, Cat# ab64238) was used to visualize reactions. Sections were
counterstained with hematoxylin (Fisher Scientific). Each immunohistochemical run
included a negative control in which the primary antibody was replaced with 5% normal
goat serum.
Expression of ERα and PR were evaluated according to guidelines by the
American Society of Clinical Oncology (Allison et al., 2020). In brief, samples with less
than 1% of ERα- or PR-positive cells were interpreted as ER or PR negative while
samples with >1% tumor nuclei expressing the respective hormone receptor were
interpreted as positive. Note that all positive samples met the criteria for “Low Positive”
because none expressed ER or PR in greater than 10% of nuclei.
We used a nuclear proliferation marker, Ki67, to quantify the fraction of tumor
cells in mitosis. Ki67 tags cells in various stages of mitosis except for G0, therefore its
expression identifies active proliferation. Samples were viewed at 20x magnification
and representative images were taken by the ZEN imaging software using a Zeiss
AxioObserver.Z1 inverted microscope and a high-resolution color camera (Carl Zeiss
Microscopy). Both positive and negative cells were counted, and the percent of
positive cells was calculated for each tumor.
Analysis of macrophages using TissueQuant
To quantify F4/80 positivity in the tumor samples, representative images were
processed using ImageJ/FIJI and TissueQuant software. TissueQuant compares
different color shades within an image to a DAB-stained reference color and calculates
a color score based on the normalized hue, saturation, and color intensity of each pixel
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(Prasad, P, Chakravarthy, & Prabhu, 2012). Before batch processing all images in
TissueQuant, the DAB stain was isolated using predetermined regions of interest with
the Colour Deconvolution ImageJ/FIJI plugin to minimize nonspecific background
staining. These DAB-filtered images were then used to calculate the overall
concentration of positive staining and density of positively stained areas using
TissueQuant.
Statistical analysis
Prior to conducting statistical analyses, we evaluated whether the mouse
should be treated as the statistical unit, or the mammary gland (considering each
mouse was given two distinct Tp53 -/- epithelial transplants). In other words, we
considered the issue of the intra-correlation among mammary glands from the same
animal and the associated increase in probability of type I error of our statistical tests
of group differences. We recognize that appropriately defined mixed model methods
for correlated data would have ensured that our hypothesis tests were based on the
correct “effective” sample size (i.e. less than 72), provided all model assumptions are
met. Our rationale in performing the simpler analyses (i.e. analyses that ignored the
correlation structure) was to balance the increased probability of type I error with the
associated limitations of fitting complex mixed models (e.g., modeling the
correlations structure in data that is unbalanced) in modest data settings. Therefore,
in ancillary analyses, we estimated the correlations in tumor characteristics between
left and right mammary tumors in the same animal. None were statistically
significant and data visualizations revealed no patterns of association (data not
shown). Therefore, we are confident that where statistically significant group
differences are reported, they are unlikely to be spurious due to type I error.
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Next, prior to analyses, we applied selected exclusions: A) n=9 transplanted
mammary glands showed no epithelial outgrowth. B) n=3 mammary glands could not
be collected due to technical problems. And C) n=7 mammary glands were excluded
because transplanted tissues exhibited ductal epithelia free from any observable
tumor growth at 30x magnification (using the Zeiss AxioImager dissection
microscope). These seven samples were excluded from all analyses. Together,
these exclusions yielded available data on 42 mice representing 72 correlated
observations in the mammary tissues.
We used GraphPad (Prism version 9.1.1) and R (2021) in all statistical
analyses. Our analyses utilized the mammary as the unit of analysis and assumed
independence. Group differences in tumor latency were assessed using KaplanMeier estimation of time to tumor and the log rank test. Variations in discrete
variable measures of tumor characteristics (type, grade, level of angiogenesis, level
of necrosis) across groups were assessed using the Fisher Exact test. Variations in
continuous variable measures of tumor characteristics (macrophage infiltration
score, LIST) were assessed using the Student t-test or the Wilcoxon Rank Sum Test
as appropriate, depending on the validity of the assumption of normality. We report
achieved levels of significance and did not adjust for multiple comparisons.
For all evaluations, a p-value of less than 0.05 was considered statistically
significant. All continuous data are graphed as mean ± standard error. Categorical
data are graphed as percentages of each treatment group assigned to each
category. All analyses were conducted by experimenters blinded to treatment group.
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8.4 Results
8.4.1 Exposure to Oxybenzone during Pregnancy and Lactation has a Modest
Effect on Tumor Latency in a Tp53 -/- mouse model
Tumor latency data were collected throughout 42 weeks of surveillance and
evaluated using survival analysis. As was anticipated for this tumorigenic model
(Jerry et al., 2000), 38 of 42 mice developed a tumor on at least one side; a total of
65 tumors were observed in 84 mammary glands. When evaluating each mammary
gland separately, a Kaplan-Meier survival curve indicates that the latency to develop
a tumor was shifted to the left in the oxybenzone-treated group compared to the
control group, although the median time to develop tumors in all mice was not
significantly different between treatment groups (Kaplan-Meier, Chi Square, 1
degree of freedom, p = 0.5, FIGURE 8.2A). When only mammary glands that
developed tumors were included in the analyses, the median time-to-tumor detection
was longer in controls (294 days) compared to the oxybenzone-treated group (265
days, Shapiro-Wilk normality test, p<0.001; Kruskal Wallis rank sum test, p=0.079,
FIGURE 8.2B). These results suggest that in the genetically susceptible Tp53-/mouse model, oxybenzone exposure modestly accelerates mammary tumor
development.
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Figure 8.2. Tumor latency.
A) Kaplan-Meier curves of survival analysis: control (black curve) vs oxybenzonetreated mammary glands (grey curve). B) Number of days to tumor detection (ShapiroWilk test of normality p < 0.001; Kruskal Wallis rank sum test, p = 0.079).

8.4.2 Oxybenzone exposure alters the extent of tumor vascularization, but not
tumor type, tumor grade, or necrosis score
Tumors from both control and oxybenzone-treated females were
characterized as solid carcinomas, adenocarcinomas, carcinosarcomas, MIN in situ,
or sarcoma/angiosarcomas. There were no statistically significant effects on the type
of tumors observed in the two treatment groups (Chi Square = 3.85, p=0.43; Fisher’s
exact test, p=0.43, FIGURES 8.3A,B). There was also no effect of treatment on the
mammary tumor grade (Chi Square = 3.94, p=0.27; Fisher’s exact test, p=0.35,
FIGURES 8.3C,D). Most tumors were considered high grade. Collectively, these
data support the conclusion that there was no effect of oxybenzone exposure during
pregnancy and lactation on tumor type or tumor grade in the Tp53 -/- model.
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Figure 8.3: Tumor Type & Grade.
A) Representative images of four tumor types. B) Tumor type distribution among control
vs oxybenzone-treated mammary glands. C) Representative images of the tumor grades.
D) Tumor grade distribution among control vs oxybenzone-treated mammary glands.

We next evaluated vascularization and necrotic foci, a morphological marker
of deficient vascularization and subsequent tissue hypoxia. In both treatment groups,
the majority of the tumors exhibited some degree of necrosis and quite naturally, all
tumors were vascularized. Tumors from oxybenzone-exposed females were more
likely to be given a score of highly vascularized compared to tumors from control
females (Chi-square = 6.778, p value=0.03; Fisher’s exact test, p =0.04, FIGURES
8.4A,B). More than half of the tumors from control animals had no or low necrosis
(scores of 0 or 1, 54.3%) whereas no or low necrosis was only observed in 26.7% of
tumors from oxybenzone-treated animals. However, there was no statistically
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significant effect of oxybenzone on necrosis scores (Chi-square = 6.59, p value =
0.16, FIGURES 8,4C,D).

Figure 8.4: Tumor severity. A) Angiogenesis in tumor tissue (Chi-square = 6.778,
p value=0.03; Fisher’s exact test, p =0.04). B) Representative image of tumor
vascularity in the tumor (arrows pointing at blood vessels). C) Necrosis in tumor
tissue. D) Representative image of necrotic tissue (the center of necrosis
encircled) E) Proliferation in the tumor. F) Ki67-positive cells in the tumor tissue
(arrows).
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8.4.3 Oxybenzone exposure during pregnancy and lactation does not alter
tumor cell proliferation in a Tp53 -/- mouse model
We used Ki67, a marker of proliferation that typically correlates well with tumor
grade in solid neoplasia (Weidner, Moore, & Vartanian, 1994), to further characterize
the tumor samples. There was no effect of oxybenzone treatment on the fraction of
tumor cells that were positive for Ki67 (Two sample t-test, p value = 0.57; FIGURES
8.4E,F). As expected, and there was a strong correlation between the Ki67 index and
the histological tumor grade across the treatment groups (data not shown).
8.4.4 Oxybenzone treatment is associated with a lower macrophage
infiltration score in tumors, but no effect on mast cells or tumor-infiltrating
lymphocytes
Tumor-associated macrophages are believed to play a role in suppressing
anti-tumor immune responses and the presence of macrophages in tumors is
associated with tumor promotion via tumor cell invasion, angiogenesis and
metastasis (Qian & Pollard, 2010; Su et al., 2014). Therefore, their presence in the
tumor microenvironment is considered to be a marker of poor prognosis in human
breast cancer (Allavena, Sica, Solinas, Porta, & Mantovani, 2008). After evaluating
the F4/80-stained tumor tissues, we found that oxybenzone exposure significantly
decreased macrophage tumor infiltration compared to parous controls (Two-sample
t-test, p value = 0.0001, FIGURES 8.5A,B).
Mast cells also play an important role in the tumor immune microenvironment,
and are associated with angiogenesis, tumor cell proliferation and pro-growth
signaling compounds in experimental models (Davio et al., 1994; Ranieri et al.,
2009). Moreover, mast cells express ER and therefore respond to ER agonists; they
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also associate with proliferating terminal end buds and promote ductal elongation in
the mammary gland (Jing et al., 2012). The role of mast cells in breast cancer,
however, remains unresolved (Aponte-Lopez, Fuentes-Panana, Cortes-Munoz, &
Munoz-Cruz, 2018). We observed no effect of oxybenzone on the number of mast
cells either in the tumor (mean 1.92 per mm2 in controls versus 1.25 per mm2 in
oxybenzone-exposed females; Two Sample t-test, p=0.51) or in the stroma
surrounding the tumor (mean 7.85 per mm2 in controls versus 9.72 per mm2 in

Figure 8.5: Tumor immune cells. A) Macrophages in the tumor tissue (TissueQuant
scores; two-sample t-test, p value = 0.0001). B) Representative images of F4/80-stained
tumor tissue. C) Mast cells in the tumor. D) Mast cells presence in the tumor-adjacent
tissue E) Representative image of mast cells in the tissue surrounding a tumor. F)
Lymphocytes in the tumor tissue: presence graded. G) Representative image of tumor
infiltrated lymphocytes. H) Lymphocytes surrounding tumor: presence graded.

oxybenzone-treated females; Two sample t-test, p = 0.34, see FIGURES 8.5C,D,E).
Likewise, the role of cell-mediated cytotoxic T-lymphocytes in the breast
tumor remains equivocal in regard to tumor prognosis; its prognostic value greatly
depends on tumor type and phenotype (Inwald et al., 2015; Stanton & Disis, 2016).
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We observed no effect of oxybenzone treatment on the score for either TILs (ChiSquare = 0.44, p=0.93; Fisher’s exact test, p=0.92) or sTILs (Chi-Square = 1.34,
p=0.51; Fisher’s exact test, p=0.59, FIGURES 8.5F,G).

8.4.5 Oxybenzone induces a non-significant decrease in ER expression in
mammary tumors in the Tp53 -/- mouse model
ER and PR expression in mammary tumors is highly relevant in the clinical
approach to treatment because only patients with sufficient ER expression in breast
tumor cells will benefit from common endocrine therapies like tamoxifen (Davies et
al., 2011). When ERα expression status was evaluated, almost half as many
oxybenzone-exposed tumors were considered ER-positive compared to controls
(26.1% and 46.7%, respectively, FIGURE 8.6A) although this difference was not
statistically significant (Chi-Square = 1.55, p=0.21; Fisher’s exact test, p = 0.16).
The fraction of PR-positive tumors was not affected by oxybenzone treatment (ChiSquare = 0, p=1; Fisher’s exact test, p =1). Low ER and PR positivity across

Figure 8.6: Expression of Receptors. A) Estrogen receptor α expression in the
tumor tissue; positive vs negative. B) Progesterone receptor expression in the
tumor tissue; positive vs negative.
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treatment groups was not surprising because the Tp53 null mouse model commonly
produces triple negative mammary tumors (Yan et al., 2010).

8.4.6 Oxybenzone exposure during pregnancy and lactation induces
permanent changes in mammary gland morphology
Our prior studies of oxybenzone revealed that exposures during pregnancy
and lactation alter mammary gland morphology five weeks after exposures have
ceased, once involution is completed (LaPlante et al., 2018). To evaluate the longterm effects of exposure to oxybenzone on mammary gland morphology in parous
females, ductal density was evaluated in the wildtype pectoral glands. Optical
density, a measure that is inversely correlated with ductal complexity, was
significantly lower in glands collected from controls compared to oxybenzone-treated

Figure 8.7: Pectoral mammary gland (wild type) analyses. A) Optical density of the
mammary epithelium (unpaired t-test, p = 0.0026). B) Abnormality score for hyperplasia,
alveolar or beaded ducts in the mammary epithelium. C) Mammary epithelium
abnormalities during involution: beaded ducts – white arrow tips, alveolar end buds –
black arrows (magnification 47x).
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mice (unpaired t-test, p = 0.0026, FIGURE 8.7A). These effects are consistent with a
permanent disruption to the morphology of the post-involution mammary gland.
Finally, whole-mounted wildtype pectoral glands were evaluated for the presence of
two gross abnormalities: hyperplastic alveolar structures (FIGURE 8.7B) and
intraductal hyperplasias, which have an appearance of beaded ducts in the wholemount (FIGURE 8.7C). When accounting for the severity of abnormal structures in
the pectoral glands, there was no difference based on oxybenzone treatment
(Unpaired T-test, p=0.09, FIGURE 8.7B).

8.5 Discussion
Genetic susceptibility to breast cancer is a well-established concept wherein
the germline or somatically mutated genes have been identified as having high,
moderate, or low penetrance. The high-risk genes include BRCA1, responsible for
about 45% familial breast neoplasia (Easton, Bishop, Ford, & Crockford, 1993),
BRCA2, TP53, and several rare germline mutations in genes encoding various
enzymes (Evans, 2016). TP53 is altered in over 50% of breast cancers, making it the
gene most closely related to cancer initiation and promotion (Ozaki & Nakagawara,
2011), and BALB/c mice with transplanted Tp53-/- mammary epithelium are highly
susceptible to tumor formation (Jerry et al., 2000).
In the real-life setting, genetic risk factors are naturally combined with risks
due to exogenous agents. Studies examining genetic and environmental interactions
remain relatively rare, but there is some evidence that genetically susceptible
animals and humans – either individuals or populations - are more sensitive to
tumorigenic environmental agents. For example, BRCA1 mutant mice displayed a

203

hypersensitivity to the estrogenic chemical bisphenol A, with enhanced proliferation
in mammary epithelial cells and more severe epithelial hyperplasias observed in the
mammary ductal epithelium after exposures (L. P. Jones et al., 2010). Further,
women with genetic breast cancer risk are met with a doubling of their risk of
developing the disease if they have detectable levels of polycyclic aromatic
hydrocarbons in their plasma compared to women without such genetic
predisposition but similar exposures (Shen et al., 2017).
There are now several experimental rodent models that are genetically
susceptible to breast cancer that can be used to investigate the effects of
environmental pollutants. We combined the genetically susceptible Tp53 -/- mouse
model with exposure to a ubiquitous environmental contaminant, oxybenzone, a
chemical which we previously reported alters proliferation in the mammary gland
(LaPlante et al., 2018), and induces both DNA double strand breaks and R-loop
formation (Majhi et al., 2020). We found that exposure to oxybenzone during
pregnancy and lactation had modest effects on tumor latency in this tumor-prone
model. At approximately 7-8 months (220 days) of age, the survival curves for the
parous controls and the oxybenzone-exposed females diverged, revealing a shorter
latency to develop tumors in the treated group (FIGURE 8.2). The mammary gland is
especially sensitive to environmental chemicals during life periods marked with
profound structural and functional changes, i.e., in utero development, puberty,
and/or pregnancy/lactation (Macon & Fenton, 2013). Alterations that occur during
these vulnerable life stages can lead to pathologies that manifest later in life (Heindel
& Vandenberg, 2015; Terry, 2020). Although parity is thought to provide protection
against mammary cancer in the long term, only a small number of rodent studies
have evaluated the impact of environmental agents on the gland during pregnancy
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on that protection (LaPlante et al., 2018; LaPlante, Catanese, Bansal, &
Vandenberg, 2017; Vorderstrasse, Fenton, Bohn, Cundiff, & Lawrence, 2004).
Post-partum remodeling of the mammary gland seems to progress normally
in mice with two defective p53 alleles (M. Li, Hu, Heermeier, Hennighausen, & Furth,
1996), but prior studies also suggest no protective effect of parity in mice lacking
Tp53 in the mammary gland (Medina & Kittrell, 2003). Our study design investigated
if oxybenzone could provide protection, or conversely enhance susceptibility to
mammary cancers in mice following transplantation of Tp53-/- mammary epithelium.
Our results were more consistent with the latter possibility. However, there is no
evidence that oxybenzone can initiate tumorigenesis in the absence of a genetically
susceptible epithelium. In the Tp53+/+ mammary tissue (e.g., the non-transplanted
pectoral glands), oxybenzone exposure during pregnancy & lactation permanently
altered mammary gland morphology (FIGURE 8.7A), but with no effect on the
severity of epithelial lesions (alveolar or intraductal hyperplasias; FIGURE 8.7B).
Carcinomas were never observed in these tissues.
In humans, the majority of mammary tumors originate in the epithelium – from
the lobules in 10-15% of cases, and the ducts connecting the lobules to the nipple in
75% of invasive breast cancers (C. I. Li, Anderson, Daling, & Moe, 2003). To
understand whether oxybenzone alters other aspects of tumor biology, we next
assessed each tumor for type and grade, guided by the consensus on murine
mammary pathology reached among veterinary pathologists during the NIH
“Annapolis meeting” (Cardiff et al., 2000). In our evaluation of features of the tumors,
we found no effect of oxybenzone on tumor grade or tumor type. Other features
associated with tumor severity include tumor necrosis, angiogenesis, and
proliferation of the tumor cells. Necrosis worsens the patient’s prognosis due to the
205

consequences of excessive cell proliferation and limited apoptosis (Richards,
Mohammed, Qayyum, Horgan, & McMillan, 2011). Loss of Tp53 typically disrupts
apoptosis or ferroptosis (Donehower, 1996; L. Jiang et al., 2015), producing necrotic
loci that are scattered throughout the tumor tissue, which can contribute to a less
favorable prognosis. Loss of Tp53 has also been documented to promote
neovascularization (Donehower, 1996); the functional product of Tp53 inhibits
angiogenesis via activating collagen α1 type IV and by releasing its product,
collagen-derived antiangiogenic factor, which decreases tumor growth in the mouse
model (Assadian et al., 2012). Although there was no effect of oxybenzone on
necrosis scores, tumors from oxybenzone-exposed females may have a worse
prognosis given the greater incidence of “high degree” of vascularization compared
to controls (Figure 8.4A). Future studies should evaluate the effect of oxybenzone on
this pathway. Lastly, we evaluated the prevalence of proliferating cells in the tumor
because sustained proliferation of tumor cells is one of the established hallmarks of
cancer (Hanahan & Weinberg, 2011). Although we previously observed increased
epithelial proliferation in post-involuting mammary glands following exposure to
oxybenzone (LaPlante et al., 2018), proliferation did not differ between tumors
collected from our two treatment groups.
The surrounding extraepithelial environment including the cells of the immune
system plays a critical part in tumorigenesis (Chollet-Hinton et al., 2018; J. B. Kim,
Stein, & O'Hare, 2005) and in chemical carcinogen-induced breast neoplasia (Maffini
et al., 2004). The dual character of macrophages underscores their possible role in
either promoting carcinogenesis via involvement in angiogenesis and
immunosuppression (C. E. Lewis & Pollard, 2006) or protection against
carcinogenesis via removal of damaged cells (Gasser, Orsulic, Brown, & Raulet,
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2005). Macrophages are also critical to the normal postpartum remodelling of
mammary ducts and repopulation of the gland with adipocytes (O'Brien et al., 2012).
Here, we found a decrease in the number of macrophages observed in oxybenzonetreated tumors [FIGURE 8.5A]. Other studies have reported that macrophage
infiltration is typically positively correlated with angiogenesis (Schwertfeger et al.,
2006) or neovasculogenesis (Bingle, Brown, & Lewis, 2002), and thus the presence
of macrophages may be linked to poor prognosis (Yamaguchi, Wyckoff, &
Condeelis, 2005). Tumor-associated macrophages are drawn to and accumulate in
the zone of tissue hypoxia (C. Lewis & Murdoch, 2005). However, in our samples,
the degree of necrosis was not correlated to the macrophage score (Pearson
coefficient r =-0.22, R2 = 0.05, p value = 0.114, data not shown). Because we have
not observed any significant differences in the degree of tumor necrosis between our
treatment groups, the varying degree of angiogenesis we observed may occur
independently of chemotactic signals produced by hypoxic cells that attract
macrophages.
Many environmental pollutants function as xenoestrogens and as such bind
primarily to the ERs, but some of these chemicals also affect metabolic and immune
responses via binding to the pluripotent aryl hydroxyl receptor (AhR), pregnane X
receptor (PXR), or peroxisome proliferation-activated receptor α (PPARα); others act
by activating CYP enzymes (Rodgers et al., 2018). While the mechanism of action
of oxybenzone in the mammary gland is poorly understood, in vitro studies using
yeast and mammalian cell cultures have demonstrated that it is an ER agonist, ER
antagonist, and AR antagonist (Watanabe et al., 2015, Kunz and Fent, 2006).
Furthermore, oxybenzone and benzophenone 8, one of its metabolites, have been
evaluated for binding to PPARγ and are suggested to have an obesogenic potential
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akin to quintessential obesogens like organotins (Heindel & Blumberg, 2019; Shin et
al., 2020). Thus, it is plausible that oxybenzone and its metabolites alter hormonal
pathways in the mammary gland, potentially promoting carcinogenesis. In human
breast cancer interventions, positive expression of receptors is associated with more
positive responses to hormonal interventions such as tamoxifen (Weinberg et al.,
2005). We observed that oxybenzone decreased the percentage of tumors that were
considered ER-positive, although this effect was not statistically significant (FIGURE
8.6A). If similar results were observed in humans, they would be consistent with
poorer responses to common clinical treatments.
Rodents have proven particularly helpful in investigations that aim to
determine how genetic susceptibility interacts with environmental features including
responsiveness to endocrine disrupting chemicals (Schaffer et al., 2013; Shull,
Dennison, Chack, & Trentham-Dietz, 2018). For example, genetic linkage studies
have revealed 9 quantitative trait loci affecting mammary tumor incidence or latency
after exposure to ER agonists, and 20 quantitative trait loci affecting aspects of
mammary ductal growth and branching after ER agonist treatments (Jerry et al.,
2018). Further, genetically susceptible or resistant rat strains respond differently to
exogenous estrogen and progestins (Shull et al., 2018). Such studies in rodents also
revealed that mutations in more than 160 genes are responsible for increasing
lifetime risk of developing breast tumors, equal to about 6.4% of all invasive breast
cancer cases. Several genes (e.g., CHEK2, PALB2, and ATM) are known to pose a
moderate risk (relative risk between 2 and 2.37 compared to individuals without
mutations in these genes) (Evans, 2016) and a small number of high penetrance
genes are associated with a much greater lifetime risk of breast cancer (Campeau,
Foulkes, & Tischkowitz, 2008). What is clear is that these genetic features do not
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sufficiently explain the risk of breast cancer women are facing today (SEER, 2021b).
Our work with oxybenzone advances the hypothesis that environmental chemicals
can act on a genetically susceptible background to decrease tumor latency and
influence tumor severity. Importantly, in human populations, the manifestation of this
disease has increased for women with familial risk, as carriers of high-penetrance
genes born before 1940 had the cumulative breast cancer incidence at the age of 50
years nearly three times lower than female carriers of the same high-risk genes born
after 1940, when environmental chemical burden increased (King et al., 2003).
All animal models of human diseases have strengths and limitations. Unlike
tumor-resistant C57BI/6 or B6CF1 mice, BALB/c mice were shown to be sensitive to
radiation-induced mammary cancer (Ullrich et al., 1996) although wild-type BALB/c
mice did not develop any tumors over 80 weeks of observation (Kuperwasser et al.,
2000). On the other hand, BALB/c mice with global loss of Tp53 have a median
survival of only 15.4 weeks; these mice develop mostly sarcomas and lymphomas,
whereas about 50% of Tp53+/- mice develop tumors within 54 weeks of surveillance.
Consequently, epithelial cells transplanted from Tp53-/- tumors into a wild-type
mammary gland were shown to produce tumors in 75% of the tissues (Kuperwasser
et al., 2000), similar to what we observed in our study (73.9% of our tissue
developed malignant epithelium-related tumors over 52 weeks of surveillance; see
FIGURE 8.2). This is an important limitation of our study, because the high
penetrance of tumors with a median latency of 294 days in the control group means
that it was statistically challenging to observe a significant change in tumor latency.
Future experiments may benefit from using alternative tumor induction. Chemically
induced neoplasia using DMBA or N-methyl nitrosourea are well-established models
in the rodent producing sufficient rates of tumors with a penetrance that can be
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modified by altering the carcinogen dose (Barros et al., 2004; Murray, Ucci, Maffini,
Sonnenschein, & Soto, 2009; I. H. Russo & Russo, 1996).

8.6 Conclusions
Combining an environmental challenge with genetic susceptibility of the
individual offers an important and relatively novel perspective on breast cancer.
Given the abundance of exogenous agents with the potential to induce
carcinogenesis (Smith et al., 2020), much more needs to be done to understand how
gene-environment interactions might contribute to diseases including breast cancer.
Here, we combined a mutation in Tp53 in transplanted epithelium in the mammary
gland of BALB/c mice with an exposure to a common environmental pollutant and
endocrine disruptor during pregnancy and lactation. We observed modest changes
in tumor latency and alterations to tumor characteristics in oxybenzone-treated
females that may be consistent with a worse clinical prognosis. Furthermore, we
have confirmed that exposures to oxybenzone during pregnancy and lactation
produce permanent alterations in the morphology of the mammary gland.
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9.1 Abstract
Background: Technological advancements make lives safer and more convenient.
Unfortunately, many of these advances come with costs to susceptible individuals
and public health, the environment, and other species and ecosystems. Synthetic
chemicals in consumer products represent a quintessential example of the
complexity of both the benefits and burdens of modern living. How we navigate this
complexity is a matter of a society’s values and corresponding principles.
Objectives: We aimed to develop a series of ethical principles to guide decisionmaking within the landscape of environmental health, and then apply these
principles to a specific environmental chemical, oxybenzone. Oxybenzone is a
widely used ultraviolet (UV) filter added to personal care products and other
consumer goods to prevent UV damage, but potentially poses harm to humans,
wildlife, and ecosystems. It provides an excellent example of a chemical that is
widely used for the alleged purpose of protecting human health and product safety,
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but with costs to human health and the environment that are often ignored by
stakeholders.
Discussion: We propose six ethical principles to guide environmental health
decision-making: principles of sustainability, beneficence, non-maleficence, justice,
community, and precautionary substitution. We apply these principles to the case of
oxybenzone to demonstrate the complex but imperative decision-making required if
we are to address the limits of the biosphere’s regenerative rates. We conclude that
both ethical and practical considerations should be included in decisions about the
commercial, pervasive application of synthetic compounds and that the current
flawed practice of cost-benefit analysis be recognized for what it is: a technocratic
approach to support corporate interests.
Key words: sunscreen, endocrine disruptor, skin cancer, benzophenone 3,
intergenerational, externality, melanoma, conflicting interests

9.2 Introduction
Thousands of synthetic chemicals (mostly inadequately tested) are currently
on the market (Z. Y. Wang, Walker, Muir, & Nagatani-Yoshida, 2020). Some of these
compounds are intended to increase human safety, while others enable medical
interventions, and still others provide human conveniences. For better or worse,
technological and chemical advances of the last century have improved and eased
individual and public well-being. Yet, these advances do not come without a cost to
the environment, other species and, somewhat paradoxically and with unintended
consequences, to human health. For example, phthalates added to flexible tubing
(an important feature of medical equipment) also interfere with male reproduction
(Pallotti et al., 2020). The conflict between the benefits of safety or convenience
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versus the unexpected cost to human health is, however, only one of the many
controversial facets of decision-making pertaining to environmental chemicals.
Environmental health decision-making also extends to the identification of
economically and environmentally sustainable solutions, exercises precaution and
prevents “plausible threats”, avoids quick fixes involving regrettable substitutions,
addresses disproportionate impacts of environmental burdens on communities, and
considers individual rights and obligations including the rights of individuals to know
(or not know) about their environmental exposures (C. L. Soskolne, 1997). Here, we
propose six principles of environmental health that can assist in environmental
health decision-making relative to environmental chemicals (FIGURE 1).

Figure 9.1: Six proposed principles of environmental health ethics.
Ethical principles of sustainability, beneficence, non-maleficence, justice,
community, and precautionary substitution provide a framework that can be used
to evaluate environmental chemicals. This framework allows for decision-making
about synthetic compounds beyond the traditional cost-benefit analysis.
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9.3 Introduction to Oxybenzone
To illustrate the framework of the proposed principles, we evaluated
oxybenzone, a synthetic UV filter used in sunscreens and other personal care
products (Figure 3). Oxybenzone it is also added to many consumer products
including cardboard inks, plastic packaging, fabrics, and furniture finishes to protect
these commodities from UV-induced fading or damage (Agency, 2015). As a result
of its popularity, oxybenzone is now among the most widespread environmental
pollutants routinely detected in fish and avian tissues, plants and microorganisms
(Balmer et al., 2005; Molins-Delgado et al., 2018; T. Zhang et al., 2013). Collectively,
in humans, all sources of exposure contribute to detectable urinary concentrations in
over 98% of the U.S. population (Han et al., 2016); it has also been measured in
blood, amniotic fluid, cord blood, semen and breast milk (Buck Louis et al., 2015;
Krause, Frederiksen, Sundberg, Jorgensen, Jensen, Norgaard, Jorgensen, Ertberg,
Petersen, et al., 2018).
Recent randomized control trials revealed that oxybenzone reaches and
exceeds the US FDA’s threshold of concern (0.5 ng/ml in blood) two hours after
sunscreen application; these concentrations remained above the threshold for 23
hours in all participants, and for three weeks in 96% of participants (Matta et al., 2020;
Matta et al., 2019). Based on these new findings, the U.S. FDA recently requested
additional safety studies on oxybenzone and other sunscreen ingredients (FDA,
2019a).
The effects of oxybenzone in vivo are broad: it is toxic to cyanobacteria (Mao
et al., 2017; Zhong et al., 2019), green algae (Mao et al., 2017; Sieratowicz, Kaiser,
Behr, Oetken, & Oehlmann, 2011) and coral (Downs et al., 2016). In rodents,

214

oxybenzone alters the development of the mammary gland, alters the weight of the
liver, kidney, and reproductive organs, decreases the number of spermatocytes in
males (LaPlante et al., 2018; K. Matouskova et al., 2019; Nakagawa & Suzuki, 2002;
Nakamura et al., 2015) and induces DNA damage in the mammary epithelium (Majhi
et al., 2020). In fish, oxybenzone interferes with reproduction (Coronado et al., 2008;
S. Kim, Jung, Kho, & Choi, 2014).
There is also evidence that oxybenzone is an endocrine disrupting chemical.
In vitro screening tests have revealed that it is an estrogen receptor (ER) agonist and

Figure 9.2: An overview of the oxybenzone case study.
Owing to the production and manufacture of products containing oxybenzone, it is
released into the environment, contributing to ubiquitous human exposures.
Exposures are associated with a range of hazards to wildlife, laboratory animals
and human health.

antagonist (Balazs et al., 2016; Kunz & Fent, 2006a; Suzuki et al., 2005) and that
some oxybenzone metabolites have greater estrogenic activity than the parent
compound (Morohoshi et al., 2005; Watanabe et al., 2015). Oxybenzone is also an
androgen receptor (AR) antagonist (Balazs et al., 2016; Suzuki et al., 2005).
Consistent with AR antagonist activity, oxybenzone induces shortened anogenital
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distance in rats (Nakamura et al., 2015) and mice (K. Matouskova et al., 2019)
following perinatal exposure (FIGURE 9.2).

9.4 Principles
“It is essential my Son in order that you may go through
this Life with comfort to yourself and usefulness to your
fellow creatures that you should form and adopt certain
principles for the Government of your own conduct and
temper—unless you have such rules and principles
there will be numberless occasions on which you will
have no guide for your Government but your
Passions…”
J. Q. Adams (Adams, 1811)
Although principles originate from virtues conceived by the Ancient Greeks
around 5th Century BCE if not earlier, the modern method of principlism in human
health emerged during the late 20th Century - initially as a response to atrocities of
the first half of the century (e.g., human experimentation by the Nazi regime, the
Tuskegee syphilis study, and others), later as reflecting emerging environmentalist
movements (D. B. Resnik, 2012). In the field of ethics, principlism is considered a
practical framework for “people making real-world decision[s]” (Hain, 2016). Our
everyday personal, societal, and professional conduct is guided by commonly
accepted ethical principles: regardless of our religiosity, we shalt not murder or steal;
democratic societies are ruled by consensus of “the people” rather than the will of an
individual; and guilds and professional organizations declare their ethics guidelines
and standards of practice.
Modern clinical medicine and related scientific disciplines have codified four
guiding principles: non-maleficence (often translated as “do no harm”), beneficence,
justice, and respect for autonomy (Beauchamp, 2019). However, the values and
principles for public health or environmental health cannot be directly transferred
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from the field of medicine owing to differences in the type of interventions in public
health vs. clinical practice (e.g., indirect and preventive vs. direct and curative), type
of professionals involved (e.g., a diverse group vs. specialized), and the ultimate
focus of interventions (e.g., to protect populations including unspecified individuals
vs. a single well-known patient) (L. M. Lee, 2012). Unlike medical ethics, public
health ethics frameworks have not yet fixed upon a set of universally accepted
principles; however, several foundational values, such as transparency, reduction of
inequities, and solidarity run through many proposed frameworks. On the global end,
a comprehensive document of sixteen principles, the Earth Charter, lays an ethical
foundation for acting based on respect and justice, nonviolence and democracy, and
ecological integrity (ECI, 2000; Schröder-Bäck & Vincenten, 2018; Colin Lionel
Soskolne et al., 2008) .
Environmental health ethics (not to be confused with environmental ethics,
which does not focus principally on the health of people) represents an approach
where human health stands paramount in the context of and connection with the
environment, non-human species, and possibly, future human generations. This may
seem to present a tension between eco-centric and anthropo-centric approaches,
but such dissention is anticipated and welcomed because applied ethics arises from
epistemic uncertainty and works to address tensions. In environmental health ethics,
an immediate focus on human health is extended towards non-human species,
ecosystems and the biosphere, as well as the responsibilities of the human species
that rises from its rights. Scholars of environmental health ethics have only begun
discussing the guiding principles of the field (D. B. Resnik, 2012). In this context, the
thousands of newly synthetized chemicals and the ubiquitous environmental
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pollution that is inevitably reaching human tissues have provided challenges to
ethical decision-making and ethical actions.

9.4.1 Principle of Sustainability
This we know: the earth does not belong to man; man
belongs to the earth. All things are connected like the
blood that unites all Man did not weave the web of life;
he is merely a strand in it. What he does to the web, he
does to himself.
Sealth, Chief Seattle
Stewardship is broadly defined as a call to “take good care of natural
resources” and implies additional subsidiary principles such as “protect species and
biodiversity” and “avoid destruction of habitats and ecosystems” [p.73 (D. B. Resnik,
2012)]. That humans are not external to ecosystems and their biodiversity has been
recognized by the global community (UN, 1992; Whitmee et al., 2015). Nonetheless,
responsible stewardship is still on occasion seen as binary– one may protect either
nature or civilization - but like many issues presented as an either/or choice, this
dichotomy is false. In fact, economists have repeatedly demonstrated that “the
viability of business itself depends on the resources of healthy ecosystems”
(Chouinard, Ellison, & Ridgeway, 2011).
Acting as responsible stewards leads to a “practice of sustainable uses of
biological resources” (D. B. Resnik, 2012). The Principle of Sustainability thus
implies a balance of using - but not overusing; harvesting - but not overharvesting.
Prior to the Anthropocene epoch, industrial chemicals would not present a threat
because their volumes did not exceed the rate of individual and environmental
biotransformation (S. L. Lewis & Maslin, 2015). In the case of oxybenzone, this is no
longer true. First synthesized in the mid-20th century, oxybenzone quickly gained
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dominance among sunscreen products and equally rapidly began polluting coastal
waters when washed off the skin of beachgoers. The levels of oxybenzone
measured in coastal waters harboring coral reefs are no longer sufficiently diluted to
avoid harm to these species (Downs et al., 2016; Mitchelmore et al., 2019). The
demand for sunburn-free midday beachgoing, combined with climatic and
oceanographic conditions produce the present situation in which oxybenzone
threatens the survival of aqueous species and ecosystems (Wijgerde et al., 2020).
Although the chemical is readily metabolized in human tissues and 93% of the
compound is transformed in the marine environment within 120 days of its
introduction, oxybenzone is routinely detected in nearly all human samples, in water
and soil, consistent with continuous pollution sources (Wolfson, Porter, Villani,
Simon, & Young, 2019).
Although people have changed landscapes for the sake of utility, beauty, or
leisure for most of human history, for millennia these changes played by nature’s
rules simply because the members of our species were “few, humble, and weak”
(Kohak, 2000). In recent history, however, technological and chemical discoveries
have led to advances in which the rules of nature could be dismissed or ignored.
Humans devised methods to defeat infectious diseases, to bypass infertility, and to
stretch the limits of materials on water-repellency, flammability, and flexibility. With
these changes, our civilization seemed invincible. Yet, in spite of these advances we
have reached several “walls” where the limits of demography, physics and biology
matter again. No longer can the biosphere transform all synthetic substances into
harmless metabolites – there are tens of thousands of newly synthesized chemical
compounds in the environment, many of them produced in large volumes, some of
them highly stable and persistent in the environment (Z. Y. Wang et al., 2020). After
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times when the elements have had extreme impacts on civilizations, and times when
civilization has had extreme impacts on the environment, it becomes necessary to
execute responsible and sustainable stewardship.
Implied in the Principle of Sustainability is the matter of future generations.
Given that coral reefs that form over thousands of years have shrunk by 20 to 80%
over the past two generations, we are already past the turning point of our
grandchildren experiencing the vast reefs as we did (Regan, 2020). Some have
argued that obligations to hypothetical future individuals is a paradox: how can
“actions that make things worse for no one [in particular] be wrong?” (Roberts,
2009). The “non-identity case” solution most relevant to environmental health
suggests replacing the hypothetical person of the future with an entire community
potentially harmed by today’s action because “we have a moral duty to promote the
overall well-being of future generations, even if we do not have moral duties to any
particular future person” [p.74 (D. B. Resnik, 2012)]. The Principle of Sustainability
weighs the impact of today’s production and use of anthropogenic chemicals along
with the wellbeing of current and future humans, non-human species and the
biosphere. Oxybenzone fails this test (Figure 9.3).

9.4.2 Principle of Beneficence
On one level, modern sunscreen isn’t so far from
smearing yourself with clays, minerals, or a mixture of
sand and oil like the ancient Egyptians or Greeks did.
But on another level, modern sunscreens are some
mind-bending magico-chemical spellwork. Our
species should be patting ourselves on the back right
now. But does our little magic trick actually work?
George Zaidan, (Zaidan, 2020)
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In the clinical setting, the Principle of Beneficence can be easily translated as
actions that benefit the patient. Experimentally, chemical sunscreens have been
clearly demonstrated to provide protection against UV-induced damage, and on the
level of populations they were pledged to decrease skin cancer incidence (Lowe,
2006; Urbach et al., 1976). Therefore, the Principle of Beneficence raises a question:
do chemical sunscreens actually offer a means of skin cancer prevention to at-risk
populations?
The incidence of malignant keratinocyte carcinomas, i.e., squamous and
basal skin cancers – previously referred to as non-melanoma skin cancers
(Karimkhani, Boyers, Dellavalle, & Weinstock, 2015) – has increased by 14%
between 2006 and 2012 with >3 million U.S. residents affected in 2012 (Rogers,
Weinstock, Feldman, & Coldiron, 2015a). Melanoma cases are reported to cancer
registries thus their statistics and trends are more precise: in 1975, the National
Cancer Institute (NCI) recorded 7.9 cases of melanoma per 100,000 US residents; in
1995 the rate doubled to 16.5, and the latest data from 2018 report 22.4 melanoma
cases per 100,000 residents (NCI, 2021).
Although their convenience is rarely disputed, the efficacy of sunscreens
remains ambiguous. Whether sunscreens modify the risk of sunburn, melanoma and
keratinocyte cancers have been studied predominantly using human cohorts, and
the body of evidence provides a heterogenous and contradictory picture. In 2001,
the International Agency for Research on Cancer published a review of case-control
studies and concluded that the evidence for sunscreen providing protection from
melanoma and basal cell carcinoma was “inadequate” while “limited” evidence for
preventive effects was found for cases of squamous cell carcinoma (IARC, 2001). A
meta-analysis of 11 human cohorts found no effect of sunscreen use on sunburn
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prevention (Huncharek & Kupelnick, 2002). On the other hand, a French
collaborative report concluded that “topical use of sunscreens reduces the risk of
sunburn in humans” yet “no conclusion can be drawn about the cancer-preventive
activity of topical use of sunscreens” (AFSSE, 2005). A more recent meta-analysis
included epidemiological studies beyond case-control designs, and carefully
assessed the quality of evidence of sunscreen-melanoma associations; yet even this
review finds the evidence inconclusive (Rueegg et al., 2019). What is more,
sunscreens seem to have no effect on melanoma risk in dark-skinned populations
(Adamson, 2019).
Only one study to date shows a protective effect of sunscreens (containing
avobenzone and octinoxate) in an Australian randomized controlled trial (Green,
Williams, Logan, & Strutton, 2011). However, individuals assigned to the “control”
group were not restricted in their use of sunscreen, and the study was burdened with
a number of biases, including selection and funding bias, and detected only half of
the melanoma cases that were expected given incidence of the disease in the
Australian population (NCCI, 2019).
In spite of the paucity of efficacy evidence, humans mass-produce and
promote sunscreens, and encourage an everyday, one-size-fits-all use. Since the
early 1970s, guidelines of the American Association for Dermatology caution users
to apply sunscreen on the “entire body before [a person] dress[es] for the day” and
repeat applications throughout the day (AADA, 2020); the goal for children and
infants older than 6 months is “to protect all parts of the skin exposed to the sun by
using a variety of techniques, including sunscreen” (Paller et al., 2011). For many,
everyday use of broad-spectrum sunscreens has become a matter of fact (Svarc,
2015), but humans’ behavior sometimes works contradictory to the best public222

health intentions. For example, there is evidence that application of sunscreen may
increase sun exposure and a false sense of sun safety (Autier, Boniol, & Dore, 2007)
by “extend[ing] the duration of intentional sun exposure, such as sunbathing…
increas[ing] the risk for cutaneous melanoma” (AFSSE, 2005). Lastly, sunscreen’s
efficacy is subverted if users apply “however much feels right” (Zaidan, 2020), i.e.
less than the recommended amount of 1 ounce per application, or if a person fails to
re-apply the product every two hours (Petersen, Datta, Philipsen, & Wulf, 2013).
The Principle of Beneficence calls for convincing evidence and significant
benefits to public health. The above arguments undermine the alleged beneficence
of sunscreens, and oxybenzone specifically, in the prevention of skin cancer.

9.4.3 Principle of Non-maleficence
“Animal studies have raised concerns about endocrine disruption and
reproductive issues. But animals are not people, [Dr. Henry] Lim [a
dermatologist] says. And despite decades of sunscreen use, there has
been no population-wide signal that rates of infertility, birth defects or
other health problems are higher in people who use more sunscreen
or in places where people apply more of it” (Sohn, 2019) .
“Primum non nocere” (first, do no harm) obligates health care professionals to
abstain from inflicting harm to a patient if s/he cannot benefit from the care provided.
The Principle of Non-maleficence builds on the argument of beneficence, and asks
“is it safe for me”?
Sunscreens are regulated by the FDA and tested for sun protection efficacy.
Yet, testing the 17 over-the-counter UV filters for safety (e.g., hazard identification)
was previously not seen as necessary; the sunscreen ingredients, including
oxybenzone, were considered by FDA to be “generally recognized as safe and
effective” because it was assumed that their concentrations would not exceed a
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threshold of 0.5 ng/mL in systemic circulation after dermal application (FDA, 2019b).
Now that this assumption has been shown to be wrong (Matta et al., 2020; Matta et
al., 2019), the FDA has called for more data and possibly stricter regulation (FDA,
2019b).
Beyond concerns about exposure, research published in peer-reviewed
journals paints a more complex story of possible health effects (e.g., hazards). An
increasing number of epidemiological studies have evaluated the effects of
oxybenzone on human health outcomes. Although many of these studies are limited
by their design (e.g., cross-sectional studies), there is evidence that oxybenzone and
its metabolites can affect human health, including effects on reproduction (time to
pregnancy, risk of endometriosis, sperm quality, measures of infertility) (Arya et al.,
2020; Kunisue et al., 2012; Peinado et al., 2020; Rehfeld, Dissing, & Skakkebaek,
2016); birth outcomes (Philippat et al., 2012; Tang et al., 2013); neurobehavioral
outcomes in the offspring (Guo et al., 2020); and health of other organs, e.g., the
thyroid gland (S. Kim et al., 2017; Schmutzler et al., 2007). Furthermore,
oxybenzone was identified as an allergen in 1-3% of the population (Heurung, Raju,
& Warshaw, 2014) and while allergic reactions to sunscreens affect only a small
proportion of the population, oxybenzone is a common photoallergic agent
(Subiabre-Ferrer et al., 2019). In addition to the weight of epidemiological cues, as
described in more detail above, mammalian toxicological studies similarly point to
oxybenzone’s effects on the structure and function of tissues including endocrine
organs (Ghazipura et al., 2017).
Regardless, some dermatologists continue to promote chemical sunscreens
as the ultimate means of sun safety and call for epidemiological studies to detect a
“population-wide signal” for an effect of sunscreen use on human health before even
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entertaining the possibility that oxybenzone might cause harm. Unfortunately, such
“population-wide” evidence will be incredibly challenging to collect. Epidemiology
studies that attempt to examine such relationships often fail due to the ecological
fallacy (i.e., drawing conclusions about individuals based on evidence collected for a
group, in this case, concluding that oxybenzone is safe for individuals based on a
failure to obtain a “population-wide signal” of harm). Furthermore, it is almost
impossible to find a population of individuals without exposure to oxybenzone to
serve as an “unexposed control group”; in 2011, the chemical was detected in the
urine of 98% of non-pregnant women and 100% of pregnant women (Woodruff et al.,
2011). Even individuals that report “never” using sunscreen have detectable levels in
their urine, indicating that exposures come from a wide variety of sources (Zamoiski
et al., 2015). Of course, if such a population-wide signal of harm were identified, that
would represent a massive public health failure; the possibility of such catastrophic
outcomes creates an even stronger case for precaution (C. L. Soskolne, 2004).
In spite of these limitations, an increasing number of human studies suggest
associations between oxybenzone and harm. These studies examine exposures and
health outcomes at the level of individuals, finding “signals” of harm that have
unfortunately been dismissed by some in the dermatology community because the
studies do not examine the population in entirety. These findings should not be
ignored in a quest for a “perfect” human cohort. With the evidence that is currently
available, the principle of “first do no harm” disqualifies oxybenzone due to its
maleficence.
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9.4.4 Principle of Justice
Hawaii is definitely on the cutting edge by banning these
dangerous chemicals in sunscreens.
Hawaii State Senator Mike Gabbard
The Principle of Justice in environmental health demands that individuals and
communities share “justly and equally both burdens and benefits” and that “societies
follow fair procedures” in making and implementing policy decisions concerning the
environment (D. B. Resnik, 2012). In the Rawlsian approach of justice – where
justice is consistent with fairness (Rawls, 1971) – and in the extension of Rawls’s
principles to health care, unequal health burdens are seen as unjust when social
determinants of health such as education or job opportunities are also unjustly
distributed (Daniels, 2008).
There are many benefits of coral reefs to humans, including tourist spending,
food sources, coastal protection and populations that live near these locations can
enjoy them (UNEP, 2004). Yet those unique ecosystems are subjected to
unprecedented worldwide losses. Oxybenzone is one of several contributors to coral
bleaching, brought to reefs indirectly from residential and municipal wastewaters or
washed off the skin of swimmers and beachgoers. Beach tourism has become ever
more popular; for example, the annual number of visitors to the State of Hawaii –
whose islands are surrounded by coral reefs - increased from 6.7 million to 10.4
million between 1999 and 2019 (DBEDT, 2000; HTA, 2019). Coastal pollution with
oxybenzone results in an unequal distribution of an environmental burden. After
Hawaiian residents realized the distributive injustice of this burden, they exercised
their right to procedural justice. In 2018 the State Senate voted to ban sunscreen
products containing oxybenzone and octinoxate from being distributed or sold in
Hawaii, taking effect in January 2021 (Senate, 2018).
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The Hawaii case study provides an example of a specific population acting
meaningfully against environmental pollution. Yet, a situation where governing
legislators rule confidently and effectively against a polluting agent is an exception
rather than a norm. Typical stories of disproportionate pollution in communities
commonly end – if resolved at all – in cumbersome repressive legal actions and
public budgets paying for the consequences of the pollution (EPA, 2021).
Ideally, distributional injustice is prevented. If it cannot be prevented, the
disadvantaged community should have the means to decide on the burden
experienced through procedural justice or to be compensated for the unequal and
unjust distribution. Concerted efforts are needed to reduce the unjust, distributional
burden of pollution on the global scale.
Oxybenzone provides one additional angle to the Principle of Justice: this
chemical has been detected in the bodies of individuals across the globe, regardless
of their personal decisions or reported use of chemical sunscreens (Zamoiski et al.,
2015). Above all, neonates are born having already been exposed to chemical
sunscreens (Woodruff et al., 2011). Polluting our descendants raises the question of
intergenerational justice, a topic described above.

9.4.5 Principle of Community
“The innocent greed of the affluent may easily be the
most threatening ecological time bomb.”
E. Kohak (Kohak, 2000)
The Principle of Autonomy – defined as “acting on the basis of choices
guided by values and principles that one accepts as one’s own” (Jameton &
Frumkin, 2010)- is the paramount guiding principle in medical practice and bioethical
theory. But public health practice typically applies a number of restrictions on this
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fundamental principle because in challenges posed by public health, the “interests of
the community” override individual choices if personal preferences pose a risk to
health or safety of the community (Holland, 2015). Examples of what we have
dubbed the Principle of Community, where the health of the community is seen as a
vital priority, include restrictions on smoking in public or shared spaces due to the
risks of secondhand smoke (Jarvie & Malone, 2008), required vaccination for the
sake of herd immunity (Luyten, 2011), or mask mandates in the case of a pandemic
caused by a respiratory virus. Environmental health practice builds on similar
premises of community kinship, where the focus is on the interests of environment
and human health even when the benefits to the community conflict with individual
preferences. The concept of the ‘tragedy of the commons’ relates to this point,
because the benefits received by the individual (or a specific industry) can detract
from the health of the whole (P. S. Dasgupta & Ehrlich, 2013).
To illustrate the environmental health conflict, Kohak [p.9 (Kohak, 2000)] uses
the example of a retired clergyman whose hobby is to fly surplus fighter jets, arguing
that it is his right to engage in the activity, even while he acknowledges the
detrimental environmental impact of fighter jet engines. Kohak frames such
reasoning as an “innocent greed of the affluent” and asserts that similar forms of
argumentation are not uncommon in human-environment conflicts (Kohak, 2000).
The “innocent greed” argument represents one of many hypothetical explanations for
individual choices to use sunscreens containing oxybenzone despite their adverse
effects on the environment. Users may think, “It is my right to use this sunscreen,
even if it contributes to environmental harm.” For those reasons, human-environment
conflicts are often addressed with regulatory action to restrict autonomous decisions.
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Although the “innocent greed” argument is certainly important to consider,
lack of awareness reflects another, more likely, concern because the general public
is not typically expected to judge the risks associated with the use of synthetic
chemicals or exposure to environmental pollutants. Instead, experienced
professionals – scientists, public health professionals, and regulators – are tasked
with using expert judgement to tackle the complex problems of environmental and
human risk assessment. In other words, regulatory agencies and their employees
are tasked to prevent the necessity of the consumers’ dilemma.
Unfortunately, autonomous choices cannot always be respected when
environmental health is at stake or when the impacts of autonomous choice are
potentially disastrous (C. L. Soskolne, 2004). Such choices should not even be
expected when addressing issues that are as complex and complicated as the case
of chemical safety evaluations. While legislative regulations are not without risk [e.g.,
what has been described as the “slippery slope of regulations (D. Resnik, 2010)], the
case of oxybenzone shows that that under the Principle of Community, some groups
may need to override autonomous (individual) decisions to ward off the magnitude of
environmental, societal and/or health costs that are attributed to the collective impact
of individual acts.

9.4.6 The Principle of Precautionary Substitution
The term ‘precautionary principle’ can be traced to the German
word Vorsorgeprinzip. An alternative translation of this word
might be the foresight or ‘forecaring’ principle—emphasizing
anticipatory, forward-looking action rather than reactive
impeding of progress.
Tickner, Kriebel & Wright (Tickner, Kriebel, & Wright, 2003)
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The Principle of Precautionary Substitution cautions against replacement of
harmful chemicals if such a replacement introduces another equally or more harmful
chemical. In recent decades, a number of everyday or industrial chemicals were
disfavored and substituted with different chemicals that were later found to be
harmful. For example, lead arsenate, an insecticide comprised of two heavy metals,
was used on deciduous trees (including many apple orchards) (EPA, 2004) until it
was replaced by the infamous DDT. The impact of Rachel Carson’s Silent Spring
brought the use of DDT in U.S. agriculture to an end and organophosphate
pesticides quickly replaced organochlorines. Yet, with time, many of these were also
found to be toxic and were later banned from residential use (although malathion is
still heavily used for mosquito control and in agriculture) (Blus, 2003; Harnly,
McLaughlin, Bradman, Anderson, & Gunier, 2005). Then came the neonicotinoids,
insecticides now described as “bee neurotoxins”; three of them are now “severely
restricted” in the EU and only three are permitted in Canada (EC, 2018; PMRA,
2020). The newest pest control inventions target genetic information, e.g. RNAi
(RNA intervention) pesticides, but whether the “blissful enthusiasm that
accompanies every new advance in modern technology and medicine” (Colborn,
2004) will lead to a similar disillusionment with these technologies remains to be
seen.
Precaution pertaining to oxybenzone requires us to examine two opposing
sides: the concern about not using chemical sunscreens which is perceived as
increasing the risk of skin cancer (Diffey, 2016), and concerns about using chemical
sunscreens, which increases environmental pollution and adverse health effects in
human and non-human species. Both these facets are rarely examined together and
often fail to address the relevant issues, e.g., a frank accounting of the effectiveness
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of sunscreens in skin cancer prevention, as well as the full magnitude of
understanding the many ways chemical sunscreens impact life on the planet. The
former issue was addressed above in the Principle of Beneficence and we turn to the
latter in this section.
Extensive evidence collected in wildlife and from experimental studies
suggests that oxybenzone harms a wide range of species including bacteria, algae,
plants, fish and mammals (Figure 9.2). When the impact of oxybenzone on coral
reefs galvanized concerns and induced a negative public response, attention shifted
towards UV protecting alternatives. Novel technological-chemical solutions (e.g.,
variants of chemical sunscreens including mineral-based sunblock improved with
nanotechnologies), and emerging chemical solutions (e.g., benzotriazoles, a newer
family of UV stabilizing chemicals added to consumer products) represent a
marketing opportunity, but they also raise red flags around human health and
sustainability. For example, titanium dioxide nanoparticles penetrate human skin in
certain formulations and emerging evidence points to their potential toxicity
(Bokobza et al., 2021; Musial, Krakowiak, Mlynarczyk, Goslinski, & Stanisz, 2020).
Similarly, UV-328, a benzotriazole UV stabilizer added to many plastics is proposed
to be added to the Stockholm Convention’s list of persistent organic pollutants
(UNEP, 2020) and other benzotriazoles such as HDBB and UV-324 induce toxicity in
aquatic species and act as endocrine disruptors in both fish and mammals (IPEN,
2020).
To address the issue of regrettable replacements, several distinct actions
have been proposed. First, it is possible to regulate chemicals by groups or classes.
An international effort on “Substances depleting the Ozone Layer” – The Montreal
Protocol – provides an example of successful regulation of a chemical class based
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on the type of harm inflicted by chemicals (Velders, Andersen, Daniel, Fahey, &
McFarland, 2007). Alternatively, chemicals could be classified and regulated based
on their intended purpose. The concept of “essential” vs. “non-essential” use
suggested for classification of per- and polyfluoroalkyl substances (PFAS) would
enable regulators to identify and phase-out the most non-essential uses (Cousins et
al., 2019). Second, the price of a product producing unintended harms could more
fully reflect those detrimental costs known as externalities. Economists specialized in
sustainability (i.e., the discipline of Ecological Economics) can apply various tools for
internalizing costs associated with disposal and pollution and can quantify the
benefits obtained by industries utilizing natural ecosystems (P. Dasgupta, 2021).
Accountability of the markets for using and overusing natural resources differs from
recent economic theories (and practice) but a society in which individuals and public
budgets cover health and societal costs associated with profit-driven polluting
producers is not sustainable on the scale we have achieved today.

9.5 CONCLUSIONS
Environmental pollution with thousands of inadequately tested synthetic
chemicals is among the many urgent threats that challenge human health and
environmental sustainability. While the Paris Agreement takes action against
greenhouse gas emissions, a similar international vision on anthropogenic pollution
has yet to be formed.
We have offered six principles that are relevant for environmental health
decision-making (Figure 9.1); these principles illustrate the complexity of the problem
of environmental chemical pollution and should be considered when searching for
solutions. A reliance on principles provides guidance to evaluate compounds that
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present a patchwork of risks and benefits in both societal and scientific contexts.
Thus, the case of oxybenzone lends an excellent opportunity to apply these six
principles of environmental health to a specific chemical that is used in consumer
products to meet a specific need (protection from UV-induced damage), but with
costs to human and environmental health that have been largely unexplored (Figure
9.3). With the framework of principlism, it becomes clear that even for a chemical
with relatively moderate stakes (compared to the wide spectrum of highly persistent

Figure 9.3: Evaluating oxybenzone based on the proposed six principles.
Oxybenzone as a UV- absorbing filter in sunscreens, products, and packaging induces
short- and long-term adverse effects on both humans and environment. Further, heavy
coastal pollution stands as unequal and unjust. Systemic regulation on regional and
global levels, tiered according to essentiality of use will affect autonomous decisions. On
the other hand, alternatives to oxybenzone exist as: 1. non-technical solutions
(preferred, when possible), 2. safer chemical UV filters (where necessary), and 3.
inorganic UV-filters (to be used with caution).

233

and highly accumulative compounds that have been released to the environment),
action is required to address the limits of the biosphere’s regenerative rates.
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CHAPTER 10

SUMMARY & FUTURE DIRECTIONS

Oxybenzone has been produced and released into the environment for
several decades yet only recently the chemical has attracted the attention of the
public and regulatory bodies. Over this same period of time, the chemical has been
integrated into numerous consumer products, ensuring ubiquitous exposures, even
of individuals that avoid using dermal oxybenzone-based sunscreens. Thus, like
many other emerging pollutants, oxybenzone poses numerous problems; compared
to pharmaceuticals like DES, which were purposefully administered to pregnant
women, oxybenzone is challenging to study in human populations due to a lack of an
unexposed population, and exposures that extend across the lifecourse.
Like many other environmental pollutants, as it is currently used, oxybenzone
does not represent a classic toxicant or teratogen in the traditional sense. By this,
what we mean is that it is not overtly killing or maiming individuals that are routinely
exposed to it via use of personal care products, consumption of contaminated food,
ingestion of dust and water, or dermal exposure to fabrics and upholsteries. This has
led some regulator to ask the question “where are the bodies?” [This question was
asked by a member of an FDA panel for evaluating chemicals in the early days of
EDC research, to suggest that without a link to mortality, chemicals need not be
considered harmful (Tom Zoeller, personal communication)]. Indeed, typical
everyday exposures to oxybenzone are not deadly, but the research to date
suggests that this chemical does contribute to adverse health outcomes in humans
and wildlife. Yet some of the most relevant effects that have been observed (e.g.,
disruption to the morphology of the mammary gland) in controlled experimental
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models are not considered adverse by the risk assessment and risk management
decision-making processes (Cardona & Rudel, 2020). Furthermore, most wildlife
species and adverse outcomes in their habitats are viewed as “invalid” due to use of
“non-standardized test species” or “lack of ecological relevance” (Burns, Csiszar,
Roush, & Davies, 2021), and the doses relevant for environmental exposures are
often too low to be tested under laboratory conditions used in traditional guideline
studies (vom Saal & Hughes, 2005; Vom Saal & Vandenberg, 2021). All of these
factors, and others, have created a Catch-22 in the evaluation of oxybenzone and
similar environmental chemicals: associations observed in epidemiology studies are
dismissed because the exposures are uncontrolled, yet results from controlled
studies in laboratory animals are dismissed because the effects seen in animals are
not considered relevant for human health.
The results presented in this dissertation offer additional evidence that the
mammary gland is a target of oxybenzone exposure. In females exposed to
oxybenzone during pregnancy and lactation, prior studies in mice revealed increased
proliferation in the mammary epithelium and decreased epithelial density, as well as
increased expression of Esr1 (the gene encoding ERα) in the uterus of oxybenzoneexposed animals compared to parous controls (LaPlante et al., 2018). Additional
mechanistic studies determined that oxybenzone induces DNA damage and R-loops
in three cells lines: T47D, MCF7, and 76N-Tert-ESR1 + dox, and in the mammary
epithelial cells of ovariectomized BALB/c mice (Majhi et al., 2020). These studies led
us to ask if exposures to oxybenzone during pregnancy and lactation could alter
susceptibility to carcinogenesis. Because the wildtype mouse is not prone to
mammary tumors, to address this question, we relied on a genetically susceptible
mouse model which is known to develop mammary tumors. Using this model, we
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found that the mammary tumors in animals treated with oxybenzone have lower
infiltration of macrophages, increased level of angiogenesis, and modestly shorter
tumor latency. Based on these results, we concluded that oxybenzone treatment
during pregnancy and lactation moderately decreases time to mammary neoplasia
and induces tumor characteristics consistent with worse tumor prognosis.
We also conducted several studies to evaluate the effects of oxybenzone on
the mammary gland of females exposed to the chemical during perinatal
development (i.e., the offspring of the mothers exposed during pregnancy and
lactation). This series of studies evaluated whether oxybenzone altered the
morphology of the mammary gland at several stages of development, whether it
altered proliferation or expression of hormone receptors in the epithelial cells,
whether there were disruptions to several components of the mammary stroma, and
whether it would potentiate (or attenuate) the effects of pubertal exposures to
estrogens. We found alterations in the epithelium including a larger area of the
mammary tree and lower rates of epithelial cell proliferation at PND21, greater
expression of ERα at PND26, greater ductal extension within the fat pad and
complexity measured as the tree branching, and disruption to progesterone
receptors at one of the doses tested (212 µg/kg/day) at puberty; in adulthood, the
oxybenzone-exposed animals differed from controls with decreased epithelial
volume fraction, lower expression of ERα, and greater numbers of alveolar buds.
The stromal changes included a thicker periductal stroma at puberty and a larger
size of adipocytes in adulthood. These results provide the first evidence, to our
knowledge, that oxybenzone affects the development of the mammary gland with
measurable disruptions to both the epithelial and stromal compartments.
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Although our experiments cannot determine if the effects of oxybenzone on
the mammary gland are due to actions via a specific hormone receptor, they also
add to the evidence that this chemical is an endocrine disruptor. A 2020 publication
proposed ten key characteristics of endocrine disrupting chemicals (La Merrill et al.,
2020) and our studies are consistent with several of these key characteristics
including alterations to the expression of hormone receptors and alterations to the
fate of cells in hormone-sensitive organs. Combined with earlier publications
indicating that oxybenzone is an ER agonist and an ER and AR antagonist (Kunz &
Fent, 2006b; Schlecht, Klammer, Jarry, & Wuttke, 2004; Watanabe et al., 2015),
there are now at least four key characteristics of an endocrine disruptor displayed by
this chemical.
Finally, in two of our studies, we evaluated the effects of perinatal exposures
to oxybenzone on the male mouse mammary gland. The male mammary gland is
relatively understudied, and ongoing work is revealing important aspects of its
normal development in addition to identifying effects of environmental chemicals on
this sensitive tissue. Our results suggested that early life exposures to oxybenzone
alter the morphology of the male mammary gland, with decreased size of the ductal
tree and reduced complexity in the right mammary gland. Interestingly, results from
our follow-up study indicate that perinatal exposures to oxybenzone alter the
response of the male mammary gland to an estrogen challenge at the onset of
puberty. Although much work still needs to be done to fully characterize the effects
of oxybenzone and other environmental pollutants on this organ, our results provide
strong evidence that it is affected by exposures during early development.
In our mouse studies (described in Chapters 4, 5, 6, and 8), and ethics
decision-making manuscript (Chapter 9), we mark the ways to go forward in
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evaluating adverse effect in the mammary gland, and describe the values and
principle-based decision making processes, respectively. Moving forward, based on
the data from our lab and others, laboratory research on oxybenzone may revolve
around three aspects: 1. Oxybenzone as a possible obesogen, 2. The effects of
oxybenzone in other models of mammary carcinogenesis; and 3. Obesity propelled
by oxybenzone leading to tumorigenesis.

Oxybenzone – a suspected obesogen?
Our data suggest that developmental exposures to oxybenzone increase the
size of the white adipocytes in the mammary gland (which encompasses the
subcutaneous fat pad) in adulthood (Chapter 5, FIGURE 5.3). In controls, the size of
adipocyte decreases from nearly 1700 to 1218 µm2 between puberty and adulthood.
In response to early exposure to oxybenzone, adult adipocytes not only reverse the
direction and grew larger, but they also grew larger by almost twice as much (from
1218 to 2023 µm2 in the 30µg/kg/day group). Moreover, adult females exposed to
3000 µg/kg/day and 212µg/kg/day of oxybenzone in utero and during the perinatal
period had significantly increased body weight at puberty and in adulthood
respectively (Chapter 4, FIGURE 4.1).
The hypothesis that endocrine disrupting chemicals could play a part in
metabolism and namely obesity was proposed by Blumberg & Grün (Grun &
Blumberg, 2006), and they coined the term obesogens for chemicals that promote
obesity in humans and animals. According to the obesogen hypothesis, which was
largely based on the effects of tributyltin, a model obesogen, these chemicals act by
altering adipocytes directly and indirectly in a number of ways including increasing
the number of adipocytes and storage of triglycerides, changing basal metabolism
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and energy balance in favor of storage of calories, and modifying food intake through
effects on other organs (Heindel et al., 2017). Importantly, the obesogen hypothesis
builds on Barker’s theory of the developmental origins of adult diseases, and
therefore emphasizes a ”set point“ or phenotypic plasticity in the fetus. Applied to the
issue of metabolism, fetuses that experience malnutrition in utero are born smaller,
but will be “programmed” to consume excess calories in expectation of scarcity in
later life.
Future research of oxybenzone should evaluate whether or not this chemical
is truly an obesogen. Such studies ought to begin with well-established cell-culture
models screening for elementary signs of metabolic disruption. A recent international
interlaboratory study used the 3R2-L1 pre-adipocyte model that has proven highly
consistent for triglyceride accumulation induced by several EDCs (Kassotis et al.,
2021). Pre-adipocyte cultures are also essential for establishing the storage of
oxybenzone and its release from the adipose tissue, as well as its effects on
adipocyte differentiation from pre-adipocytes (Kassotis et al., 2021; Sun et al., 2021).
Both cell cultures and animal models would enable evaluating the
mechanisms that may lead to disruption of the adipose tissue in oxybenzone-treated
animals. While my analyses did not detect significant differences in relative mRNA
expression of PPARγ, adiponectin, or fatty acid synthase (FIGURE 5.3), studies
using human bone marrow-derived mesenchymal stem cells demonstrated that both
oxybenzone and its metabolite benzophenone 8 increases the size and number of
lipid droplets in differentiated adipocytes similar to two phthalates (BBP and DEHP),
and tributyltin; this study also determined that oxybenzone significantly increased the
mRNA levels of PPARγ (but not PPARα and PPARβ, adiponectin or fatty acid
binding protein 4) while directly binding PPARγ (Shin et al., 2020).
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Based on this prior study and our evaluations in mice, oxybenzone is a
suspected metabolism disrupting chemical. While there is a genetic component to
obesity (Fawcett & Barroso, 2010), FIGURE 10.1. summarizes also the nonMendelian aspect of obesogenesis and the potential roles of oxybenzone in
pathogenic features such as adipocyte differentiation, proliferation and apoptosis,

Figure 10.1: Hallmarks of obesogenesis for oxybenzone.

and disruption of obesity and other metabolism related hormones [e.g., the balance
between insulin and glucagon or leptin, as demonstrated for BPA (Angle et al.,
2013)]. In humans, parental obesity begets offspring obesity via persistent lifestyle
habits (Gray, Hernandez Alava, Kelly, & Campbell, 2018) but emerging hypotheses
also point to possible epigenetic transgenerational inheritance of obesity due to
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maternal diet and possibly also due to exposures to environmental contaminants
(Chamorro-Garcia et al., 2013; Lillycrop, 2011). Additional studies are also needed
to investigate whether adipose tissue has ”windows of sensitivity“ to oxybenzone and
other metabolism disrupting chemicals, and if, so how long these windows last as
well as the span between an exposure and effect. The in utero ”set point“ seems the
most likely window of vulnerability, however as Heindel & Blumberg emphasize,
these windows may differ by chemical (Heindel & Blumberg, 2019).

Oxybenzone – a mammary carcinogen?
Several studies over the past decade have indicated oxybenzone’s potential
to co-induce tumorigenic conditions in the mammary gland. Increased proliferation in
the post-involuting epithelium and increased volume fraction of the epithelial
compartment, along with an increased ratio of ERα positive cells, and DNA damage
as well as R-loop formation suggest oxybenzone-induced disruptions to the
mammary epithelium consistent with risk factors for mammary cancer. Furthermore,
the increased angiogenesis and altered number of macrophages in the mammary
tumors we observed in oxybenzone-treated animals, combined with increased
motility of breast cancer cells in in vitro models, are suggestive of a worse tumor
prognosis in oxybenzone-exposed individuals. Smith et al. proposed ten key
characteristics of human carcinogens, some of which are overlapping with the up-todate findings about oxybenzone [FIGURE 10.2] (Smith et al., 2020). Like the key
characteristics of endocrine disrupting chemicals, the goal is not to “check all the
boxes” to determine if a chemical meets the criteria for a carcinogen. Rather, strong
evidence for even one of those key characteristics is sufficient to determine that a
chemical is a carcinogen (or an endocrine disruptor). The case for oxybenzone in
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carcinogenesis could be made stronger by further investigating the important
emerging hallmarks of cancer including oxidative stress and tumor-associated
inflammation, and epigenetic markers of tumorigenesis (Hanahan & Weinberg,
2011). Oxidative stress exemplifies the interconnectivity of the individual hallmarks.
Tissue oxidative stress may lead to damage to the DNA, as well as chronic
inflammation, increased proliferation and evasion of apoptosis, and angiogenesis
(Hayes, Dinkova-Kostova, & Tew, 2020). Epigenetic changes by estrogens and ER
agonists include binding to the EREs of the HOX antisense intergenic RNA
(HOTAIR) promoters and thereby silencing genes in normal cell development (Bhan
et al., 2014; Mozdarani, Ezzatizadeh, & Rahbar Parvaneh, 2020).

Figure 10.2: Hallmarks of Carcinogenesis of Oxybenzone in the Mammary Gland.
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In addition to additional studies evaluating these key characteristics of
carcinogens, a stronger case for oxybenzone in the process of carcinogenesis would
include studies utilizing other models of tumor induction. In Chapter 8, we propose
that future studies might utilize mammary carcinogens such as DMBA or NMU,
which could be titered to allow evaluations of whether oxybenzone enhances or
prevent tumor development at different stages of development. Other ongoing
studies in the Schneider lab are evaluating how oxybenzone alters features of
metastasis in a mouse model. Collectively, these studies will shed greater light on
the role of different cell types (including immune cells) in the response of the
mammary gland to oxybenzone.

Oxybenzone – Acting at the intersection of adipose and mammary cancer
Finally, two studies have been published recently that create a link between
the two features discussed above: adipose tissue and carcinogenesis. Bokobza et
al. considered the adipose tissue a source of chronic exposure to EDCs that can be
dissolved, and thus stored, in the fat. Oxybenzone has a partition coefficient (logK ow)
of 3.45, therefore it is moderately distributed to the body lipids. Obesogenic EDCs
capable of accumulating in the fat often create a vicious cycle: while inducing
lipogenesis, they also accumulate in the fat and their chronic stimulation of
adipocytes releases obesogenic cytokines that further stimulate adipocyte
differentiation and triglyceride accumulation that further accumulate obesogenic
EDCs such as PFOA or TBT (Bokobza et al., 2021). While oxybenzone has been
detected in various bodily samples including the breast tissue, additional evidence is
needed to determine the extent that it is stored in body fat.
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The second manuscript revealed the results of a dietary experiment
combined with an exposure to oxybenzone in the mouse model. It showed that a
low-fat diet may provide a degree of protection against mammary tumors in the
presence of oxybenzone. On the contrary, even short-term exposure to a high-fat
diet during puberty allows oxybenzone to alter some of the key tumor characteristics
including tumor latency and tumor type (Kariagina et al., 2020). These findings open
up some concerning aspects of the effects of high-fat diet and obesity, both of which
have been on the rise worldwide.

Beyond scientific issues
Oxybenzone, like other environmental chemicals and many endocrine
disruptors, has implications that reach beyond research to quantify levels of
exposures and their effects. As a compund produced in volumes up to 500,000
lbs/year in the U.S. alone (U.S.EPA, 2017), with data suggesting that much of its
production has been shifted overseas, oxybenzone is an important chemical in the
marketplace. Four industries use the majority of the oxybenzone that is produced
annually: the paint industry, floor and wall covering manufacturers, producers of
rubber and plastic products, and the industry for perfumes, personal care products
and toiletries (SPIN, 2021). The large magnitude of oxybenzone production implies
that an a posteriori characterization of its hazards, and assessment of its exposures
and the possible risks that the chemical may pose to the human health and
environment is needed; it is already too late for a truly public health protective action,
considering its widespread use, its contamination of the environment, and its
detection in human bodies.
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Effects of oxybenzone in traditional toxicity tests elicit decision-making and
risk-management decisions issued by respective regulatory state, national or
supranational agencies including the U.S. EPA, the U.S. FDA, or the European
Commission in the U.S. and EU, respectively. Therefore, apart from being a
scientific issue, endocrine disrupting chemicals and their regulation are a political
issue. The large magnitude of oxybenzone production also naturally invites the
attention of manufacturers of oxybenzone-based products to contribute to political
and scientific perspectives. Chemical manufacturing industries perform their own
research and create ties to decision-makers in both the regulatory and scientific
tiers.
For cosmetics containing oxybenzone, manufacturers in the U.S. rely on the
Personal Care Products Council (PCPC) to “cultivat[e] a strong working relationship
on behalf of the industry with […..] National Academies” and to “engage with FDA
regarding the implementation of [over-the-counter] drug reform” as “PCPC created
technical teams for work streams dedicated to supporting eight key sunscreen
ingredients” (PCPC, 2021). While theoretically, the regulatory process is open to
commentaries and suggestions from all stakeholders, both historically and practically
industry’s active involvement in the regulatory process represents a conflict of
interest. As an example, the petroleum industry exists “to explore for, find, develop,
and sell petroleum resources, and by doing so to make a profit and return value to
shareholders” [p.65 (Oreskes, 2019)]. Industries have developed a large number of
strategies to conceal these types of conflicts of interest; industries use these tactics
extensively (Goldberg & Vandenberg, 2021; Michaels, 2020). One of the latest
efforts regarding oxybenzone has been publication of a collaborative paper “critically
re-analyzing” the hazard data on oxybenzone while reaching conclusions that
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downplay the earlier concerns (Mitchelmore, Burns, Conway, Heyes, & Davies,
2021).
Lastly, oxybenzone and UV protection of the skin is a medical issue in the
most complex sense. Medical practitioners are rarely versed in environmental
aspects of health beyond the patient’s lifestyle choices and occupational risks. As we
argue throughout this dissertation, oxybenzone exposure influences multiple aspects
of health, including the larger environment of an individual. Therefore,
communicating the risks and benefits of various types of skin protection must
become a routine practice for medical professionals.
In conclusion, the case of oxybenzone reflects on multiple aspects of human
relationships towards their individual choices and the larger environment, on values
prevailing in communities, and on regulatory decision-making when facing complex
range of variables. Our research has contributed with a small yet not insignificant
share to the enormous mosaic of research on endocrine disrupting chemicals, the
mammary gland, and environmental health.
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